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Understanding how the genetic risk factor Disrupted-in-schizophrenia 1 contributes to 
neuropsychiatric disorders will help direct therapeutic efforts. Disc1 functions in neurogenesis and 
neuronal migration. Defects in early neurodevelopment are thought to be a contributing factor in 
neuropsychiatric disorders. Our group previously demonstrated that ENU-generated disc1Y472X/Y472X 
mutants have alterations in hypothalamic development from 2 days post fertilisation. Critically, 
behaviours relating to the hypothalamic-pituitary-interrenal (HPI) axis such as stress responses were 
also perturbed in larvae and adult.  
Here, we generated a novel disc1exon6/exon6 CRISPR knockout line with a frameshift mutation closer to 
the human translocation breakpoint. Following mutant validation, we characterised previously 
identified hypothalamic markers and found altered expression of retinal homeobox 3 and 
steroidogenic factor 1 (sf-1/ff1b). In addition, we identified increased expression of oxytocin in the 
developing hypothalamus. Behaviourally, a decrease in feeding and hunting behaviour was observed 
in both disc1Y472X/Y472X and CRISPR-generated disc1exon6/exon6 mutant larvae. Sleep regulation was altered 
in disc1Y472X/Y472X only. Conversely, only disc1exon6/exon6 mutants had maladaptive responses to acoustic 
and light stimuli as larvae, and to a novel environment as adults. These behaviours are associated with 
hypothalamic function and relevant to neuropsychiatric comorbidities such as eating disorders, 
insomnia, and anxiety.  
Using immunostaining for phosphorylated ERK as a measure of neuronal activity, we noted that loss 
of disc1 led to significant increases and decreases in neuronal activity in different neuronal 
populations in 7 dpf larvae. Regions of interest (ROIs) with increased activity included the forebrain 
and cerebellum, while ROIs with decreased activity included hypothalamic and connected regions. 
Finally, GSK-3β inhibition during a critical time window normalised ff1b expression in disc1Y472X/Y472X 
mutant embryos, with later effects on neuronal activity and feeding behaviour at larval stages. This 
study demonstrates the validity of zebrafish in neuropsychiatric disease research and characterises 
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Chapter 1: General Introduction 
1.1 Background  
1.1.1 Neurodevelopmental basis of neuropsychiatric disorders 
Neuropsychiatric disorders are common among the general population and include schizophrenia, 
bipolar disorder, and major depression. After many centuries of research, disease aetiology still 
remains unknown; however, increasing evidence points toward abnormal brain development as a key 
feature (Fatemi and Folsom, 2009; Insel, 2010). Schizophrenia affects 1% of the population and 
symptoms can be classified into positive (visual and auditory hallucinations, catatonia, paranoia), 
negative (withdrawal, anhedonia, depression, lack of motivation) and cognitive (memory, learning, 
processing) (Altschul, 1988). Even though these disorders are late onset, in the sense that behavioural 
symptoms only arise during early adulthood, it is common for cognitive symptoms to emerge during 
prodromal stages (childhood, late adolescence), prior to disease onset (Conroy et al., 2018). For 
example, a reduced intelligence quotient (IQ), slower motor development and social withdrawal/ play 
were reported in children who eventually developed schizophrenia (Khandaker et al., 2011; Welham 
et al., 2009).  
Abnormalities in brain development could occur as early as the first trimester in utero and impinge on 
neurogenesis and neural circuitry formation (Fatemi and Folsom, 2009). There is also a high 
prevalence of minor facial abnormalities in patients with schizophrenia (Scutt et al., 2001), which could 
also indicate disturbances as early as gastrulation or during neural crest migration: contributing 
processes towards bone and cartilage morphogenesis (Drerup et al., 2009). In adults with 
schizophrenia, neuroanatomical differences become more pronounced and include enlarged lateral 
ventricles, prefrontal cortex and hippocampal atrophy, and white matter abnormalities (Buckley, 
2005; Weinberger et al., 1979). 
1.1.2 Environmental and genetic interplay 
Neuropsychiatric disorders are idiopathic and hypothesised to arise via a multitude of pathways which 
converge towards similar symptoms (described above). Their underlying biological causes remain 
unknown, however a combination of interacting genetic and environmental risk factors is thought to 
be important. The need to identify highly heritable components that separately or in combination are 
causative of disease has been addressed using genome wide association studies (GWAS). GWAS 
provide supportive evidence towards a polygenetic and multifactorial model of inheritance (Ripke et 
al., 2014). Genetic overlap between schizophrenia, depression and bipolar disease is highlighted by 
common variants identified in patients with these different mental illnesses. Another 
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neurodevelopmental disorder which shares common variants with the aforementioned diseases is 
autism spectrum disorder (ASD) (Kilpinen et al., 2008), again reinforcing the neurodevelopmental 
hypothesis of neuropsychiatric disorders. There is also a strong environmental component. Certain 
experiences appear to increase the susceptibility of developing schizophrenia (e.g. cannabis use, 
exposure to urban living, developmental trauma). This reflects the multi-hit hypothesis where a single 
or multiple mutations would predispose carriers by causing minor disruptions in neurodevelopment 
which could increase an individuals’ vulnerability to environmental risk factors (Davis et al., 2016).  
1.1.3 Heightened susceptibility during critical time windows  
Critical time windows are delineated by heightened susceptibility to risk factors that, at any other 
stage of development, would be considered harmless. Rapid brain growth and neuroplasticity in the 
first two years after embryonic fertilisation is considered a critical time window in humans. 
Neuroplasticity is the ability of the central nervous system (CNS) to change throughout life and is 
required for synaptic pruning, memory formation and storage (Hensch, 2005; Selevan et al., 2000). 
Maternal viral infection during the second trimester of gestation can lead to severe immune activation 
and can significantly increase the incidence of major affective disorders (Machon et al., 1997). Slightly 
later in development, childhood trauma and social isolation were identified as other developmental 
risk factors associated with schizophrenia and depression (Heim et al., 2008; Howes et al., 2017). 
Finally, another critical time window being increasingly studied is adolescence (Patton et al., 2018). 
These studies postulate that early insults followed by quiescent periods result in an increase in 
incidence of neuropsychiatric disorders in early adulthood and that time, rather than level of 
exposure, would be the largest determinant of vulnerability (Lewis and Levitt, 2002; Schloesser et al., 
2007). 
1.1.4 Conservation throughout vertebrates 
To understand disease mechanisms, researchers turn to model organisms to investigate alterations in 
neural circuits, molecular pathways and associated behaviours caused by disease-associated 
mutations and environmental factors. The zebrafish is an attractive model organism as it offers a 
unique compromise between reduced complexity (only 105 neurons) and conserved neuroanatomy/ 
neurotransmitter systems. Although teleosts lack a cerebral cortex, there is a high degree of 
conservation in subcortical areas, that, incidentally, are heavily implicated in neuropsychiatric 
disorders (Geng and Peterson, 2019). Moreover, the pallium contains homologues for the mammalian 
amygdala (dorsomedial pallium) and hippocampus (ventral dorsolateral pallium) which are known to 
be affected in these disorders. Another region of interest (ROI) is the hypothalamus, which makes up 
a significant part of the larval zebrafish brain and is highly conserved throughout evolution. The 
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neurosecretory preoptic area (PO), equivalent to the paraventricular nucleus (PVN)/ supra-optic 
nucleus (SON) in mammals, also expresses oxytocin (oxt), arginine vasopressin (avp), orthopedia (otp) 
and corticotrophin-releasing factor (crf) neurons. The arcuate nucleus, as well as its cellular markers 
proopiomelanocortin (pomc) and agouti-related protein (agrp), is also conserved in the zebrafish 
hypothalamus. However it should be noted that some regions present in the zebrafish hypothalamus, 
such as the caudal periventricular hypothalamus, do not have a mammalian counterpart (Biran et al., 
2015).  
The ease of genetic manipulation combined with the rapidity of development of optically transparent 
zebrafish embryos allows for real time in vivo visualisation of neurodevelopment and make this model 
ideal for investigating the genetic basis of neurodevelopmental disorders.  Furthermore, molecular 
and cellular changes can be correlated with quantifiable behavioural phenotypes in zebrafish larvae 
and adults. Indeed, larvae display locomotive behaviour and respond to their environment as early as 
5 days post fertilisation (dpf). While zebrafish behaviours were initially viewed as simplistic and mainly 
driven by instinct, more recent studies have revealed the behavioural complexities of this model and 
how their behaviour is regulated by aversive learning, anxiety and emotionality (Jesuthasan, 2012; 
Speedie and Gerlai, 2008; Stewart et al., 2011). 
1.1.5 Zebrafish models of neuropsychiatric disorders  
Different genetic zebrafish models of neuropsychiatric disorders have been characterised. Morpholino 
(MO) antisense oligonucleotides targeting two risk genes, disrupted-in-schizophrenia 1 (disc1) and 
neuregulin 1 (nrg1), caused altered development of oligodendrocytes due to reduced numbers of  
oligodendrocyte transcription factor (olig2)-expressing precursor cells  (Wood et al., 2009). Another 
study found that nrg1 knockdown impairs mitosis in both the subventricular zone (SVZ) and the 
ventricular zone (VZ) (Sato et al., 2015). The latter gene is also linked to myocardial development, and 
in zebrafish may not be a valid model of schizophrenia as CRISPR-generated nrg1 homozygote mutants 
only survived until juvenile stages. They also had reduced cardiomyocyte cell numbers and a 
dysregulated heartbeat due to inadequate innervation (Brown et al., 2018). Similarly, Nrg1 knockout 
mutant mice have cardiac defects leading to early embryonic lethality (Gassmann et al., 1995). 
Although, Nrg1+/- heterozygote mutants do display multiple schizophrenia-related features (Karl et al., 
2007; O'Tuathaigh et al., 2008; Stefansson et al., 2002). 
ENU (N-ethyl-N-nitrosourea) mutagenesis has been used in TILLING (Targeting Induced Local Lesions 
in Genomes) screens to induce and identify point mutations in protein-coding regions. Two disc1 ENU 
mutants were identified with two different nonsense mutations in exon 2: disc1fh291 and disc1fh292 
(Draper et al., 2004), renamed disc1L115X and disc1Y472X, respectively, referring to the change in amino 
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acid (aa) sequence. disc1Y472X/Y472X homozygous mutants developed strong defects in brain connectivity 
and morphological phenotypes at 24 hours post fertilisation (hpf) (De Rienzo et al., 2011). However, 
after multiple rounds of outcrossing, these observations were not reproducible, suggesting these 
phenotypes were due to additional ENU-induced mutations. For example, our group found only subtle 
developmental abnormalities such as altered hypothalamic progenitors and impaired behavioural and 
endocrine response to stress in larval and adult disc1Y472X/Y472X homozygous mutants (Eachus et al., 
2017). 
 Schizophrenia, depression and other anxiety disorders are associated with impaired social functions 
(Iosifescu, 2012; Schmidt et al., 2011). Recently, a large scale CRISPR-based targeted mutagenesis 
study examined 35 schizophrenia and autism-associated genetic risk factors using an unsupervised 
machine learning assay to classify social interactions in mutant zebrafish (Tang et al., 2020). In 
particular, alpha-1a adrenergic receptor a (adra1aa) -/- and alpha-1a adrenergic receptor b (adra1ab) 
-/- mutants remained in tighter shoals and froze for prolonged periods of time. Notably, polymorphisms 
in the promoter of ADRA1A have been linked to schizophrenia in humans (Clark et al., 2005). A 
mutation in the glucocorticoid receptor (gr), which has been used to model clinical depression, led to 
increased cortisol levels due to aberrant negative feedback in grS357 larvae. Behaviourally, locomotion 
was reduced, habituation was impaired, and the startle response was dysregulated. Importantly, long-
term treatment with the antidepressant fluoxetine was able to rescue some of the defects (Ziv et al., 
2013).  
Chemically induced zebrafish models can be used to replicate neuropsychiatric endophenotypes 
(Gottesman and Gould, 2003) and are a powerful tool in this field of research. Acute treatment with 
the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 elicits phenotypes in zebrafish, such 
as hyperlocomotion, which can be reversed through co-administration of antipsychotics (Seibt et al., 
2010). On the other hand, reserpine treatment (commonly used in rodents to model depression) 
affects the monoamine system and leads to hypolocomotion and a decrease in social interaction/ 
cohesion in zebrafish, representing depressive-like features (Kyzar et al., 2013). Finally, larvae treated 
with subconvulsive concentrations of pentylenetetrazol (PTZ), a GABA antagonist, have been used to 
model endophenotypes related to bipolar disorder (Ellis and Soanes, 2012). The activity of the 
hypothalamic–pituitary–interrenal (HPI) axis, the fish equivalent of the human hypothalamic-
pituitary-adrenal (HPA) axis, was increased, leading to anxiety and stress-related behaviours such as 
an increase in darting and a maladaptive response to changes in illumination.  
Antipsychotic and antidepressant medication can reverse some of the phenotypes described above, 
suggesting that these drugs affect neuronal signalling via highly conserved molecular targets 
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throughout vertebrates. In addition, zebrafish larvae are amenable to non-invasive drug 
administration into the medium that bathes them. Phenotype-based drug discovery is an exciting 
technique that can uncover new therapeutic targets. Indeed, a novel class of antipsychotics named 
‘finazines’ acting on sigma-1 receptor were discovered using high throughput screening in zebrafish 
and retained activity in mammals (Bruni et al., 2016; Rennekamp et al., 2016). Moreover, in zebrafish 
models of ASD, behavioural phenotyping was successful in identifying estrogen receptors as promising 
targets to treat autism (Hoffman et al., 2016).  
1.1.6 Limitations to the use of zebrafish in neuropsychiatric research 
Despite its strengths for studying neurodevelopment and behaviour, there are limitations to using 
Danio rerio as a model to study neuropsychiatric disorders. Firstly, although 70-80% of disease-causing 
genes are conserved in zebrafish (Howe et al., 2013), genome duplication and aa differences in CNS 
receptors could have important pharmacological implications, especially when testing new 
compounds in vivo (Vardy et al., 2015). 
Another genetic difference in zebrafish limits their ability to inbreed. Inbreeding, brother x sister or 
progeny x parent mating, is commonly used in animal research to generate genetically homogenous 
lines, where each progeny is considered a clone. Inbred animal models are used to investigate the 
contribution of exogenous factors (exposure to an event or a compound) towards a specific 
phenotype. Zebrafish, however, tend to show an increased susceptibility of inbreeding depression, 
referring to the reduced viability of progeny after multiple rounds (<13) of inbreeding (Shinya and 
Sakai, 2011). This difference is thought to arise from a lack of chromosomal sex determination in 
teleosts (Bradley et al., 2011), and therefore progeny arising from a single pair-mating event exhibits 
extensive genetic diversity.  
Furthermore, various strains of zebrafish are used in animal research such as AB, Tüpfel Long-Fin (TL), 
Tübingen (TU), leopard and WIK. Morphological differences such as skin pigmentation, fin size as well 
as genetic differences define these strains. Recent studies have also elucidated several physiological 
and behavioural differences developing from larval stages and persisting into adulthood. In this 
project we had to use two strains of wild-type zebrafish, the TL strain in Sheffield and the AB strain in 
Singapore. It has been previously reported that AB and TL larvae show different motor responses to 
light-induced or dark-induces changes in locomotion (Liu et al., 2015; Gao et al., 2016). Moreover, the 
habituation, baseline HPI activity and shoal cohesion also appear to differ between these two strains 
(Segueret et al., 2016; van de Bos et al., 2017). It is important to take this into account when designing 
high throughput behavioural experiments to investigate neuropsychiatric endophenotypes.  
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  A major component of schizophrenia such as auditory and  visual hallucinations rely on self-reporting 
from patients, which poses a problem in any animal model lacking higher order communication and 
language functions (Russell, 1980). Lastly, zebrafish display nowhere near as many behavioural 
complexities as humans. It is therefore imperative to differentiate between animal “model” and 
“tool”, with the latter more applicable here and still providing key insights into the pathophysiology 
of these disorders (Blaker-Lee et al., 2011). The zebrafish does have key advantages and can 
complement studies from its mammalian counterparts. For example, like humans, zebrafish are 
diurnal (vs. nocturnal mice and rats), indicating parallels between sleep regulation. Moreover, as in 
humans, the main corticosteroid synthesised and released in response to stress is cortisol, as opposed 
to corticosterone in mice and rats (Alsop and Vijayan, 2009).  
1.1.7 Hypothalamic-related changes in neuropsychiatric disorders  
The hypothalamus is an evolutionarily ancient part of the brain and a key regulator of whole-body 
energy homeostasis. Situated in the ventral forebrain and extending rostrally, the highly 
interconnected hypothalamic nuclei integrate multiple sensory inputs and coordinate different 
neuroendocrine outputs. Their primary role is to modulate sleep, appetite, and the stress response 
(see sections 4.1 and 6.1, for detailed introduction). Defects in the hypothalamus have been suggested 
to contribute to disease mechanisms underlying neuropsychiatric disorders and ASD. In patients with 
schizophrenia, bipolar and unipolar disorder, the volume of the hypothalamus (particularly the PVN 
and SON) was significantly increased compared to healthy controls and correlated positively with 
anxiety (Goldstein et al., 2007; Schindler et al., 2019). In ASD, grey matter density was found to be 
decreased in the hypothalamus of affected children. These abnormalities were associated with 
changes in the macrostructure, including increased volume of the 3rd ventricle, which lies adjacent to 
the hypothalamus (Wolfe et al., 2015). In addition to volumetric changes, changes in hypothalamic 
cell types have been reported in numerous human studies. For example, increases in the number of 
CRF+, AVP+ and OXT+ neurons were reported in the PVN of patients with major depression and bipolar 
disorder (Bao et al., 2005; Purba et al., 1996; Raadsheer et al., 1994). Functional magnetic resonance 
imaging (fMRI) studies have enabled the visualisation of brain activity in these patients. Abnormal 
hypothalamic activation to aversive images was reported in bipolar patients (Malhi et al., 2004) and 
functional connectivity scores between the hypothalamus and other subcortical areas were reduced 
in patients with major depression (Liu et al., 2018; Wang et al., 2019). In the MK-801 induced mouse 
model of schizophrenia, neuronal activation in the hypothalamus was also significantly reduced (Zuo 
et al., 2009). In another model previously mentioned, Nrg1+/- mice, neurons in the PVN appeared to 
be hypersensitive to cannabinoid exposure (Boucher et al., 2007). These results suggest that the 
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pathophysiology of neuropsychiatric disorders is tightly associated with aberrant hypothalamic 
patterning and function.  
In response to stress, the PVN of the hypothalamus releases CRF, acting on the pituitary and leading 
to release of adrenocorticotropic hormone (ACTH) into the vasculature. This triggers the synthesis and 
release of cortisol from the adrenal cortex, which can be used as a readout of stress. Cortisol provides 
negative feedback to the hypothalamus via multiple brain regions also linked to neuropsychiatric 
disorders such as the prefrontal cortex, amygdala, and hippocampus. There is ample evidence 
suggesting HPA axis hyperactivity in major depression. Indeed, hypersecretion of ACTH and cortisol 
have been reported, as well as altered peripheral levels of CRF in patients with depression (Drevets et 
al., 2008; Holsboer, 2000; Swaab et al., 2005). Impaired negative feedback signalling from 
glucocorticoid receptors (GR) is hypothesised to contribute to this hypersecretion (Pariante and Miller, 
2001). Medication-naïve patients with first episode psychosis exhibited a blunted cortisol release 
when acutely stressed (van Venrooij et al., 2012). Furthermore, repeated stressful experiences are 
often referred to as “triggers” of these disorders. Chronic corticosterone (CORT) injections induced 
depressive-like behaviours in male rats (Gregus et al., 2005). Conversely, Nrg1+/- mice injected with 
CORT to mimic HPA activation were hyporesponsive to stress, characterised by blunted 
neuroendocrine and behavioural responses (Chohan et al., 2014). These findings demonstrate that 
HPA axis dysfunction is present in many neuropsychiatric disorders and that chronic activation of the 
HPA axis can trigger depressive-like endophenotypes in mammals. Aberrant HPA axis function 
characterised by either an increase or decrease in activity could therefore cause maladaptive 
responses to stressful situations. 
1.1.8 Disrupted-in-schizophrenia 1 (DISC1)  
Disrupted-in-schizophrenia 1 (DISC1) is a protein-coding gene located on chromosome 1 and possibly 
the most widely studied genetic risk factor in neuropsychiatry. The balanced translocation of t (1;11) 
(q42.1; q14.3) was initially characterised in a Scottish pedigree with a high incidence of diagnosed 
schizophrenia, bipolar disorder and major depression (Millar et al., 2000). Linkage and association 
studies also uncovered DISC1 single nucleotide polymorphisms (SNPs) in disease groups from Japan, 
Taiwan and Finland (Chubb et al., 2008; Ekelund et al., 2004; Hashimoto et al., 2006; Liu et al., 2006b). 
Another DISC1 mutation, a 4 base pair (bp) frameshift mutation in exon 12, co-segregated with 
schizophrenia in a small North American pedigree (Sachs et al., 2005). The causality of this particular 
mutation was debated as concerns regarding the sample size were raised (Green et al., 2006). In 
addition, following the most recent neuropsychiatric GWAS, DISC1 was not identified in the list of 108 
susceptibility loci associated with schizophrenia (Ripke et al., 2014). Controversy in the field emerged, 
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with some researchers proposing to stop investigating this gene altogether (Sullivan, 2013). Others 
acknowledged its lack of involvement in schizophrenia per se, instead linking it to schizoaffective and 
depressive disorders (Porteous et al., 2014). Importantly, GWAS only identified relatively common 
variants from genetically heterogeneous disorders. Thus, high risk alleles present at low frequencies 
in the general population, such as the DISC1 translocation, are excluded. However, DISC1 mutations 
are highly penetrant and have a strong biological impact in neuropsychiatric disorders (Blackwood et 
al., 2001) and they remain one of the highest single linkage risk factors associated with schizophrenia, 
bipolar disorder and major depression to date.  
DISC1 is expressed in the brain during early development, and expression analysis in carriers suggested 
a 50% reduction in DISC1 mRNA and DISC1 protein levels in translocation carriers (Millar et al., 2005). 
Additionally, there was a complete loss of DISC1 protein in neurons derived from induced pluripotent 
stem cells (iPSCs) with biallelic frameshift mutations in DISC1 leading to a premature stop codon (PTC) 
exon 8 (Srikanth et al., 2015). Therefore, the mechanism of action in the Scottish pedigree is likely to 
be haploinsufficiency. However, other groups reported that the putative truncated form of DISC1 
forms a dimer with wild type DISC1 providing evidence for a dominant negative (DN) mechanism of 
action (Kamiya et al., 2005; Pletnikov et al., 2007). Another study reported that DISC1 can 
homodimerise, pointing to protein mis-assembly and the formation of toxic aggregates (Atkin et al., 
2012), common to many CNS disorders. Therefore, the exact mechanism by which mutations in DISC1 
increase the risk of developing neuropsychiatric disorders still remains unknown; although it seems 
likely that different variants could function through different mechanisms.  
1.1.9 Phenotypes in Disc1 rodent models 
Multiple strains of transgenic and/ or mutant Disc1 rodent models have been generated to study the 
role of DISC1.  Multiple phenotypes relating to the clinical symptoms of depression and schizophrenia 
have emerged from these studies, although there are discrepancies. Depressive-like endophenotypes 
such as reduced sociability and reward responsiveness were identified in the missense Disc1Q31L 
mutants, whereas missense Disc1L100P mutants recapitulated more schizophrenia-like 
endophenotypes such as deficits in sensorimotor gating and information processing (Clapcote et al., 
2007).  Sensorimotor gating was also abnormal in a transgenic mice expressing dominant-negative 
truncated DISC1 (DN-DISC1) under the αCaMKII promoter (Hikida et al., 2007); however, this was not 
the case in transgenic mice with inducible expression of a mutant form of human DISC1 lacking the C-
terminus (hDISC1-ΔC) limited to the cerebral cortex, hippocampus and striatum (Pletnikov et al., 
2008). Conflicting results were also reported when examining sociability of Disc1 mutants. Some 
groups observed reduced social interactions in Disc1 mutant mice (Clapcote et al., 2007; Li et al., 2007; 
9 
 
Pletnikov et al., 2008), whereas other groups reported no difference (Hikida et al., 2007). These 
differences in behavioural phenotypes could differ based on the location of disruption or perhaps the 
different methods used to generate the mouse lines.   
 
In addition to behavioural features, pathological analysis of Disc1 mutants revealed the presence of 
morphological features related to schizophrenia. For example, the volume of the lateral ventricles is 
significantly increased in Disc1 mutants compared to wild type littermates (Hikida et al., 2007; 
Pletnikov et al., 2008; Shen et al., 2008). Furthermore, a reduction in total brain volume was reported 
in both Disc1Q31L and Disc1L100P mutants (Clapcote et al., 2007). A reduction in immunoreactivity for 
parvalbumin, another hallmark of schizophrenia, was demonstrated in the medial prefrontal cortex 
and hippocampus (Hamburg et al., 2016; Hikida et al., 2007; Shen et al., 2008). Finally, synaptic spines 
and dendritic complexity were significantly reduced in the hippocampus of DN-Disc1 mice  (Kvajo et 
al., 2008; Li et al., 2007), consistent with working memory deficits in this disorder.  
1.1.10 Vertebrate conservation 
The mammalian DISC1 gene is located on chromosome 1 and is made up of 13 exons. The full length 
protein contains 854 aa. There are over 23 different reported transcripts in humans. In zebrafish, the 
disc1 gene is located on linkage group 13, contains 998 aa and 4 different isoforms have been 
annotated. The DISC1 protein does not share overall homology with any other known protein and its 
tertiary structures are speculative due to the absence of any solved crystal structure. Proteomic 
studies have identified a highly conserved C-terminus containing α-helical coiled-coils, thought to be 
important in protein-protein interactions, suggesting its evolutionarily conserved role as a scaffold 
protein (Soares et al., 2011). The globular N-terminus is not well conserved with the exception of a 
string of 15 aa: the arginine rich motif (ARM). This motif is thought to play a crucial role in mRNA 
transport (Tsuboi et al., 2015).  
1.1.11 Cellular and molecular role of DISC1  
Numerous functions have been suggested for DISC1, including roles in neurogenesis, axon guidance, 
neuronal migration and synapse function. The DISC1 protein has no endogenous enzymatic activity, 
however it interacts with a myriad of binding partners (Camargo et al., 2007; Morris et al., 2003). The 
protein is reported to localise to the nucleus, cilia, centrosome, mitochondria, growth cone, synapse 
and dendrites (James et al., 2004; Miyoshi et al., 2003). The diverse subcellular distribution and 
interactome is indicative of its diverse roles in neurodevelopmental processes, such as progenitor 
proliferation, neuronal migration and differentiation (Chandran et al., 2014; Hennah et al., 2006; Mao 
et al., 2009). Some of DISC1’s direct and indirect interactome consists of other proteins classed as risk 
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factors for psychiatric disorders such as NDEL1, PDE4 and NRG1 (Li et al., 2007; Seshadri et al., 2015), 
suggesting that DISC1 could act as a hub in common pathways underlying mental illness (Chubb et al., 
2008).   
1.1.12 Roles in neurodevelopment 
Since its initial discovery, DISC1 has been found to regulate a number of key neurodevelopmental 
processes.  High levels of Disc1 expression are observed during embryonic development and decrease 
postnatally (Nakata et al., 2009). DISC1 plays a key role in neural progenitor cell (NPC) proliferation 
and the formation of new neurons (neurogenesis). During early development, neurons arise from 
multipotent cells found in the neuroectoderm. They go through rounds of proliferation and 
differentiate at particular timepoints by synchronously responding to external and internal cues. Most 
developing neurons undergo neural migration guided by molecular cue recognition (Chubb et al., 
2008). Dynamic changes in gene expression occur to orchestrate these processes. As transcriptional 
changes slow, committed cells give rise to different mature cell types, each with a unique molecular 
fingerprint. During this period, the CNS is sensitive to both internal and external stimuli (Holmes et al., 
2005). 
 
Disc1 knockdown in embryonic mice led to premature differentiation of neurons in both primary 
neuronal culture and the cerebral cortex, depleting the number of neural progenitors (Ishizuka et al., 
2011; Mao et al., 2009). At a molecular level, DISC1 is thought to modulate cell proliferation via 
Glycogen Synthase Kinase 3β (GSK-3β) inhibition (see section 7.1, for detailed introduction). Loss of 
DISC1 reduced proliferation and migration in mouse NPCs. There was an increase in the proportion of 
cells in G0/G1 indicating cell cycle progression was stalled (Wu et al., 2017b). Disc1 transgenic mice 
expressing two copies of truncated Disc1 (exon 1-8) had reduced neural proliferation visualised by 
decreased BrdU labelling (Shen et al., 2008). At 24 hpf, the expression of phosphorylated histone H3 
(phosH3), an M-phase marker, was increased in disc1Y472X zebrafish mutants; however at 3 dpf, phosH3 
expression decreased compared to controls, suggesting that disc1 is also required to maintain NPCs 
during early zebrafish development (Eachus et al., 2017). Expression of retinal homeobox 3 (rx3), a 
marker for hypothalamic progenitors, was also decreased at 3 dpf in these mutants, and a concurrent 
increase in steroidogenic factor 1 (sf-1/ ff1b) + cells which differentiate from this lineage was also 
noted, further supporting the role of disc1 in cell fate determination. DISC1 expression persists into 
adulthood but becomes restricted to specific neural stem cell (NSC) niches such as the olfactory bulb, 
dentate gyrus and hypothalamus (Austin et al., 2003; James et al., 2004; Lipska et al., 2006; Schurov 
et al., 2004). Progenitor populations also persist into adulthood, playing a critical role in 
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neuroplasticity, and loss of Disc1 can also reduce levels of adult neurogenesis (Faulkner et al., 2008; 
Kim et al., 2012; Mao et al., 2009; Ye et al., 2017).  
 
DISC1 associates with microtubule-interacting proteins such as MIPT3 (Morris et al., 2003) and 
centrosome-associated ones such as NDEL1 (Shu et al., 2004). Overexpression of DISC1 in C.elegans 
motor neurons caused axonal guidance defects (Chen et al., 2011). Silencing of Disc1 by RNAi in 
cortical pyramidal neurons of embryonic mice inhibited neuronal migration by a failure to anchor 
dynein and dynactin to the centrioles (Kamiya et al., 2005). Further, disc1 knockdown also affected 
the migration and differentiation of cranial neural crest cells in zebrafish embryos through 
transcriptional repression of foxd3 and sox10 (Drerup et al., 2009). Therefore, DISC1 plays a role in 
neurodevelopment through both neural proliferation and neuronal migration.  
 
As previously proposed (see section 1.1.3), the neurodevelopmental effects from loss of DISC1 could 
have adverse consequences on neural circuitry and cause behavioural hallmarks of neuropsychiatric 
disorders. Indeed, behavioural characterisation of mouse models with neurodevelopmental 
abnormalities also revealed anxiety-related and schizoaffective endophenotypes (Clapcote et al., 
2007; Mao et al., 2009). Furthermore, neurobehavioural effects of DISC1 disruption are time 
dependent. Transient expression of the C-terminal portion of DISC1 at postnatal day (P) 7 resulted in 
deficits in spatial working memory, depressive-like traits, and reduced sociability. Strikingly, there 
were no acute effects when expression was induced in adults (Li et al., 2007). Another study used the 
inducible expression of mutant human DISC1 (hDISC1) (Pletnikov et al., 2008) to investigate the effect 
of transient early prenatal or postnatal mutant hDISC1 expression (Ayhan et al., 2011). Selective early 
prenatal expression led to minor effects on behaviour. Depression-like behaviour was present in 
female mice with selective postnatal expression, while aggression was only detected in male mice 
expressing mutant hDISC1 throughout their life.  
As well as the effect of varying Disc1 expression, environmental stressors interact with DISC1 and have 
implications for later behaviours. For example, in gene-environment (GxE) studies, Disc1 mutant mice 
were exposed to prenatal polyinosinic: polycytidylic acid (Poly I:C) infection to induce a cytokine 
response prenatally. At adult stages, the GxE mice exhibited exacerbated deficits in sociability, anxiety 
and depressive-like traits compared to Disc1 mice with no immune activation (Abazyan et al., 2010; 
Ibi et al., 2010).  Other studies evaluated the effect of psychosocial stress on different Disc1 mutant 
mice. Chronic social defeat administered to heterozygote Disc1Q31L and Disc1L100P mice exacerbated a 
number of behavioural phenotypes previously observed in homozygous Disc1Q31L and Disc1L100P mice 
(Hague et al., 2012). Another form of stress: isolation stress (IS) was administered during another 
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critical time window, in adolescence. DN-Disc1 mice exposed to stress (GxE) displayed hyperactivity in 
the open field and anxiety-related behaviours compared to controls (DN-Disc1 only or IS only). This 
was linked to hyper-responsiveness of the HPA with a failure to return corticosterone to baseline levels 
(Niwa et al., 2013). Similar studies have also been performed in zebrafish. Acute exposure to stress 
induced behavioural responses and increased plasma cortisol in wild type zebrafish larvae, while these 
responses were absent in in disc1Y472X and disc1L115X zebrafish larvae. This suggests that functioning of 
the HPI axis is impaired in disc1 mutants (Eachus et al., 2017). These results suggest that the 
mechanisms through which Disc1 contributes to affective disorders also involves environmental 
interactions and could explain the incomplete penetrance and variety of clinical diagnoses in 
translocation carriers from the Scottish pedigree (Millar et al., 2000).   
1.2 Hypothesis  
In light of the background information aforementioned, we hypothesised that loss of DISC1 confers 
vulnerability to neuropsychiatric disorders due to deficits in early neurodevelopment. Particularly, 
alterations in cell proliferation and differentiation are affected in a DISC1-dependent spatiotemporal 
manner, according to its expression profile. Given that disc1 is widely expressed in the developing 
brain, we hypothesised that mutations in disc1 lead to brain-wide developmental consequences and 
are not solely localised to the periventricular hypothalamic cells identified in a previous study (Eachus 
et al., 2017). Such developmental changes would be expected to have far reaching effects on activity 
of neural circuits and behaviour.  
1.3 Objective and Aims  
The objective of this project was to determine how the variation of a highly penetrant genetic risk 
factor for neuropsychiatric disease, namely Disrupted-in-schizophrenia 1 (DISC1), affects the early 
development of the brain and particularly the hypothalamus.  This will contribute to elucidating why 
there is an increased susceptibility of developing schizophrenia, bipolar and major depressive 
disorders in populations with mutation or SNPs in DISC1. It will therefore expand knowledge about 
mechanisms and the pathophysiology of neuropsychiatric disorders.  
The primary aim of this project was to characterise phenotypes in disc1 mutant larvae and adults. 
Initial findings from our group suggested that neuroendocrine function was compromised in disc1Y472X 
and disc1L115X mutants from 5 dpf, as a result of mispatterning of the rx3+, ff1b+ hypothalamic cells 
populations observed at 2 dpf (Eachus et al., 2017). We set out to generate another disc1 mutant 
zebrafish model using CRISPR/ Cas9 genetic engineering, to create a loss of function mutation and  
address existing discrepancies around severity of phenotypes in the literature (De Rienzo et al., 2011; 
Eachus et al., 2017; Wood et al., 2009). We specifically targeted exon 6 of disc1, a locus proximal to 
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the human equivalent breakpoint in intron 8 of DISC1. Following validation, we investigated the 
expression rx3, ff1b and pomc in CRISPR-generated disc1exon6 and compared results with ENU-
generated disc1Y472X zebrafish embryos. 
Another aim was to investigate whether altered hypothalamic development in disc1 mutants affected 
key neural circuits and contributed to hypothalamus-associated behavioural hallmarks of 
neuropsychiatric disorders such as arousal, sleep, feeding and anxiety-related behaviours. To uncover 
the magnitude of the role of disc1 in establishment of neural circuitry, we wanted to consider other 
affected brain areas, and avoid focussing on the hypothalamus exclusively.  
A major objective of all disease-modelling studies is to rescue or at least ameliorate deficits induced 
by genetic or environmental insult. As Disc1 is known to bind and inhibit GSK-3β (Mao et al., 2009), 
we planned to use pharmacological inhibition of GSK-3β in disc1Y472X mutant embryos to investigate 
its potential therapeutic effects.  
1.4 Experimental Plan  
We set out to generate the tools necessary for achieving these aims. To generate a disc1 CRISPR/ Cas9 
null zebrafish mutant, we co-injected guide RNA (gRNA) targeting exon 6 and Cas9 mRNA to produce 
double strand breaks (DSB) in the zebrafish genome. We raised the injected F0 generation until 
adulthood and selected the most appropriate allele. We outcrossed the F0 to AB wild types and 
incrossed identical (16 bp deletion) siblings to achieve a stable F2 generation. Progeny from this 
generation was used for further characterisation. We ensured a simple and cheaper method of 
genotyping by restriction digestion analysis rather than by sequencing as in the ENU mutants. 
We repeated some of the characterisation work performed on the disc1Y472X line (Eachus et al., 2017) 
by investigating the hypothalamic/ pituitary expression of rx3, ff1b and pomc using probes and RNA 
in situ hybridisation. This also involved investigating the response to dark/ light flashes in larvae and 
the response to stress in adult zebrafish.  
To investigate if other hypothalamic-associated behaviours were affected, we characterised other 
behavioural parameters. At larval stages, we measured locomotion during pseudo-natural daytime 
and night-time to study sleep behaviours. Next, we measured food intake by fluorescently dying 
Paramecia (zebrafish prey) and measuring gut fluorescence, post-ingestion. We used another 
measure, quantification of prey captures, to assess hunting behaviour. Then, we measured 
locomotion in response to unanticipated acoustic stimuli during the night, using the night-time arousal 
(NTA) test. In adults, we investigated innate fear by quantifying swimming behaviour using the novel 
tank diving (NTD) assay.  
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To determine whether brain activity was affected and avoid biased selection of hypothalamic neuronal 
populations, we used a previously developed method (Randlett et al., 2015) to measure whole brain 
neuronal activity in disc1 mutants and identified aberrant neuronal circuits. Briefly, following rapid 
fixation at larval stages, we performed immunofluorescence against the immediate early gene (IEG): 
phosphorylated extracellular signal-regulated kinase (pERK). This provided information about baseline 
brain activity. We scaled up this experiment, to image 30-40 larval brains per condition and used 
predesigned methodology (Randlett et al., 2015) to create brain activity maps.  These maps were 
normalised and computationally compared to a pre-annotated larval brain atlas 
(stackjoint.com/zbrain). Once neuronal populations with significant differences in brain activity were 
identified, we designed the necessary antisense RNA in situ probes against these hits. RNA in situ 
hybridisation was performed at earlier stages, to assess if deficits arose from a developmental origin.  
Once robust phenotypes were established, we selected a commercially available GSK-3β inhibitor: 
CHIR99021, previously applied between 1-2 dpf in disc1Y472X mutants, and which successfully rescued 
the expression of the hypothalamic marker ff1b (see section 7.2.1). We investigated the long-term 
effects of CHIR99021 on brain activity and larval behaviour in the disc1Y472X line.  
Another unresolved issue in this field is both the tissue distribution and subcellular localisation of 
endogenously expressed DISC1 protein orthologues. To this end, a zebrafish-specific polyclonal 
antibody was synthesised in order to localise zDisc1 expression in wild type zebrafish embryos and 
investigate whether disc1 mutations lead to null knockout mutants. A polypeptide comprising the N-
terminus of the zDisc1 protein, previously expressed and purified from bacterial cells, was sent for 
rabbit immunisation prior to starting the project. Once the serum returned, we purified the zDisc1(N)-
specific antibodies and tested their specificity in both in vitro (western blotting) and in vivo 


















Chapter 2: Materials and Methods 
 
2.1 Buffers and Solutions  
Name  Composition  
E3 Medium  5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4 
PEI 1 mg/ml polyethylenimine (PEI) (Polysciences Inc., #23966) 
Phosphate Buffered Saline 
(PBS)  
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
20X Tris buffered saline (TBS)  400 mM Tris, 2.742 M NaCl, pH 7.6 with HCl 
TBST 1X Tris-buffered saline (TBS), 0.1% Tween 20  
5X Laemmli Buffer 250 mM Tris HCl (pH 6.8), 50% glycerol, 10% sodium dodecyl sulfate (SDS), 
25% β-mercaptoethanol, 0.5% bromophenol blue 
 
RB100 buffer  25 mM HEPES (pH 7.5), 100 mM KOAc, 10 mM MgCl2, 1 mM dithiothreitol 
(DTT), 0.05% Triton X-100, 10% glycerol 
GSH elution buffer 50 mM Tris, 100 mM NaCl, 40 mM reduced Glutathione (pH 7.5) 
Wash buffer  20 mM Hepes-KOH, 150 mM NaCl pH 7.8 
Wash buffer (2) 20 mM Hepes-KOH, 1 M NaCl pH 7.8 
Binding buffer Wash buffer, 0.5% Triton X-100  
Crosslinker  100 mM disuccinimidyl suberate (DSS) in dimethyl sulfoxide (DMSO) 
(37mg/ml) 
Crosslinking solution 12.5% crosslinker, 87.5% wash buffer 
Elution buffer 0.1 M Glycine (pH 2.5) 
Lysis buffer 80 mM K-PIPES (pH 6.8), 1 mM EDTA, 1mM MgCl2, 1% NP40, 150 mM NaCl, 
10 mM NaF, 1 mM Na2VO4, 10 mM β-Glycerophosphate, 5 mM Na4P2O7 
with 1X Halt Protease Inhibitor Cocktail (ThermoScientific)  
Resolving Gel (7.5%)  7.5% acrylamide, 375 mM Tris HCl (pH 8.8), 0.1% SDS, 0.1% ammonium 
persulfate (APS), 0.01% tetramethylethylenediamine (TEMED) 
Stacking Gel (4%)  4% acrylamide, 125 mM Tris HCl (pH 6.8), 1% SDS, 0.06% APS, 0.003% 
TEMED 
Running buffer 25 mM Tris, 192 mM glycine, 0.1% SDS 
Transfer buffer  25mM Tris, 192 mM glycine, 20% methanol 
Blocking buffer (WB) 5% non-fat dry milk in TBST  




Fish fix 0.1 M Sodium phosphate buffer, 12 mM CaCl2, 4% paraformaldehyde (PFA), 
4% sucrose 
Bleaching solution 3% H202, 1% KOH in PBS 
PBT  1X PBS, 0.1% Triton X-100 
PBDT  1X PBS, 2% bovine serum albumin (BSA), 1% DMSO, 0.1% Triton X-100 
Blocking solution (IF)  PBDT + 2% sheep serum 
PTW 1X diethyl pyrocarbonate (DEPC)-treated PBS, 0.1% Tween 20 
Incomplete hybridisation 
solution  




50% formamide, 5X SSC, 0.1% Tween 20, 9.2 mM citric acid, heparin (5 
ng/ml), tRNA (200 ng/ml) 
Blocking solution (in situ)  PTW, 2% sheep serum, 2% BSA 
Staining buffer 0.1 M Tris pH 9.5, 0.5M MgCl2, 1 mM NaCl, 0.1% Tween 20 
Staining solution Staining buffer, nitro-blue tetrazolium chloride (NBT) (4.5 μl/ml), 5-bromo-
4-chloro-3'-indolyphosphate p-toluidine salt (BCIP) (3.5 μl/ml) 
LB agar 10 g/l agar, 10 g/l tryptone, 5 g/l NaCl, 5 g/l yeast extract 
LB broth 10 g/l tryptone, 5 g/l NaCl, 5 g/l yeast extract 
Terrific Broth (TB)  24 g/l yeast extract, 12 g/l casein peptone, potassium phosphate 
(monobasic) 2.2 g/l, potassium phosphate (dibasic) 9.4 g/l, 0.4% glycerol  
Alkaline Lysis buffer 25 mM NaOH, 0.2 mM ethylenediaminetetraacetic acid (EDTA) 
Neutralisation buffer 40 mM Tris-HCl (pH 8) 
Paramecia water  0.3 mg/ml Instant Ocean, pH 7 with NaHCO3 
 
2.2 Ethics Statement 
Animal models were handled following standard practices and guidelines from the UK Home Office 
under the Animals Act (1986) and were approved by the University of Sheffield Ethical Review 
Committee. In Singapore, ethical approval was issued by the Institutional Animal Care and Use 




2.3 Zebrafish Husbandry 
Wild type Danio rerio were maintained in the Zebrafish Core Facility in the Bateson Centre, Sheffield 
(TL) and Institute of Molecular and Cell Biology, Singapore (AB). Adult zebrafish were kept at 28.5°C 
with a light/ dark cycle of 14 hours/10 hours. Both pair-mating and group mating (using the marbling 
method) were used to obtain embryos. Embryos were sorted from unfertilised eggs and left to develop 
in E3 containing methylene blue at 28°C. For larvae used in behavioural assays, embryos were 
transferred to E3 at 24 hpf and placed in an incubator with a light/ dark cycle of 14 hours/10 hours 
and fed once a day with live paramecia from 5 dpf. Tricaine Mesylate (50 mg/ml) was used for 
anaesthesia and euthanasia for fish older than 5 dpf.  
2.4 Bacterial Cultures  
For both LB-antibiotic plates and LB Broth, throughout these methods, final concentrations of 
antibiotics were 100 μg/ml for carbenicillin/ ampicillin, 50 μg/ml for kanamycin. 
 
2.5 Purification of zDisc1 polyclonal antibody serum  
A previously purified zDisc1 (N)-GB1 fusion protein (A. Zarkesh MSc thesis, University of Sheffield, 
2016) was used to raise a new rabbit polyclonal antibody (Eurogentec). In order to purify the serum 
from non-specific antibodies and antibodies selective to GB1 tag, we used GST-tagged zDisc1 (N). 
 
2.6 Expression and purification of GST-tagged zDisc1 (N)  
A GST-tagged zDisc1 (N) plasmid was synthesised using pGEX-6b1 (kind gift of Dr G. Hautbergue). 
Primer pairs were designed with BamHI and XhoI restriction sites to ensure directionality. A 600 bp 
product was amplified using Herculase II (Agilent) proofreading polymerase. Adenosines were added 
and the polymerase chain reaction (PCR) product was subcloned into pCR-II TOPO vector. Following 
sequencing, a double digest was performed on the subcloning vector pCR-II-disc1 and pGEX-6b1 using 
BamHI and XhoI. The linearized vector was dephosphorylated using recombinant Shrimp Alkaline 
Phosphatase (rSAP). Vector and insert were purified and a 10 μl ligation reaction was set up using T4 
Ligase (BioLabs):  
 
Reagent Volume (µl) 
Insert 1.5 
Linearized vector 4.5 
10 X T4 Ligase buffer 1 
Sterile water 2.5 




This reaction was incubated overnight (O/N) at 16°C and 2 μl was transformed into library efficiency 
TOP10 cells which were spread and grown in LB + Carbenicillin. Plasmid DNA was extracted and 
purified using a Miniprep kit (QIAGEN). Sequencing was performed to confirm the reading frame. 
 
One hundred ng of pGEX6b1-disc1 plasmid was transformed into Rosetta cells and large-scale protein 
expression was induced using IPTG (3 mM). Briefly, the bacterial cell pellet was lysed in 25 ml of RB100 
buffer (+ 150 μl Protease Inhibitor Cocktail (PIC) + 0.6 mM PMSF). The solution was sonicated for 2.5 
minutes (min) and centrifuged for 20 min at 48,000 g at 4°C. The supernatant was then added to 150 
μl of washed GSH sepharose beads 4B (GE Healthcare) and left to bind via rotation for 30 min at room 
temperature (RT). Bound protein and the beads were washed twice in RB100 buffer and eluted in GSH 
elution buffer. 
2.6.1 GST-fusion protein crosslinking  
Eight mg of purified Disc1 (N)-GST was dialysed in 100X the volume of wash buffer O/N at 4°C to 
remove amine groups that can react with DSS. Binding of Disc1 (N)-GST with 1.5 ml of GSH beads was 
performed for 1 hour at 4°C. Bead complexes were washed 1X in binding buffer and 3X in wash buffer. 
The wash buffer was removed, and the beads were incubated in a crosslinking solution for 30 min at 
RT. The unreacted DSS was quenched by adding 100 μl of 1 M Tris (pH 7.4). 
2.6.2 Antibody binding 
Serum was centrifuged at 20,000 g for 20 min at 4°C. Five ml of supernatant was incubated with the 
crosslinked protein-bead complex O/N at 4°C on via rotation. Keeping the temperature at 4°C, the 
solution was poured through a column and beads were allowed to settle. The tap was opened to drain 
off the supernatant and unbound antibodies. Twenty ml of wash buffer (1) was poured through and, 
subsequently, 20 ml of binding buffer. Then, 20 ml of wash buffer (2) was poured through and, again, 
20 ml of binding buffer. Beads were soaked in 2.5 ml of elution buffer for 15 min. The eluate was 
collected and neutralised using 50 μl of 1 M Tris (non-pHed). This was then dialysed in wash buffer for 
3 hours and a final dialysis step was performed in wash buffer with 40% glycerol. The contents of the 
dialysis tubing, with apore size of 12-14 kilodaltons (kDa) were transferred to a microcentrifuge tube 
and stored at -20°C. 
 
2.7 Mammalian cell culture and transfection 
Full length PCS2+disc1-FL was transfected into HEK293 cells (ATCC) at 70-80% confluency, using 
polyethyleinimine (PEI) transfection reagent. Two μg of plasmid DNA was first mixed with 6 μl PEI (28.8 
ng/μl) in 200 μl of OptiMEM media (Invitrogen) and left 20 min at RT. Transfection was performed by 
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pipetting the mixture onto the cells which were incubated 20 min at RT and then transferred to an 
incubator (37°C, 5% CO2). After 6 hours, the media was replaced with fresh DMEM. 
 
2.8 Protein extraction from mammalian cells 
Protein was extracted 24 hours post-transfection. Cells were washed in PBS, scraped into ice cold lysis 
buffer and lysed on ice for 30 min. Protein was separated from cell debris by centrifugation for 1 min 
at 14,000 rpm at 4°C. Protein concentrations were calculated from a standard curve of BSA using a 
Bradford assay. Samples were diluted at a 1:1 ratio in 2X Laemmli buffer and stored at -80°C. 
 
2.9 Protein extraction from zebrafish larvae  
Protein was extracted from 26 and 52 hpf zebrafish head lysates. Extracts were prepared by 
homogenising 40 decapitated heads in 100 µl of 1X Laemmli sample buffer then heating at 95°C for 5 
min. Protein extracts were stored at -80°C. 
 
2.10 Western Blotting  
Protein extracts were thawed, heated for 5 min at 95°C and centrifuged for 1 min at 14,000 rpm. Glass 
plates were washed and cleaned with 100% ethanol, then assembled, fixed upright, and checked for 
leaks. Five ml of 7.5 % resolving gel was loaded between the plates. Once set, 1 ml of 4% stacking gel 
was loaded and left to set with a gel comb to form wells. Fifteen µl of protein in Laemmli buffer 
(equivalent to 3 or 6 embryo heads) or 20 µl of mammalian cell lysate in Laemmli buffer (1 ug/ µl) was 
loaded into each well and resolved by SDS-PAGE for 75 min at 150 V in running buffer. A wet transfer 
to methanol activated PVDF membranes was performed for 1 hour at 120V or O/N at 30V in transfer 
buffer. Membranes were then incubated in blocking buffer (WB) for 1 hour at RT and probed with 
anti-zDisc1 antibody (1:1000) O/N at 4°C. Membranes were then washed for 3 x 10 min in TBST before 
a 1-hour incubation with goat-anti-rabbit HRP-conjugated secondary antibody (1:5000) at RT. 
Membranes were washed for 3 x 10 min in TBST again before detection using enhanced 
chemiluminescence (ECL) (Geneflow), using a 1:1 ratio of reagents. Protein bands were detected using 
ECL hyperfilm (GE healthcare) and developing solution or imaged using a G-BOX (Intellichem) and 
analysed with FIJI software.  
 
2.11 Tissue fixation  
Embryos were dechorionated, anaesthetised and transferred to microcentrifuge tubes prior to 
fixation. They were washed 3 times in PBS and fixed in Fish fix O/N at 4°C. Skin pigmentation was 
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removed by incubating the samples in bleaching solution for 20 min. Samples were washed 3 times in 
PBT. These were then dehydrated via a series of washes with 25, 50 and 75% methanol: PBS and stored 
in 100% methanol at -20°C. 
 
2.12 Immunofluorescence  
Fixed embryos were rehydrated to PBS via a series of 75%, 50% and 25% methanol in PBS then washed 
in PBT. Embryos were cracked using prechilled acetone for 6 min (24-72 hpf) at -20°C or permeabilised 
with 0.125% of Trypsin-EDTA in PBS for 30 min (5 dpf and above) on ice. They were then washed for 3 
x 5 min in PBT followed by 3 x 10 min in PBDT. Then, they were blocked in blocking solution for 3 
hours. Embryos were incubated in primary antibodies diluted in Blocking solution (IF) O/N at 4°C. On 
the second day, embryos were washed for 6 x 15 min in PBDT at RT and incubated in secondary 
antibodies. For α-Disc1, Alexa Fluor 488 anti-rabbit (1) was used (Table 2.1). For anti-pERK and anti-
tERK, a combination of Alexa Fluor 488 anti-rabbit (2) and Alexa Fluor 647 anti-mouse were used 
(Table 2.1). Incubations were left O/N at 4°C. To minimise exposure to ultraviolet (UV) light, tubes 
were kept in foil. On the third day, secondary antibodies were removed and embryos were co-stained 
with DAPI (1:1000) for 30 min. Embryos were washed for 6 x 15 min in PBT, transferred through a 
series of 10%, 25% and 50% to 75% glycerol and mounted on microscope slides. Alternatively, larvae 
were washed for 6 x 15 min in PBT and mounted in 2% low-melting point agarose (LMA) in PBS, ventral 
side up, in 15 μl, 2-well glass-bottomed slides (Ibidi) for large-scale analysis. 
Table 2.1. Antibody specifications  
Antibody Epitope Host  Dilution  Company  
i) Primary     










zDisc1  rabbit 1:200 (IF)  
1:1000 (WB) 
Dr Jon Wood lab 
α-tubulin  mouse 1:1000 
 
Sigma #T6557 
β-actin  mouse 1:1000 Abcam #8226 





Mouse IgG  goat 1:5000 Dako 
HRP 
α-rabbit  
Rabbit IgG  goat 1:5000 Dako 
Alexa Fluor 488 α-
rabbit (1)  





Alexa Fluor 488 α-
rabbit (2) 
Rabbit IgG  goat 1:500 
 
ThermoFisher 
Alexa Fluor 647 α-
mouse 






2.13 Z-brain registration and brain-mapping  
Samples were imaged on an LSM-700 inverted microscope (Zeiss) and acquired with ZenBlue software 
using a 20X air objective. Full-brain stacks (z=137) and image tiling (2x1) was performed to capture the 
entire brain at 7 dpf and stitching was performed post-acquisition. Analysis was performed using FIJI 
and MATLAB (Mathworks), as published in Randlett et al. (2015). The Computational Morphometry 
Toolkit (https://www.nitrc.org/projects/cmtk) was used for image registration as previously described 
by Randlett et al. (2015). Calculation of brain activity was done using the MakeTHEMAPMap.m 
function in MATLAB. Another MATLAB function called ZBrainAnalysisOfMAPMaps.m was used to 
identify regions of interest (ROIs).  
 
2.14 Digoxigenin (DIG) labelled probe synthesis 
Antisense probes against steroidogenic factor 1 (ff1b), retinal homeobox 3 (rx3), and tyrosine 
hydroxylase (th) were synthesised from existing plasmids (generously provided by Prof M. Placzek and 
Dr L. Trollope). Complementary DNA (cDNA) of orthopedia b (otpb), oxytocin (oxt) and hypocretin 
(hcrt) was amplified using primers (Table 2.3) and cloned into pCR-II vector. Templates were linearised 
with the appropriate restriction enzymes (Table 2.2) and purified. A 20 μl in vitro transcription reaction  
was set up using 1 μg of fully linearised template, 2 μl of 10X transcription buffer, 2 μl 10X DIG-UTP 
labelling mix (Roche Applied Science), 1 μl of murine RNase inhibitor, DEPC-treated water and  2 μl of 
T7 or SP6 RNA polymerase. This was mixed and incubated at 37°C for 2 hours. The DNA template was 
eliminated by adding 2.5 μl 10X DNase buffer and 2.5 μl (5U) RNase-free DNase incubated at 37°C for 
an additional 30 min. The probe was then precipitated by adding 2.5 μl of 4M LiCl, 75 μl of 100% 
ethanol and placing at -80°C O/N. The following day, the pellet was collected by centrifugation for 20 
min at 13,000 rpm at 4°C. The pellet was then washed with 100 μl RNA grade 75% ethanol and 
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recentrifuged at 13,000 rpm for a further 15 min at 4°C. The supernatant was removed and tubes were 
left open for 5 min to air dry. RNA was then resuspended in 50 μl DEPC-treated water and allowed to 
rehydrate for 5 min, then placed on ice. Three 0.5 μl samples were taken after synthesis, digestion 
and resuspension and were analysed on a gel to check for recovery. Probe concentrations were 
assayed using a UV spectrophotometer (Nanodrop) and stored at -80°C after the addition of 50 μl of 
deionized formamide. 
Table 2.2. RNA in situ hybridisation plasmid information  
Probe Enzyme to linearise at 5’ end RNA polymerase  
ff1b EcoRV T7 
hcrt XhoI SP6 
otpb XhoI SP6 
oxt XhoI SP6 
rx3 XbaI T7 
th1 XhoI T3 
 
2.15 Wholemount in situ hybridisation  
Wholemount in situ hybridisation (WISH) was used to detect mRNA expression in fixed tissue (Thisse 
and Thisse, 2008). On the first day, fixed embryos were rehydrated via a series of 75%, 50% and 25% 
methanol: PBS washes. Embryos were washed 4 x 5 min each in PTW. Tissue was permeabilised using 
Proteinase-K (10 μg/ml) treatment for differential times according to embryonic stage. To stop the 
reaction, fish were refixed in Fish fix for 20 min at RT and washed 5 x 5 min each in 1 ml of PTW. 
Embryos were then rinsed in 250 μl of incomplete hybridisation solution and then prehybridised in full 
hybridisation solution for 3 hours at 68°C. Hybridisation with the preheated (68°C) riboprobes mix 
(1:200) diluted in full hybridisation solution was performed O/N at 68°C. On the second day, the 
diluted riboprobes were removed and kept at -20°C for reuse. Embryos were washed in preheated 
(68°C) solutions: 50:50 2X SSC: incomplete hybridisation solution for 20 min, in 2X SSC for 20 min, and 
twice in 0.2X SSC for 60 min each at 68°C. Next, they were washed in 50:50 0.2X SSC: PTWS and 
blocking buffer (in situ) for 10 min at RT. Non-specific binding was inhibited by a 3-hour blocking step 
at RT in blocking buffer (in situ) prior to an O/N incubation in DIG-AP antibody (1:2000) in blocking 
buffer (in situ) at 4°C. On the final day, samples were washed in PTW for 6 x 20 min at RT. Embryos 
were equilibrated by 3 x 10 min washes of staining buffer. Alkaline phosphatase activity was detected 
using staining solution and left to develop for 90-180 min (probe-dependent) in the dark. Staining was 
stopped by washing for 3 x 5 min in PTW and fixing the embryos O/N in Fish fix at 4°C. Embryos were 
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further washed and transferred through a series 25%, 50% and 75% glycerol solutions prior to 
mounting on microscope slides for imaging. 
 
2.16 Generation of a disc1 mutant  
2.16.1 Design and synthesis of disc1 guide RNA 
The CRISPR/Cas9 gene editing technique was used to create a disc1 mutation. A single guide RNA 
(gRNA) targeting exon 6 (AGATGCAGGGACCCGTCCTC AGG) was designed by R. Lucas (MSc thesis, 
University of Sheffield, 2014) using the online CRISPR design tool (Zhang lab, MIT; 
http://crispr.mit.edu/). This gRNA also contained the T7 promoter and sequences to recruit Cas9. The 
target site was designed with an internal restriction enzyme site for binding and cleavage by DdeI. The 
following oligonucleotide was ordered from IDT (Integrated DNA Technologies):  
(5’-GAAATTAATACGACTCACTATAAGATGCAGGGACCCGTCCTCGTTTTAGAGCTAGAAATAGC-3’).  
To ensure DNA cleavage, the antisense oligonucleotide was amplified, and in vitro validation of gRNA 
was performed by R. Lucas (MSc thesis, University of Sheffield, 2014). In Singapore, the antisense 
oligonucleotide was amplified using Phusion polymerase mix (ThermoScientific) in a 100 µL reaction 
with the following cycling conditions:  
Reagent Volume (µl) 
Custom Oligonucleotide (100 μM) 2.5 
Reverse primer (50 nM) 2.5 
dNTPs (10 µM) 2.5 
DMSO  2.5 
5X Phusion Buffer 20 
Phusion polymerase 1 
Sterile water 69 
 
 Steps  Temperature (°C) Time 
 Initial denaturation 98 30 s 
35 cycles of Denaturation  98 10 s  
 Annealing 60 30 s 
 Extension 72 15 s  
 Final extension 72 10 min 
 
 
Subsequently, the PCR product was purified (QIAGEN kit) and transcribed using T7 MEGAshortscript 
kit (Life Technologies) in a 20 µl reaction and incubated at 37°C for 4 hours. 
 
Reagent Volume (µl) 
Purified PCR product (1 µg)  8 
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dUTPs (10µM) 8 
10X T7 buffer 2  
T7 enzyme mix 2 
 
To remove the template, 2 µl of TurboDNAase was added and incubation was continued for an 
additional 30 min. The transcribed RNA was precipitated at -20°C O/N by addition of 15 µl ammonium 
acetate, 300 µl of 100% ethanol and 115 µl of nuclease-free water.  
 
2.16.2 Microinjection of gRNA into zebrafish embryos  
Needles were pulled using a micropipette puller (P2000 - Sutter instrument Co.). Tips were carefully 
removed using forceps. Needles were loaded with a 1:1 ratio of gRNA (1.5 µg/µl) and Cas9 (1.5 µg/µl). 
The injection volume was calibrated to 0.75 nl. The needle was inserted through the yolk sac and the 
mixture was injected into the 1-cell stage zebrafish embryos. Injected embryos were incubated at 28°C 
and dead embryos were removed at the end of the day. Uninjected controls were kept for later 
comparative analyses. All of this work was performed by Yan Ling Chong prior to my arrival in 
Singapore.   
2.17 Genomic DNA extraction 
In adults, genomic DNA (gDNA) was extracted from fin-clips performed at 2 months post fertilisation 
(mpf). In embryos, extraction was performed at both 24 hpf and at 7 dpf dependent on the genotyping 
needs. Samples were placed in strip-tubes containing 100 µl PBS. PBS was then removed and replaced 
with alkaline lysis buffer and incubated at 95°C for 30 min: 
 
Tissue  Alkaline Buffer volume (µl) 
Fin (2 mpf)  40 
Whole embryo (24 hpf) 10 
Whole larva (7-8 dpf) 25 
 
Post-lysis, neutralisation buffer was added to the strip tubes at a 1:1 ratio.  For PCR set-up, 1 µl of 
gDNA was used as template DNA. 
 
2.18 In vivo validation of gRNA 
 
To determine the efficiency of disc1 gRNA, gDNA was extracted from 8 injected and 8 uninjected 
controls and amplification of the target site in exon 6 was performed by PCR in a 10 μl reaction:  
 
Reagent Volume (µl) 
gDNA (100 ng)  1 
disc1 exon 6 Forward (500 nM) 2.5 
25 
 
disc1 exon 6 Reverse (500 nM)  2.5 
MiFy mix 4 
 
 Steps  Temperature (°C) Time 
 Initial denaturation 95 60 s 
39 cycles of Denaturation 95 20 s  
 Annealing 57 30 s 
 Extension 72 40 s  
 Final extension 72 60 s 
 
Efficiency was determined based on digestion of the locus-specific amplicon by DdeI in a 25 µl 
reaction:  
 
Reagent Volume (µl) 
PCR product (500 ng) 8.5 
Cutsmart buffer (NEB) 2.5 
DdeI (NEB)  0.5 
Sterile water  13.5  
 
Embryos were raised to sexual maturity. F0s were outcrossed to AB wild types and F1 embryos were 
checked for transmission rates. disc1 exon6-specific amplicons were amplified as described above and 
cloned into pCR-II using the TOPO TA cloning kit (Invitrogen). Briefly, a ligation reaction of 3:1 (insert: 
vector) ratio was set-up and then transformed into chemically competent DHα cells. These were 
grown O/N at 37°C on LB agar plates containing carbenicillin (33 μg/ml). Fives clones from each ligation 
reaction were picked and grown in LB broth containing carbenicillin. Cultures were miniprepped using 
QIAGEN Miniprep kit and the pCR-II vector containing the insert was sequenced using MI3R primer 
(Table 2.3) to discover the nature of the insertion-deletions (indels).    
Table 2.3. Primer sequences  
Primer Name   Primer sequence 
disc1-GST primer Forward 5’ -- GGATCCATGATGTTCGCAGGAATGGTCAGG -- 3’ 
disc1-GST primer Reverse 5’ -- CTCGAGTCAGCTGGTTTCTGATTGGCTCA -- 3’ 
otpb primer Forward  5’ -- AACTCCGGTCTTCAACTCCAC -- 3’ 
otpb primer Reverse  5’ -- AGACGGGAACTGAGGCAAAC -- 3’ 
oxt primer Forward  5’ --CTCCGCAAGCTCTCGGTGTC -- 3’ 
oxt primer Reverse 5’ -- CTGCACTAATGTACAGTCAAGC -- 3’ 
hcrt primer Forward  5’ --CTGCACAGCTAAGAAGCTCCA -- 3’ 
hcrt primer Reverse 5’ --GCGACAAGTGTCATCGTTTTTC -- 3’ 
disc1 genotyping exon 6 Forward 5’ -- ACCATTGCTGCATGGGGAAT -- 3’ 
disc1 genotyping exon 6 Reverse 5’ -- AAAGTGGGACTGGGTCTACA -- 3’ 
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disc1 F3 CRISPR mRNA Forward 5’ – CGAGAGACGCTGTTAGAGGAG -- 3’ 
 
disc1 F3 CRISPR mRNA Reverse 5’ – CCCAGCTGTCACTGAAGTAGT -- 3’ 
disc1 qPCR CRISPR Forward 5’ -- ACCATTGCTGCATGGGGA -- 3’ 
disc1 qPCR CRISPR Reverse 5’ -- CTGAGACAGCATCGCCTGAAG -- 3’ 
hprt1 qPCR CRISPR Forward 5’ -- TCATCGAGCCCGTGTGTCGT -- 3’ 
hprt1 qPCR CRISPR Reverse 5’ -- ACCCGCTCTAAGTCAGCCGCAT -- 3’ 
disc1 GST tag Forward 5’ -- GGATCCATGATGTTCGCAGGAATGGTCAGG -- 3’ 
disc1 GST tag Reverse 5’ -- CTCGAGTCAGCTGGTTTCTGATTGGCTCA -- 3’ 
 
2.19 RNA extraction    
Forty embryos were collected and washed once in PBS and once in dH2O. As much liquid as possible 
was removed as possible and 600 µl of TRIZOL (Ambion) was added to the microcentrifuge tube. Tissue 
was homogenised using a needle (23G 1¼TW -0.6 mmx32 mm) by 10 times upwards and downward 
suctions. Homogenate was left to sit for 5 min at RT. Subsequently, 120 μl of chloroform was added 
and tubes were inverted vigorously for 15 seconds (s). Tubes were left to sit for 3 min at RT and then 
centrifuged at 14,000 rpm for 15 min at 4°C. All of the subsequent steps were done on ice. The clear 
aqueous layer was transferred into a fresh tube containing 216 μl of isopropanol. Flicking was used to 
mix, and the solution was left to sit for 10 min at RT. Tubes were centrifuged at 12,000 rpm for 10 min 
at 4°C. The supernatant was removed to reveal a white RNA pellet. Molecular grade 75% ethanol was 
added to wash the pellet. This was vortexed and centrifuged on the same settings. The supernatant 
was removed and tubes were air-dried for 5 min. The pellet was resuspended in 20 μl of DEPC-treated 
water and RNA was stored at -80°C.  
 
2.20 First-strand synthesis of cDNA  
Two μg of RNA was used for first-strand cDNA synthesis. The following 10 μl reaction was incubated 
for 5 min at 65°C:  
  
Reagent Volume (µl) 
RNA (1000 ng/µL)  2 
Olig (dT) 20 (50 µM) 1 
dNTPs mix (10 mM)  1 




This reaction was placed on ice and to each tube was added:  
Reagent Volume (µl) 
10X RT buffer 2 
MgCl 2 (25 mM) 4 
DTT (0.1 M) 2 
RNAase OUT (40 U/µL) 1 
Superscript III Reverse Transcriptase 1 
 
This reaction was incubated for 1 hour at 50°C and terminated by a 5 min incubation at 85°C. Tubes 
were then placed on ice and 1 μl of RNAase H was added to digest RNA. Tubes were incubated for 20 
min at 37°C and stored at -20°C. 
 
2.21 Quantitative Polymerase Chain Reaction (qPCR)  
qPCR was performed to measure levels of disc1 mRNA in CRISPR-generated mutants. Wild type and 
mutant embryos were collected at 55 hpf for RNA extraction. Two µg of total RNA was used for First 
Strand cDNA synthesis using the Superscript III kit (Invitrogen, #18080-051). Primers (Table 2.3) were 
designed downstream of the target site and flanking intron-exon boundaries to eliminate the 
possibility of gDNA contamination. Primers against the reference gene hprt1 (Table 2.3) were used 
internal controls. The qPCR reaction was assembled using Ultrafast SYBR green Master mix (Invitrogen, 
11780200) in 20 µl reactions with the following cycling conditions:  
Reagent Volume (µl) 
cDNA (2 ng/µL) 6 
SYBR green 10  
Forward primer (5 µM) 2 
Sterile water (5 µM) 2 
 
 Steps  Temperature (°C) Time 
 Initial denaturation 95 20 s 
40 cycles of Denaturation 95 1 s  
 Annealing/ Extension 60 20 s 
 
Reactions were carried out in experimental and technical triplicates in MicroAmp Fast 96-well reaction 
plate (Applied Biosystems) using Fast 7900HT Real Time machine (Applied Biosystems).  2^ddCt was 
used to calculate fold changes between samples.  
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2.22 Behavioural assays in larval zebrafish 
2.22.1 Hunting assay 
At 7 dpf, zebrafish larvae received their daily live feed (Paramecia) at 9 AM. Subsequently, Paramecia 
were flushed, individual larvae were transferred to a 24-well plate devoid of food and starved for 3 
hours. Meanwhile, Paramecia were dyed with Neutral Red (5 µg/ml, Abcam #14635) for 30 min on 
the rocker to facilitate their visualisation. The plate was positioned on the behaviour rig with bottom 
LED lighting for 30 min for habituation, following which 100 µl of dyed Paramecia was added to each 
well and left for 5 min prior to video recording. Hunting behaviour was recorded for t=10 min at 30 
frames.s-1. Hunting bouts and strikes were manually counted post-hoc. Data was plotted using 
GraphPad (Prism 8).  
2.22.2 Feeding assay 
At 7 dpf, zebrafish larvae received their daily feed at 9AM. Subsequently, Paramecia were flushed, 
and larvae were starved for 3 hours. Meanwhile, harvested Paramecia were centrifuged in 50 ml 
plastic tubes at 2,750 rpm for 5 min. The supernatant was removed and 5 ml pellets were pooled and 
aliquoted into microcentrifuge tubes. DiD dye (2.5 mg/ml in ethanol, D7757; 5 µl dye/ml of 
concentrated paramecia) was used to dye the Paramecia for 2 hours (covered with foil, gentle 
rotation). After 2 hours, dyed Paramecia were centrifuged at 2,750 rpm for 5 min and the supernatant 
was replaced with 1ml of E3. After two washes, the contents of all tubes were pooled and the volume 
of dyed Paramecia was adjusted to 1 ml per dish of larvae. One ml of dyed Paramecia was added to 
habituated zebrafish larvae (n=30 per plate), ensuring dyed Paramecia were distributed evenly around 
the dish. Larvae were left to feed for 15 min. After this period, the zebrafish were poured through 
tubed sieves, washed with E3 and submerged in ice cold 4% paraformaldehyde (PFA) in PBS. These 
were left to shake O/N at 4°C. Gut fluorescence (Fig. 2.1) was quantified the next day, using a 
stereoscope (Leica) under far red Cy5 LED illumination. Images were analysed in FIJI (ImageJ) using a 
macro (written by Dr. Caroline Wee, available on www.github.com/carolinewee) for automation. 




2.22.3 Locomotion and Dark-Flash test  
At 7 dpf, zebrafish larvae received their daily feed at 9 AM. Subsequently, Paramecia were flushed and 
individual larvae were transferred to a 48-well plate. The plate was placed in an incubator (28.5°C) 
with bottom illumination (LED or infrared lighting) with a Basler acA2040-90u mNIR camera (30 
frames.s-1) placed above. Recordings were performed over 2 days. On day 1, larvae were habituated 
and then exposed to a series of 6 dark-cycles (40 min) intercalated with light-cycles (20 min). The final 
light OFF (infrared) was continuous for 10 hours and considered “night-time”. On day 2, locomotion 
was recorded for a further 6 hours. Tracking of X:Y coordinates was performed by custom PyCharm 
(Python) software (by Dr. R. Cheng) and raw data was collected as signatures in Excel (Microsoft). 
Seconds of activity per min (active s.min-1) was plotted using GraphPad (Prism 8).  
2.22.4 Night-time arousal test  
The same setup was used for measuring sensory-motor gating in 11 dpf larvae. To assess arousal 
during sleep, different intensities of sound were emitted through an audio speaker controlled by a 
modified version of the activity-tracking code in Python. Locomotion was recorded over 2 nights, 
starting at 1 AM every night, where eighteen stimuli of nine different intensities, were delivered for 
200 ms at a rate of 1 sound.min-1. Intensities started at 0% and increased 12.5% every minute to reach 
a maximal value (100%) of 72 decibels (dB). At odd hours (1 AM, 3 AM, 5 AM), the stimulus intensities 
were descending from 0-9min and ascending from 10-19 min. At even hours (2 AM, 4 AM, 6 AM), the 
stimulus intensities were ascending from 0-9 min and descending from 10-19 min (Fig. 2.2). A total of 
(19x6) 114 sounds were delivered each night. Tracking of X: Y coordinates was performed by PyCharm 
(Python) and raw data was collected as excel files. Percentage of fish responding was averaged over 
the 2 nights of recordings and plotted using GraphPad (Prism 8). We corrected measurements for 
variations in basal locomotor activity using the equation (Woods et al., 2014): 
 





Figure 2.2 Scheme of Night-time Arousal (NTA) test  
 
 
2.23 Drug treatment 
2.23.1 Developmental CHIR99021 treatment 
GSK-3 activity was inhibited using 2, 4-dibenzyl-5-oxothiadiazolidine-3-thione (CHIR99021) 
(MedChemExpress #05974). Aliquots of stock solution (50 mM) were made up in DMSO and stored at 
-20°C. Embryos were dechorionated and treated with 50 μM CHIR99021 from 24-48 hpf. The drug was 
washed-off by transferring embryos through E3 and placing them in fresh E3. They were left to develop 
at 28.5°C until fixation for in situ hybridisation at 55 hpf or for feeding assays at 7 dpf. DMSO (0.5%) 
was used as negative control. 
 
2.23.2 Acute CHIR99021 treatment 
Larval zebrafish were treated acutely with CHIR99021 prior to addition of the dyed Paramecia. Briefly, 
30 μl of stock solution was diluted in 30 ml of E3. Larvae were transferred from their habituated/ 
starved state to either DMSO (0.5%) or CHIR99021 (50 μM). After 30 min of exposure, dyed Paramecia 
were added to petri dishes and the feeding assay was continued as per usual.  
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2.23.3 Acute larval stress 
Larval zebrafish were treated acutely with varying concentrations of sodium chloride (NaCl) prior to 
the addition of the dyed Paramecia. Briefly, a volume of 500 μl stock NaCl stock solution was added 
to 30 ml of E3 to get a final concentration of 100 mM or 250 mM and larvae were exposed for 10 min. 
This was washed off and larvae were left to habituate for 5 min before dyed Paramecia were added 
and the feeding assay was continued as per usual.  
 
2.24 Paramecia propagation and harvest 
Propagation was performed once a week. Briefly, a week-old Paramecium culture was used to 
propagate 8 subcultures. One hundred ml of Paramecia culture was transferred to new subcultures in 
glass bottles (1 l) containing 500 ml of Paramecia water and 100 ml of wheat pellets (Carolina), 3.75 
mg/ml. Five drops of RotigrowPlus were added and Paramecia were grown at 28 °C. Paramecia 
cultures were fed twice a week with RotigrowPlus. To harvest Paramecia, the culture was first filtered 
through a large-pored (120 μM) sieve. The collected through-flow was then filtered through a second 
small-pored (25 μM) sieve. The second through-flow was discarded and 30 ml of Paramecia water was 
used to rinse the collected Paramecia. The harvested Paramecia were transferred to a 50 ml plastic 
tube, left to sediment O/N and subsequently used to feed the fish.   
 
2.25 Novel Tank Diving (NTD) Assay  
Adult zebrafish were tested consistently from 1-4 PM to account for circadian cortisol fluctuations. 
Tall and narrow one litre tanks (20 cm x 10 cm x 5 cm) were filled with filtered facility water. Top light 
illumination at low intensity (1.5 μW/mm2) was used. Videos were recorded using a Basler Ace 
(acA1300–200 μm; 1,280 × 1,024) camera placed ~40 cm in front of the tanks. Locomotion was 
recorded for 10 min at 20 frames.s-1. Tracking of X: Y coordinates was performed using PyCharm 
(Python) and raw data was collected as signatures in excel files and automated analysis scripts were 
applied (Haghani et al., 2019). Bottom dwell was quantified by the percentage of time spent in the 
bottom third (red line, Fig. 2.3) of the tank at every 2 min interval. Thigmotaxic behaviour was 
quantified by measuring the percentage of time spend near the walls of the tank (maroon zone, Fig. 
2.3). The script enabled calculation of the number of freezing episodes (>1 s of immobility) and the 




Figure 2.3 Adult behavioural setup   
 
 
2.26 Statistical Analysis 
Data are presented as mean ± standard error of mean (SEM) or mean ± standard deviation (SD) when 
appropriate, with N indicating the sample size (number of larvae). The Shapiro-Wilks test was 
performed to assess if data sets followed a normal distribution. If data passed the normality test, 
statistical analysis of two groups was measured using Student t-test (unpaired). Statistical analysis of 
more than two groups was performed using a one or two-way analysis of variance (ANOVA), followed 
by Tukey post-hoc analysis, to account for multiple comparisons. For data that did not pass the 
normality test, the Mann-Whitney test was used to compare two groups and the Kruskal-Wallis for 
more than 2 groups, with pairwise comparison. For behavioural measures comparing the same 
samples at multiple timepoints or exposed to different stimuli, factorial ANOVA with repeated 













Chapter 3: Tools for elucidating disc1 function in zebrafish 
 
3.1 Introduction  
3.1.1 Expression of disrupted-in-schizophrenia 1 (disc1) in zebrafish 
The genetic tractability and optical transparency of the zebrafish enables an in-depth investigation 
into the specific function of genes and proteins of interest. The developmental expression of the 
genetic risk factor disc1 has previously been characterised. In the zebrafish embryos, maternal 
contribution of disc1 appears as early as 3 hpf and levels gradually decrease before another round of 
zygotic disc1 expression occurs around 10 hpf (De Rienzo et al., 2011) coinciding with the maternal to 
zygotic transition. Expression of disc1 occurs predominantly between 1 and 3 dpf and peaks at 52 hpf, 
a timepoint when most of organogenesis has already occurred. disc1 is expressed in the muscle trunk 
and in the developing brain and is particularly enriched in the ventral diencephalon (Eachus et al., 
2017). Expression in the larval zebrafish is thought to decrease over time but has not been thoroughly 
investigated at later stages due to lack of a zebrafish-specific antibody.  
3.1.2 The challenge of immunohistochemistry in zebrafish research 
Tens of thousands of commercially available antibodies exist against various proteins and they remain 
an essential component of the backbone of the molecular biology toolkit. They have significantly 
contributed to our understanding of basic cellular biology thanks to methods such as 
immunohistochemistry, immunoprecipitation, and SDS-PAGE. Two main types of commercially 
synthesised antibodies exist. Polyclonal antibodies consist of heterogeneous immunoglobulin (Ig) 
molecules which can bind to several different epitopes from a single antigen. These are usually 
purified from the serum of immunised rabbits, donkeys, or goats. Monoclonal antibodies, as the name 
suggests, bind to a single epitope within a target antigen, composed of homogenously cloned 
immunoglobulin molecules. These single specificity antibodies are made by fusing antibody-producing 
cells from the immunised animal to an immortalised cell line.  
 
Due to the early divergence from humans over 450 million years ago, protein conservation between 
mammals and zebrafish is limited. These differences mean that many commercial antibodies do not 
cross react with most zebrafish orthologs, but this ultimately depends on the degree of homology 
between the two specific proteins and whether the antibody binds to common epitopes. 
Commercially available antibodies for non-mammalian model organisms are underrepresented 
compared with mammalian models. This lack of zebrafish antibodies could be attributed to less 
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funding in the field. Nevertheless, polyclonal antibodies are often made “in-house” and shared 
amongst research groups.  
 
The lack of zebrafish-specific zDisc1 antibody can hinder research progress, particularly when 
investigating its mechanisms in cellular biology. It was therefore important to synthesise a high affinity 
antibody against zDisc1, as an essential research tool for this project. The estimated molecular mass 
of the endogenous zebrafish Disc1 protein (zDisc1) is 112 kDa (expasy.org/compute_pi) but the 
protein has not been fully characterised in zebrafish. Cross-species sequence conservation between 
zebrafish, mice and humans is largely restricted to the C-terminus (Porteous and Millar, 2006). Due to 
the differences in the sequence of the N-terminus between species, we decided to use a zDisc1 N-
terminal polypeptide for raising a polyclonal antibody. The reason being that most commercially 
available antibodies raised against the C-terminus will react with mammalian Disc1 isoforms, however, 
they do not react with zDisc1. 
3.1.3 Generating disc1 zebrafish models 
Morpholino studies, carried out by microinjection of antisense oligonucleotides targeting disc1, 
contributed to the initial characterisation of disc1’s function in zebrafish. In these studies, different 
MO targeted different parts of the disc1 locus. MO targeting the start codon (AUG) resulted in gross 
developmental abnormalities and oligodendrocyte mislocalisation by 5 dpf. This was also the case for 
another MO targeting the exon 2/intron 2 splice boundary (Wood et al., 2009). MO targeting the 
intron 2/exon 3 splice-acceptor site altered disc1 pre-mRNA splicing and introduced a premature stop 
site, leading to deletion of exon 3. This resulted in abnormalities in craniofacial development and 
delayed neural crest migration at 5 dpf in a high proportion of disc1 morphants (Drerup et al., 2009). 
The same phenotypes were also observed in morphants using another MO targeting the exon 8/ intron 
8 boundary. Another study used MO targeting the splice donor site between exon 1 and intron 1/2, 
ablating all disc1 mRNA. Two groups of morphants emerged, divided into strong and mild phenotypes. 
Strong phenotype morphants had abnormal brain morphogenesis and lack of tail. Mild phenotype 
morphants had less defined, smaller brain ventricles and defects in somitogenesis at 24 hpf. Axon 
outgrowth and organisation was also affected to a corresponding extent between strong and mild 
morphants (Brandon et al., 2009). The same group used another MO targeting the intron between 
exons 8 and 9, recapitulating the human equivalent breakpoint. These morphants had much less 
severe phenotypes with no severe morphological differences in neurodevelopment. The reduction in 
ventricle size was restricted to midbrain and hindbrain ventricles only. These morphants also had 




In zebrafish, evidence suggest that in 15-20% of cases, MOs can cause off-target effects. In most cases, 
off-target effects result from p53 activation from 1-2 dpf leading to apoptosis (Robu et al., 2007);  
Simultaneous morpholino knockdown of p53 can rescue this apoptosis and is now used to control for 
gene-specific phenotypes. In other cases, off-target toxicity can occur through interaction with other 
mRNA sequences unrelated to the gene of interest. To ascertain whether these disc1 phenotypes are 
a consequence of disc1 knockdown or due to off-target effects, it was necessary to use stable disc1 
knockout models. 
 
ENU (N-ethyl-N-nitrosourea) mutagenesis has been used in TILLING (Targeting Induced Local Lesions 
in Genomes) screens to induce and identify point mutations in protein-coding regions. Two disc1 ENU 
mutants were identified with two different nonsense mutations in exon 2: disc1L115X and disc1Y472X 
(Draper et al., 2004). Homozygous mutants had defects in brain connectivity and morphological 
phenotypes at 24 hpf (De Rienzo et al., 2011). Since then, though, these results have not been 
successfully reproduced by other groups. After multiple generations (≥ than 3) of alternating 
outcrossing to TL wild types and incrossing, homozygous disc1L115X/L115X and disc1Y472X/Y472X mutant 
embryos appear to develop relatively normally and only very mild phenotypes have been reported 
(Eachus et al., 2017).  Contradictions in phenotypes between disc1 knockdown using MOs and disc1 
homozygous knockout mutants raise questions over the true loss of function phenotype. A new 
approach using targeted genome editing is therefore necessary to resolve these discrepancies.  
 
3.1.4 Targeted genome editing  
Since the introduction of precise genome editing methods to create stable mutant lines, the use of 
MOs has fallen from favour in the zebrafish community. Creating targeted mutations has become 
accessible, thanks to the development of tools such as zinc finger nucleases (ZFNs) and transcription 
activator-like effector nucleases (TALENs). Both techniques function through precise protein-induced 
genome cleavage, creating DSB. This causes changes in the genetic sequence of the target site through 
error-prone repair mechanisms such as non-homologous end joining. However, both techniques come 
with their limitations: TALENs are very large and require laborious cloning steps to obtain the 
numerous repeat sequences required for their function. On the other hand, ZFN are much smaller, 
enabling their incorporation into viral vectors, the delivery method used in mammalian models. 
Unfortunately, they are more difficult to design, more expensive and harbour a lower mutagenesis 
rate compared with TALENs (Joung and Sander, 2013). Multiple attempts to generate a disc1 TALEN 
knockout and knock in mutants have been made by our group but with no success, due to a low 
frequency (10%) of in vivo cleavage (P. Boyd PhD thesis, University of Sheffield, 2014).  
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3.1.5 The CRISPR/ Cas9 system 
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/ Cas (CRISPR-associated system) 
has recently revolutionised targeted genome editing. In zebrafish, it has been widely used to generate 
stable mutants via site-specific mutagenesis or transgenic lines by the subsequent insertion of 
reporter tags. This system utilises the adaptive immune response endogenous to prokaryotes and 
archea. As a defence mechanism, most bacteria can store genomic sequences from viruses by splicing 
them into the host’s genome near CRISPR sites. Upon viral infection, these regions are then 
transcribed into gRNAs which function to direct Cas endonucleases to the foreign DNA which is 
subsequently degraded (Deltcheva et al., 2011; Wiedenheft et al., 2012). This system has been 
reported to be more precise than the aforementioned ZFN and TALEN system due to the stronger 
bond formation between RNA and DNA as opposed to protein/ DNA (Gaj et al., 2013). The type II 
CRISPR/ Cas9 system from Streptococcus pyogenes has been engineered and is applied in various in 
vitro and in vivo models for genetic engineering. A 20 bp gRNA can be designed to complement any 
target site, provided that a protospacer adjacent motif (PAM) is present immediately upstream of the 
binding site, to enable DNA cleavage by Cas9 (Jinek et al., 2012). gRNAs are injected along with Cas9 
mRNA or protein into one-cell stage embryos. This leads to the generation of DSB in the organism’s 
DNA causing the formation of indels at the target site. In zebrafish, the efficiency of mutagenesis is 
relatively high with studies reporting ~85% (Hruscha et al., 2013). While the CRISPR/Cas9 system is 
the preferred method for targeted genome editing, off-target mutagenesis can still occur due to base 
mismatches. This is especially evident in human cell lines (Fu et al., 2013; Rayner et al., 2019; Zhang 
et al., 2015). Importantly though, occurrences of off-target mutations in zebrafish remain relatively 
low (Hruscha et al., 2013). Another drawback of the CRISPR/Cas9 system in zebrafish research 
emerged after a lack of phenotype was observed in many loss of function CRISPR/ Cas9 mutants. This 
has been attributed to the phenomenon of genetic compensation (Rossi et al., 2015).  
 
There was a need to generate a CRISPR/ Cas9 disc1 mutant due to the discrepancy in results from the 
ENU-generated disc1 mutants. Additionally, the zebrafish community has moved away from using 
morpholinos for genetic characterisation, as mentioned above. The simplicity of the CRISPR/ Cas9 
system as well as the relatively short zebrafish life cycle meant it was perfectly reasonable to design, 




3.2.1 Anti-zDisc1 serum recognises epitope in wild type zebrafish embryos 
To investigate the expression profile and location of the zebrafish zDisc1, a novel zebrafish-specific 
antibody was raised against an N-terminus zDisc1 polypeptide (~20 kDa). A construct previously 
synthesised was used to express a fusion protein of zDisc1 (N) fused to the GB1 tag: zDisc1 (N)-GB1 (A. 
Zarkesh MSc thesis, University of Sheffield, 2016). The GB1 tag was used as it increases the solubility of 
the recombinant protein facilitating its purification. Purified zDisc1 (N)-GB1 was sent for rabbit 
immunisation and antiserum was generated.  
To determine if there was a need to purify the antiserum to enrich for polyclonal antibodies, we first 
tested the serum. Protein was extracted from zebrafish heads at 52 hpf, a timepoint where disc1 is 
highly expressed (Boyd et al., 2015; Eachus et al., 2017; Wood et al., 2009). We performed western 
blotting using two different concentrations of heads lysates and blotted with antiserum from pre-
immune and zDisc1 (N)-GB1-immunised bleeds from rabbits (Fig. 3.1). A weak band was detected at 40 
kDa on blots using the pre-immune antiserum. A much stronger band was detected at 70 kDa on blots 
using antiserum from zDisc1 immunised antiserum. The intensity of the signal increased proportionally 
to the amount of protein loaded and was absent in pre-immune samples. Four weaker and smaller bands 
were observed in the most concentrated samples. Antibodies from the zDisc1 (N)-GB1-immunised 
antiserum also cross reacted with the molecular weight standards. Such cross reactions are common as 




Figure 3.1. Western blots of zebrafish embryo 
head lysates with pre-immune and zDisc1 
antiserum 
Western blot protein extracted from wild type 
zebrafish heads at 52 hpf. Two different 
concentrations (3X and 6X heads per well) were 
loaded and using pre-immune antiserum (left) 
and zDisc1-immunised antiserum (right). A 
strong 70 kDa band, marked with an asterisk (*) 




3.2.2 Two-step purification of zDisc1 antiserum 
After establishing that the antiserum did not recognise the expected size of zDisc1 (112 kDa), we 
decided to deplete the serum of antibodies specific to the GB1 tag. This small tag (~12 kDa) is a 
modified version of protein G expressed by Streptococci and specifically binds the Fc arm of IgG 
(Akerstrom et al., 1985). GB1-specific antibodies were depleted by column purification and collection 
of the eluate: GB1-depleted zDisc1 antiserum (see section 2.5.2). 
 
Next, zDisc1-specific antibodies were enriched by using an affinity column. Briefly, a zDisc1 (N)-GST 
protein was synthesised by cloning the same disc1 (5’) sequence used for zDisc1 (N)-GB1 synthesis 
into pGEX-6b1 (kind gift of Dr G. Hautbergue). After confirming the reading frame by sequencing, 
pGEX-6b1-disc1 was transformed into competent cells, expressed and purified (see section 2.5.1). 
zDisc1 (N)-GST and GSH sepharose bead complexes were crosslinked and incubated with the GB1-
depleted zDisc1 antiserum. The beads were packed into a column for antibody purification. The 
through-flow was made up of non-specific antibodies and serum proteins. After multiple washes, an 
acid glycine elution was performed to release zDisc1-specific antibodies from the zDisc1 (N)-GST 
antigen. The eluate was immediately neutralised and dialysed against wash buffer (see section 2.6.2). 
The yield was estimated at ~1-2 mg of specific antibodies. 
 
To confirm GB1-specific antibody depletion and that the remaining antibodies still retained specificity 
to zDisc1, we resolved recombinant protein by SDS-PAGE, blotted and immunostained with the three 
stages of sera: i. crude zDisc1 antiserum, ii. GB1-depleted antiserum, iii. Purified zDisc1 antibody (Fig. 
3.2). zDisc1 (N)-GB1 was detected at ~32 kDa [zDisc1 (N) (20 kDa) fused to GB1 (12 kDa)] while zDisc1 
(N)-GST ran at ~48 kDa [zDisc1 (N) (20 kDa) fused to GST (~28 kDa)]. The antiserum recognised zDisc1 
(N)-GB1, zDisc1 (N)-GST and the GB1 tag alone (12 kDa). After GBI-specific antibody depletion, 
detection of the GB1 tag decreased considerably but did not totally disappear. Blots from GB1-
depleted antiserum and zDisc1 antibody were more specific for zDisc1 recombinant proteins. The 
bands observed below these proteins correspond to partially degraded zDisc1 protein, explaining why 







To test the specificity of the purified antibody to endogenous zebrafish zDisc1, we performed 
western blotting on embryo head lysates (Fig. 3.3). The same strong 70 kDa band was detected using 





Figure 3.2. Western blots of purified zDisc1-GST, zDisc1-GB1 and GB1 protein 
Western blot using protein purified from bacterial cultures blotted using zDisc1 antiserum (left), GB1-
depleted antiserum (middle) and zDisc1 antibody (right).  
Figure 3.3. Western blots of 
zebrafish embryo head lysates 
after a 2-step purification 
Western blot using protein 
extracted from 52 hpf wild type 
(WT) zebrafish heads blotted 
using zDisc1 antiserum (left), 
GB1-depleted antiserum (middle) 
and zDisc1 antibody (right).  
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To determine the apparent molecular weight of zebrafish Disc1, we turned to a mammalian cell 
culture system and overexpressed full length zDisc1 (zDisc1-FL) in HEK 293 cells (Fig. 3.4). The zDisc1 
antibody was able to recognise overexpressed zDisc1-FL, which ran close to its expected molecular 
weight, as shown by the presence of a 112 kDa band in transfected cells (right lane), which was absent 
in un-transfected cells (left lane).  
 
 
Finally, to establish whether the 70 kDa ban present wild types was a previously uncharacterised 
zDisc1 isoform, we extracted protein from disc1Y472X/Y472XX homozygous mutants at 52 hpf and 
immunoblotted them alongside extracts from disc1+/+ controls using the purified antibody (Fig. 3.5). 
The disc1Y472X nonsense mutation codes for a PTC in exon 2 of disc1 and leads to 0.6-fold decrease in 
disc1 mRNA (Eachus et al., 2017). The functional effect at the polypeptide level remains 
uncharacterised. We would expect to see a decrease in protein levels or the possibility of a truncated 
protein (around 51 kDa) containing the N-terminal domain of the polypeptide or a complete lack of 
protein due to nonsense-mediated decay (NMD) of the shortened mRNA transcript. The presence of 
the same 70 kDa band in the disc1Y472X/Y472X homozygous mutant lysates indicates that the purified 
antibody does not recognise endogenously expressed zDisc1 in zebrafish embryo extracts and that the 
strong band is not a newly identified zDisc1 isoform. 
 
Figure 3.4.  zDisc1 antibody can recognise 
overexpressed full-length zebrafish zDisc1 
Western blot using protein extracted from and 
HEK 293 cells expressing full-length zebrafish 
Disc1 (zDisc1 F-L) and blotted using purified 
zDisc1 antibody. The antibody recognises a 
band corresponding to the zDisc1 size. Tubulin 
was used as a loading control. 
Figure 3.5. zDisc1 antibody does not recognise endogenous 
levels of zDisc1 
Western blot of protein extracted from disc1+/+ and 
disc1Y472X/Y472X mutants at 52 hpf, immunoblotted with 
purified zDisc1 antibody. The antibody recognises a band at 





To ensure that the lack of specificity to endogenous zebrafish protein was not a result of the protein 
denaturation step performed prior to polyacrylamide gel electrophoresis (PAGE), we sectioned the 
heads of wild type zebrafish at 52 hpf and performed immunohistochemistry (Fig. 3.6). Staining 




3.2.3 Generation of a disc1 mutant zebrafish using CRISPR/ Cas9 genetic editing 
Another tool commonly used to investigate the function of genes is loss of function (LOF) mutants. In 
mice, a multitude of different strains of transgenic mice containing partial loss and/or inducible Disc1 
gene mutations have been generated and studied (Clapcote et al., 2007; Hikida et al., 2007; Koike et 
al., 2006; Pletnikov et al., 2008; Shen et al., 2008) with very few groups having studied the effect of a 
complete lack of Disc1. A Disc1 model lacking exons 2 and 3 of the Disc1 gene was generated and 
developed no gross abnormality. As in other mutants, defects in long-term potentiation (LTP) were 
reported. Behaviourally, Disc1Δ2-3/Δ2-3 were less anxious and displayed higher impulsivity compared to 
wild type littermates (Kuroda et al., 2011). In zebrafish, two disc1 nonsense mutants have previously 
been identified following a TILLING screen (Draper et al., 2004). In recent years, the zebrafish 
community has moved towards creating stable genetic mutants using the CRISPR/ Cas9 system. The 
reasons for creating a disc1 CRISPR/ Cas9 mutant for my project were four-fold: i. there was a 
possibility of additional closely linked mutations in ENU mutants, ii. no previously CRISPR disc1 mutant 
had been generated, iii. a line with an indel mutation would enable faster and cheaper genotyping, iv. 
a mutation much closer to the human equivalent translocation site was desired. The need for a 
Figure 3.6. Immunofluorescence in 
vivo using purified antibody 
Coronal section through the anterior 
diencephalon. Fluorescence showing 
DAPI nuclear staining (in blue) and 
purified antibody staining (in green). 
Staining appears disperse with a 
considerable edge effect. Scale bar 




definitive LOF model to investigate the role of disc1 was therefore addressed by using CRISPR/Cas9 
technology.  
 
A single gRNA was designed and validated for in vitro cleavage (R. Lucas MSc thesis, University of 
Sheffield, 2014) resulting in indels at the target site in exon 6. We then injected this gRNA and Cas9 
mRNA into 1-cell stage zebrafish embryos. Mosaic F0s were screened for on-target in vivo cuts at 24 
hpf. Targeting of disc1 exon6 was efficient with mutations occurring in 70-80% surviving embryos. 
Eight injected embryos were pooled together for gDNA extraction and screening was carried out by 
amplifying a 438 bp PCR product around the target site (Fig. 3.7A). There was no difference in band 
size observed between un-injected and injected embryos. Bands were gel extracted and inserted into 
the pCR-II vector via TOPO cloning for sequencing. Colonies were picked and the target site of injected 
embryos showed a 4 bp deletion (Fig. 3.7B), validating the initial efficiency of disc1exon6 gRNA in vivo. 
The lack of difference in band size can be explained by the small size of the deletion.  
 
 
F0s were grown-up to sexual maturity and genotyped. To identify founders harbouring germline 
mutations, they were crossed with AB wild types and gDNA was extracted from individual progeny to 
look for transmission of mutant alleles. Various lengths of indels ranging from 2 bp to 30 bp were 
identified near the target region by sequencing. We selected an indel (16 bp deletion) that we had 
identified in numerous F1 genotyped fish and one which caused a PTC close (7 amino acids) to the 
Figure 3.7.  Validating efficiency of disc1 exon6 gRNA in vivo 
(A) gRNA and Cas9 mRNA were injected into 1-cell stage zebrafish embryos. Injected and un-
injected controls were pooled respectively and gDNA was extracted. Primers were used to 
amplify the region spanning the gRNA target site. PCR products from both injected and un-
injected controls show similar sizes.  
(B) Products were gel extracted, cloned into pR-II TOPO and sequenced. Alignment shows gDNA-
injected sequence (above) aligned with un-injected sequence (below). Sequence targeted by 
the gRNA is highlighted in blue. Initial screening showed a 4 bp deletion. 
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disc1exon6 target sequence (Fig. 3.8A). A frameshift mutation occurring at residue G625P resulted in 
scrambled amino acids after this position until a truncation at residue S633X due to a PTC. 
Heterozygote F1s were subsequently incrossed to produce a genotypically homogenous F2 
generation. Genotyping was carried out on F2 adults using PCR and DdeI digestion (Fig. 3.8B). 
Genotypes followed Mendelian ratios: wild type +/+ (25%), heterozygote +/- (50%) and mutant -/- 
(25%). Finally, because of the previously reported maternal contribution of disc1 mRNA (De Rienzo et 
al., 2011; Drerup et al., 2009), disc1exon6/exon6 homozygous mutants from the F2 generation were 
incrossed once more to produce F3 disc1exon6 maternal zygotic (MZ) mutants. disc1exon6 maternal 
zygotic mutants (disc1exon6 MZ) showed no gross morphological abnormalities compared to wild types.  
 
3.2.4 Validation of the disc1exon6 mutant line 
We next wanted to investigate if the effect of the CRISPR-generated deletion in gDNA of disc1exon6/exon6 
was transcribed to mRNA. Recent studies in zebrafish have shown cases of exon-skipping whereby the 
endogenous transcription machinery bypassed mutations generated by CRISPR/ Cas9 editing, causing 
a truncated but functional protein (Anderson et al., 2017). We pooled 52 hpf F3 homozygous mutant 
embryos together, extracted RNA and performed cDNA synthesis. Primers spanning exon-exon 
Figure 3.8. Generation of a stable CRISPR/Cas9 disc1 zebrafish mutant 
(A) Schematic of the disc1 gene with untranslated regions (white boxes), exons (red boxes) and 
introns (black connecting lines). The gRNA was designed complementary to target sequence 
(blue) in wild types (wt) at exon 6. When translated (pink boxes), the 16-bp deletion in the 
disc1 mutant sequence causes a frameshift mutation at residue G625P leading to a premature 
stop codon at residue S633*.  
(B) Gel electrophoresis of disc1 amplicons from gDNA isolated from adult F2 fin-clips.  
(C) DdeI digestion of amplicons: wild type (+/+) generates 2 bands (290 bp and 148 bp). Loss of the 
restriction site due to on target mutagenesis gives undigested products in mutants (422bp: 
16bp smaller than 438bp wild type band). Heterozygotes (+/-) have all 3 bands (422 bp, 290 bp 
and 148 bp).  
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junctions were designed and used to specifically amplify disc1 transcripts (Fig. 3.9A). A PCR product 
was observed in disc1exon6 MZ mutants (right lane). The band was gel extracted, inserted into pCR-II 
via TOPO cloning and sequenced. Sequence alignment showed the 16 bp deletion was conserved in 
disc1 mRNA transcripts (Fig. 3.9B) with no evidence of exon-skipping. Next, qPCR was performed on 
RNA extracted from these samples. There was a significant decrease (0.7-fold) of disc1 expression in 
disc1exon6 MZ mutants compared to wild types (Fig. 3.9C). 
 
 
To obtain conclusive evidence of the ineffectiveness of the zDisc1 zebrafish-specific antibody 
previously synthesised, protein from 52 hpf disc1exon6/exon6 mutants was extracted and western blotting 
was performed (Fig. 3.10). Again, the 70 kDa band was still present in the disc1exon6/exon6 mutant 
samples (right lane) similar to results observed from disc1Y472X/Y472X western blots (Fig. 3.5). Therefore, 
we concluded that the synthesised antibody was unable to recognise endogenous zDisc1. 
 
Figure 3.9. Validation of 16 bp deletion in disc1 transcripts from maternal zygotic mutants and qPCR 
analysis of disc1 expression 
RNA was extracted from disc1 maternal zygotic mutants and controls at 52 hpf. First strand cDNA 
synthesis was performed.  
(A)  Primers were used to amplify a region spanning the target site disc1 transcripts. There were 
no apparent differences in transcripts between disc1exon6 MZ mutants and disc1+/+ controls. 
(B) Products were gel extracted, cloned into pCR-II TOPO and sequenced. Alignment shows the 16 
bp deletion in the disc1 transcripts from mutants (above) wild type sequence (below). 
(C) Primers were designed and validated for qPCR. 3 technical replicates and 3 experimental 
replicates were performed. Bars indicate mean ± SD. Data distribution passed the Shapiro-Wilk 






3.3 Discussion  
3.3.1 Novel zDisc1 antibody detects overexpressed but not endogenous zDisc1 
The polyclonal antibody can recognise overexpressed zDisc1 protein (Fig. 3.4), which is estimated to 
have a molecular mass of 112 kDa (expasy.org/compute_pi). However, this same antibody was 
incapable of recognising the endogenous protein from zebrafish head extracts (Figs. 3.1, 3.3, 3.5 and 
3.10), despite studies in zebrafish finding that disc1 is most highly expressed at 2-3 dpf (De Rienzo et 
al., 2011; Drerup et al., 2009; Eachus et al., 2017; Wood et al., 2009). Antibody specificity can depend 
on several factors such as purity of the antigen used to immunise, purity of the serum returned, 
immunogenicity of the protein and conditions of purification. For example, the final acid elution step 
may not have caused enough change in conditions to permit release of all bound antibodies which 
could lead to low yields in the final dialysed product (Devanaboyina et al., 2013). However, in this case, 
this scenario is unlikely as similar strong bands were observed when using purified antibodies 
compared to antiserum to recognise recombinant zDisc1 proteins (Fig. 3.2). The most prominent 
protein detected was at a lower molecular mass than predicted. This protein was also present in 
disc1Y472X/Y472X (Fig. 3.5) and disc1exon6/exon6 (Fig. 3.10) which indicates non-specific binding of the zDisc1 
antibody to an irrelevant protein. In hindsight, antibody purification may not have been worthwhile 
as when comparing crude antiserum to purified zDisc1 antibody, the laborious process does not seem 
to have significantly increased specificity or sensitivity (Fig. 3.2).  
 
Protein extraction from zebrafish embryos is not a common laboratory technique and some groups 
report its ineffectiveness. This is often due to the presence of yolk lipids or proteases present in vast 
Figure 3.10. zDisc1 antibody does not detect endogenous 
levels of zDisc1 at 52 hpf 
Western blot using protein extracted from disc1+/+ and 
disc1exon6/exon6 mutants at 52 hpf, blotted using purified 
zDisc1 antibody. The antibody recognises a band at 70 kDa 
which does not correspond to zDisc1 as it is size and present 
in disc1exon6/exon6 mutants. There is no band detected at 112 





quantities in the gut that are used to break down nutrients into single amino acids (Link et al., 2006). 
In our experiments, we avoided this by decapitating heads prior to protein extraction. Moreover, the 
42 kDa bands corresponding to β-actin used as loading controls, clearly show a good yield of intact 
protein (Fig. 3.10).  
 
Another possibility is that endogenous protein detection was not successful due to an endogenous 
low abundance of zDisc1. The expression of DISC1 appears to be extremely low in both transcriptomic 
and mass spectrometry data (Kuroda et al., 2011). This was also noted in iPSCs, where Wilkinson et al. 
(2019) were unable to detect endogenous levels of DISC1. They used CRISPR/ VP64-p65-Rta activation 
to upregulate DISC1 expression by 2-fold and detected the DISC1 at centrosomes and the perinuclear 
region. This inherent low abundance is not aided by the fact that DISC1 undergoes rapid degradation. 
Its half-life is estimated between 3-6 hours in mammalian cells. This is very short for a scaffold protein, 
the average for structural proteins being usually 20-24 hours (Barodia et al., 2015; Yalla et al., 2018). 
Protein stability is reportedly affected by subcellular localisation; for example, multiple proteins in the 
cytosol, Golgi and transmembrane proteins have shorter half-lives compared to nuclear or 
mitochondrial proteins (Toyama and Hetzer, 2013). Therefore, differential cellular 
compartmentalisation of DISC1 may affect its half-life. Recently, synaptic activity was also found to 
have an influence of the half-life of specific neuronal proteins (Fornasiero et al., 2018). 
Immunohistochemistry was also performed to determine if the purified antibody could recognise 
zDisc1 in its tertiary structure. Protein expression pattern was examined and compared to previously 
published disc1 in situ hybridisation figures (De Rienzo et al., 2011; Eachus et al., 2017; Wood et al., 
2009). Immunofluorescence staining was dispersed and did not mirror results from RNA in situ 
hybridisation at 52 hpf, indicating non-specific binding of the purified antibody (Fig. 3.6). In future 
work, antigen-retrieval could be used before immunostaining to optimise epitope availability (Inoue 
and Wittbrodt, 2011). In addition, disc1 expression could be upregulated by activating known 
upstream regulators such as the Sonic hedgehog pathway (Boyd et al., 2015). The lack of a high quality 
antibody could be addressed by raising zebrafish-specific zDisc1 monoclonal antibodies through 
hybridoma banks; however, this technique is notoriously expensive.  
3.3.2 Uses and application of the new disc1exon6 mutant line 
The decision to target exon 6 arose because of the high degree of conservation between the C-
terminal part of zDisc1 and human DISC1. This coiled-coil region is evolutionarily conserved in 
vertebrates and is essential for protein folding and protein interactions. Inhibiting interactions at the 
C-terminus but potentially retaining those at the N-terminal end could hypothetically provide a better 
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model of the human t (1; 11). However, the gRNA does not target the human equivalent breakpoint, 
located in exon 8 of disc1. The mutant is therefore not designed to mimic the human DISC1 
translocation but aims to generate a novel tool for investigating disc1 biology. Previous work by our 
group indicated the high efficiency of a specific gRNA by both in vitro and in vivo validation (R. Lucas 
MSc thesis, University of Sheffield, 2014). This was also the case in my hands. Promisingly, the 16 bp 
deletion is predicted to cause a frameshift mutation which would result in a severely altered protein 
with a non-functional C-terminal domain. Compared to point mutations, this type of disruption is 
much more likely to affect zDisc1 expression and function. Precise targeting of this locus also meant 
we could choose to delete a restriction enzyme binding site (DdeI), to facilitate genotyping through 
restriction fragment length polymorphism (RFLP). This enables genotyping to be performed through 
restriction analysis only, rather than sequencing, used for genotyping the disc1Y472X line. This 
significantly accelerated and lowered the cost of genotyping which was invaluable during 
characterisation stages and for high throughput assays. To our knowledge, this was the first CRISPR-
generated disc1 zebrafish mutant and we predict that this new mutant will help to resolve phenotypic 
discrepancies observed between disc1 MO and ENU-generated homozygous mutant zebrafish. 
However, during the course of this study, another group reported the generation of a CRISPR disc1 
mutant using a gRNA targeting exon 2 (Tang et al., 2020). Social interaction phenotypes including an 
enhanced cohesion and reduced dispersion were observed in disc1 adult zebrafish mutants. This 
highlights the necessity of such mutant lines and the ongoing relevance to the neuropsychiatric field.  
 
The CRISPR/Cas9 system can also be used to knock in donor DNA sequences via homology directed 
repair (HDR). By using this method or Bacterial Artificial Chromosome (BAC) recombineering, we could 
tag the disc1 gene or zDisc1 protein with small epitopes (ie. FLAG, Myc, HA) or larger fluorescent 
proteins (GFP, mCherry, Cerulean) to study the dynamics and localisation in vivo. To overcome the 
current lack of reliable or commercially available antibodies against zDisc1, we attempted to generate 
a zDisc1-GFP BAC transgenic however attempts were unsuccessful and are not presented in this thesis. 
The novel line presented in this chapter will be used to study the behaviours relevant to the diverse 
hypothalamic functions. Homeostatic behaviours relating to sleep and feeding as well as stimulus-
induced responses at the larval stage and finally innate fear in adults will subsequently be assayed. 
Hypothalamic cellular phenotypes will then be probed in the developing disc1 mutants and these 







Chapter 4: Homeostatic behaviours in disc1 mutants 
 
4.1 Introduction  
Homeostasis is the dynamic state of equilibrium maintained by living systems. An animal’s behaviour 
is strongly influenced by homeostatic drives that are crucial for survival and reproduction, such as the 
drive to eat, sleep or escape from aversive stimuli. The impact of “threatened homeostasis” is involved 
in many disease processes. 
4.1.1 Feeding and hunting 
Foraging for external food sources is a key behaviour in the animal kingdom and dominates our time 
spent in wakefulness. Meeting the metabolic needs to match energy expenditure is key to survival. 
When this balance is disrupted, it can lead to malnutrition, starvation, weight gain and obesity at an 
individual level, and at a larger scale, can cause the extinction or expansion of an entire species. Our 
relationship with food becomes more complex in humans. This can be attributed to an over-supply of 
nutrients with high calorific content and the transition to a sedentary lifestyle. The constant social 
pressure of attaining happiness through aesthetic beauty and health also adds to this complexity.  
  
Eating disorders such as obesity, anorexia nervosa and bulimia nervosa are often reported as 
comorbidities in patients with neuropsychiatric disorders. For example, in a cohort of major 
depressive disorders, 40% were overweight (Faulconbridge et al., 2011). Anorexia nervosa is often co-
diagnosed in patients with schizoaffective disorders and often precedes psychosis. Some of these 
reports have been documented in medicated patients who are administered antidepressant and/ or 
antipsychotics. Adverse metabolic side effects are well-known from both atypical and typical 
antipsychotics but eating disorders are also present in medication-naive cases. In Bleuler’s first report 
of schizophrenia, anorexia was even considered one of the negative symptoms (Hoff, 2012). Lifestyle 
choices could explain the link between eating disorders and mental illness. Many patients report binge 
eating disorder which can be classified as a "coping" mechanism (Troop et al., 1998). Notably, the 
stress axis and metabolism are intimately linked. Weight gain and/or loss is commonly observed in 
people under high stress and a loss of appetite is a key sign of anxiety and stress (Epel et al., 2000).  In 
mice, acute stress inhibits feeding behaviours, whilst chronic stress leads to an overall increase in 
weight and body fat. The appetite-suppressing effects of stress in zebrafish have been linked to levels 
crf. In goldfish, central injections of crf elicit a dose-dependent decrease in food intake which was 
reversed by pretreatment with helical crf(9–41), a crf-receptor antagonist (dePedro et al., 1997). 
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Hyperosmotic conditions causing the activation of the HPI axis and downstream expression of crf can 
also lead to a decrease in food intake in zebrafish larvae (De Marco et al., 2014). 
 
Many gene regions that have been linked to schizophrenia overlap with regions linked to type II 
diabetes (Gough and O'Donovan, 2005). Specifically, copy number variations (CNV) in the human 
chromosome 16 (16p11.2) increase the risk of developing schizophrenia by 16-fold (Maillard et al., 
2015). Duplications in 16p11.2 are associated with decreased body mass whereas microdeletions are 
associated with obesity (D'Angelo et al., 2016). A recent GWAS elucidated the similarities in genetic 
architectures between risk factors for schizophrenia and anorexia (Duncan et al., 2017; Warrier et al., 
2018). Animal models expressing genetic risk factors for affective disorders have alterations in weight 
and feeding behaviour (Thyme et al., 2019). In Disc1 mutant mice, consumption of sugar is decreased 
in homozygote mutants. While this was interpreted as a sign of anhedonia, where mutants did not 
perceive the reward as "strongly" as their siblings linking caloric intake to the dopaminergic reward 
pathway (Clapcote et al., 2007), the neural circuitry of appetite could also be involved.  
 
A major centre involved in the control of feeding and appetite is the hypothalamus, though many 
other brain regions are also involved. The hypothalamus integrates peripheral signals from the 
gastrointestinal tract, liver and adipose tissues, including nutrient levels sensed by vagal afferents and 
the nutrient-sensing neurons lining the ventricular system, as well as endocrine signals sensed through 
the neuroendocrine system. A range of neuropeptides and hormones play a role in appetite control. 
These can be grossly divided into orexigenic, which induce feeding, and anorexigenic, which inhibit 
appetite and food consumption. Orexigenic peptides conserved in teleosts include neuropeptide Y 
(NPY), orexin A/B, Agouti-Related protein (AgRP) and ghrelin. The most potent and conserved 
anorexigenic peptides include cocaine- and amphetamine-regulated transcript (CART), 
proopiomelanocortin (POMC) and corticotropin-releasing factor (CRF) (Volkoff et al., 2005). In 
zebrafish, pomc is expressed from 32 hpf in the corticotropic cells of the pituitary gland and in the 
hypothalamus (Hansen et al., 2003). Acute stress (vortex) in adult zebrafish was followed by an 
upregulation of pomc expression (Fuzzen et al., 2010). It was recently shown that stress-induced 
decreases in food intake are associated with increased levels of central pomc (Cortes et al., 2018), 
linking this neuronal circuit to stress-induced anorexia. At 5 dpf, pomc+ neurons appear disorganised 
in disc1Y472X mutants, and were not detected in the characteristic horseshoe pattern found in the wild 




Steroidogenic factor 1+ (Sf-1) neurons are also involved in feeding. Their activation through 
optogenetic manipulation in the ventral medial hypothalamus of mice suppresses feeding (Viskaitis et 
al., 2017). Prenatal ablation of these neurons leads to diet-induced obesity in adult mice (Cheung et 
al., 2015). It was shown that these neurons directly synapse and inhibit Pomc+ neurons (Sternson et 
al., 2005) and therefore, would alter feeding through direct changes in appetite. Interestingly, Sf-1 
neurons also play a prominent role in stress and anxiety, and their activation also increases anxiety-
like phenotypes (Viskaitis et al., 2017). The observed alteration in food intake could also arise from a 
secondary effect from glucocorticoid (GC) activation. The expression of the zebrafish orthologue of Sf-
1, ff1b, is increased in developing hypothalamus and unchanged in the interrenal gland of 
disc1Y472Xmutants (Eachus et al., 2017). This, in turn, was linked to a maladaptive response to stress. 
We therefore predict that these mutants would also exhibit changes in their feeding behaviour. Non-
homeostatic mechanisms regulating food intake have also been uncovered. Monoaminergic systems, 
particularly serotonergic and dopaminergic, mediate the effect of hedonic feeding (Bojanowska and 
Ciosek, 2016). Based on sensory perception or pleasure, circuitry is thought to be tightly linked to the 
brain reward system (Rossi and Stuber, 2018). Drugs targeting serotonin (5HT2c) and dopamine (D2 
and D3) receptors have been shown to increase appetite effect on feeding behaviour (Lett et al., 2012). 
In teleosts, the lateral tuberal nucleus (NTL) or PVN, the homologue of the mammalian arcuate 
nucleus, is believed to be an important feeding centre. The NTL contains pomc+, agrp+ and the leptin 
receptor+ neurons. Neural activity signatures in hunting zebrafish larvae show increases in this area 
during consumption (Muto et al., 2017). Zebrafish embryos develop around and feed from their yolk 
until 5 dpf. When this internal source of food depletes, larvae instinctively start to forage for external 
sources of food. Many laboratories use Paramecia to study feeding behaviour in larvae. Paramecia 
are freely swimming, unicellular organisms that propel themselves via ciliary movement. From 6 dpf, 
zebrafish display a stereotypical hunting behaviour characterised by J turns, approach, and decision 
to ingest prey. Each step has been fully characterised, and machine learning software is available to 
automatically track such behaviour. Feeding networks and systems are highly conserved in zebrafish, 
in which drug library screens revealed similar effects on consumption in rodents (Jordi et al., 2018).   
4.1.2 Regulation of sleep 
Another key behaviour vital for physical and mental health in animals is sleep. It is controlled by both 
a homeostatic process, which increases sleep “pressure” relative to duration of wakefulness, and the 
circadian rhythm, which is responsible for physiological fluctuations of neuropeptides throughout the 
day. Sleep is a body wide phenomenon, common to all animals, however its duration, frequency and 
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time of onset vary between animals. Human electroencephalogram (EEG) recordings, measured from 
the neocortex, reveal different neural signatures known as “waves” which differentiate the different 
stages of sleep. Despite it being a well-studied behaviour, the function of sleep is still highly 
contentious. Memory consolidation, brain and peripheral tissue repair are all processes which occur 
during sleep. It is believed that being in wakeful state causes the build-up of "by-products" such as 
reactive oxidative species which are cleared during sleep. Sleep disorders are reported in 30-80% of 
patients with psychiatric disorders and are characterised by an increase in sleep onset latency and 
reductions in total sleep time, sleep efficiency, rapid eye movement (REM) and slow wave sleep in 
schizophrenic and depressive patients (Monti et al., 2013; Nutt et al., 2008). For bipolar disorder, sleep 
disturbances can evolve with the various stages of illness. For example, in the manic stages, 70-99% 
of individuals report a lessened need for sleep, whereas in the depressive stages, hypersomnia is 
reported in 40-80% of cases (Kaplan et al., 2015; Robillard et al., 2013). Sleep disruptions could be 
viewed as originating from medication as most antipsychotic medication, if taken at high doses, has 
severe sedative effects. However, in a recent study, schizophrenia patients treated with typical 
antipsychotics showed an increase in their sleep efficiency and duration, reporting improvements in 
their sleep quality compared to their sleep during premedication stages. Moreover, sleep 
disturbances, in many cases, are reported in newly diagnosed, medication-naive patients. Therefore, 
a common mechanistic origin is more likely to account for this comorbidity as common 
neurotransmitter systems and regulatory pathways are involved (Wulff et al., 2010).  
 
Transgenic αCaMKII-Disc1 mice display wild type-like intrinsic circadian periods in constant darkness, 
however, spent more time awake and less time asleep compared to wild types during both light and 
dark periods (Jaaro-Peled et al., 2016). In addition, overexpression of wild type human DISC1, 
disturbed sleep homeostasis in Drosophila (Sawamura et al., 2008). Testing a LOF animal model would 
provide additional insight into the role of Disc1 in sleep regulation. In another schizophrenia-relevant 
Drosophila model, a reduction in AKT signalling shortened the circadian period (Zheng and Sehgal, 
2010). Deficits in working memory and in prepulse inhibition (PPI) are observed in some Disc1 mouse 
models (Clapcote et al., 2007; Hikida et al., 2007; Niwa et al., 2010; Pletnikov et al., 2008; Wang et al., 
2011). Because of the role played by sleep in memory, one might speculate these memory deficits 
arise, partly, due to lack of sleep or decrease in quality of sleep, however few of these mouse studies 
concurrently tested for sleeping behaviour. 
  
Sleep regulation is mediated via the histamine, GABAergic and acetylcholine neurotransmitter 
systems (Baghdoyan et al., 1989; Sitaram et al., 1976). This is particularly evident in studies using 
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hypnotic drugs, a class of psychoactive drugs which induce sleep. Commonly used compounds are H1-
receptor antihistamines (mepyramine and promethazine), a GABAA-receptor agonist (Gaboxadol) and 
an acetylcholine esterase inhibitor (Eserine). In mammals, precise neural networks responsible for 
sleep-wake states have been mapped to the pontomedullary neuronal network, the lateral 
hypothalamus (LH) and preoptic area (PO). Two important peptidergic systems in the LH are 
hypocretin (HCRT) and melanin-concentrating hormone (MCH)-positive neurons. HCRT neuronal firing 
is most active during wakefulness and knocking out of these neurons causes excessive sleepiness 
(narcolepsy) in mice (Chemelli et al., 1999). MCH neurons are involved primarily in REM sleep (Jego et 
al., 2013). The PO also contains sleep-active neurons. Lesions in the PO have been shown to cause up 
to a 40% loss of sleep in rats. Both optogenetic and chemogenetic activation of the ventrolateral PO 
increases sleep (Kroeger et al., 2018).  
 
Teleost models have been used to study sleep, because like humans they exhibit a diurnal sleep 
rhythm, as opposed to rodents which tend to be nocturnal. Due to their decrease in swimming during 
the night, it is simple to monitor and determine their state. Moreover, subcortical regions and 
neurotransmitter systems involved in sleep (discussed above) are well conserved throughout 
vertebrates. An exception is HCRT which in mammals is expressed in monoaminergic regions in both 
developing and mature brain areas, whereas in zebrafish, hcrt does not colocalise with dopaminergic 
or serotonergic neurons (Yokogawa et al., 2007). Nevertheless, this neuropeptide still plays a role in 
sleep and arousal in zebrafish, as hcrt overexpression causes an increase in sleep episodes (Prober et 
al., 2006). Until recently, because of their lack of neocortex (the area from which EEG recordings are 
made), it was unknown whether sleep architecture and the presence of non-REM and REM sleep were 
conserved in lower vertebrates. Due to the optical transparency of larvae, Leung et al. (2019) were 
able to observe different brain activities, muscle tones and heart rates analogous to those observed 
during different sleep states in humans, confirming the conservation of this sleep feature in zebrafish 
larvae. 
 
4.2 Results  
4.2.1 Food intake is reduced in disc1 mutant zebrafish larvae 
We measured food intake in 7 dpf larval zebrafish. In normal laboratory conditions, at 5 dpf, larvae 
would be transferred to a nursery and are fed powdered food. Although hunting is an instinctive 
behaviour, we trained larvae to hunt and feed on the Paramecia by exposing them from 5 dpf. 
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Paramecia used for feeding at 7 dpf were labelled with Dil dye which emits fluorescence under far red 
light. Fixation was performed after 15 min to precede gut-emptying/digestion mechanisms. Gut 
fluorescence was used as a measure of food intake. There was a significant decrease in gut 
fluorescence between disc1-/- mutants and their respective disc1+/+ controls in both disc1Y472X (Fig. 




Food intake was also measured in progeny from a disc1exon6 heterozygote incrosses, and larvae were 
genotyped post-hoc. This was done to avoid any environmental contributions from differences in 
rearing conditions (number of larvae, food source, experience, etc.). Again, we found a significant 
Figure 4.1. Food intake in disc1 maternal zygotic mutants at 7 dpf  
Points represent individual larvae, bars indicate mean ± SD. Wild type (+/+), wild type in-cross larvae 
(non-sibling); Mutant (-/-), homozygous mutant in-cross larvae. Data pooled from 3 independent 
clutches of embryos for each genotype.  
(A) For disc1Y472X, N= 94. Data distribution did not pass the Shapiro-Wilk normality test. Mann-
Whitney test, *** = p < 0.001. 
(B) For disc1exon6, N= 159. Data distribution did not pass the Shapiro-Wilk normality test. Mann-
Whitney test, *** = p < 0.001. 
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decrease in gut fluorescence in disc1exon6 homozygous mutants compared to heterozygotes and wild 
types (Fig. 4.2, Table 4.1). 
 
Table 4.1. Tukey’s post hoc multiple comparison  
Tukey Multiple Comparison P value Sig. 
Wild type: Heterozygote 0.999 n.s 
Wild type: Mutant 0.011 * 
Heterozygote: Mutant 0.023 * 
 
4.2.2 Hunting behaviour is reduced in disc1 mutant zebrafish larvae 
The decrease in gut fluorescence observed in disc1 mutant larvae could arise from abnormal hunting 
behaviour. We manually quantified hunting by recording 10-min videos, 5 min after addition of 
Paramecia at 7dpf. There was a significant decrease in hunting bouts between disc1-/- mutants and 
their respective disc1+/+ controls in both disc1Y472X (Fig. 4.3A) and disc1exon6 lines (Fig. 4.3B). 
 
Figure 4.2. Food intake in progeny 
from a disc1exon6 heterozygote 
incross at 7 dpf   
Points represent individual larvae, 
bars indicate mean ± SD. Wild type 
(+/+), heterozygote in-cross larvae 
(sibling); Heterozygote (+/-), 
heterozygote in-cross larvae 
(sibling); Mutant (-/-), homozygous 
mutant in-cross larvae. Data 
pooled from 4 independent 
clutches of embryos. N = 250. Data 
distribution passed the Shapiro-
Wilk normality test, one-way 
ANOVA, F (2, 206) = 5.396, * = p < 





4.2.3 Stress-induced anorexic behaviour is attenuated in disc1 mutant zebrafish 
larvae 
It was previously shown that hyperosmotic conditions cause activation of stress response in teleosts 
(Yeh et al., 2013). Zebrafish exposed to hyperosmotic conditions display a difference in lateral 
displacement toward Paramecia (De Marco et al., 2014). Recently, it was shown than disc1 mutants 
have an altered response to stress (Eachus et al., 2017). Considering disc1 mutants also have an altered 
feeding behaviour (Fig. 4.1, 4.2), we decided to investigate the effect of stress on food intake in disc1 
mutants. We applied sodium chloride (NaCl), an osmotic stressor, to the larvae 10 min prior to the 
feeding assay. This delay was chosen as cortisol peak occurs 10-15 min after exposure to a stressful 
stimulus (Yeh et al., 2013). We observed different effects between disc1+/+ and disc1Y472X/Y472X in 
response to varying concentrations of NaCl. As expected, acute stress causes a decrease in food intake 
in a dose-dependent manner in wild type larvae (Fig. 4.4). In disc1Y472X/Y472X mutants, acute stress had 
Figure 4.3. Hunting behaviour in disc1 maternal zygotic mutants at 7 dpf  
Violin plots represent sample distribution, full lines indicate median, and dotted lines indicate first 
quartile (below) and third quartile (top). Wild type (+/+), wild type in-cross larvae (non-sibling); Mutant 
(-/-), homozygous mutant in-cross larvae. Data pooled from 2 independent clutches of embryos for 
each genotype.  
(A) For disc1Y472X, N= 36, data distribution passed the Shapiro-Wilk normality test. Student's t-test, 
*** = p < 0.001. 
(B)  For disc1exon6, N= 23, data distribution passed the Shapiro-Wilk normality test. Student's t-test, 
** = p < 0.005. 
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no effect on gut fluorescence at lower NaCl concentrations (100 mM) whereas the effect was 
comparable with wild types at higher NaCl concentrations (250 mM).  
 
 
Figure 4.4. Stress-induced anorexia in disc1Y472X maternal zygotic mutants 
Points represent individual larvae, bars indicate mean ± SD. Wild type (+/+), wild type in-cross larvae 
(non-sibling); Mutant (-/-), homozygous mutant in-cross larvae. Data from a single clutch of embryos. 
N+/+= 22, N-/-= 33, N+/+ [100 mM]= 27, N-/- [100 mM]= 30, N+/+ [250 mM]= 30, N-/- [250 mM]= 26, data distribution did 
not pass the Shapiro-Wilk normality test. Two-way ANOVA and Tukey’s multiple comparison ** = p 
<0.01, *** = p < 0.001). See Table 4.2 for statistics.  
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Table 4.2. Tukey’s post hoc multiple comparison for gut fluorescence in disc1Y472X after 
exposure to varying concentrations of sodium chloride 
 
4.2.4 Sleep is decreased in disc1 mutant zebrafish larvae 
In zebrafish, the circadian rhythm can be measured through locomotor activity as early as 5 dpf 
(Hastings et al., 2003). As in all diurnal animals, activity is greatly reduced during night-time. This state 
can be simulated by exposure to a 14hr: 10hr light: dark cycle. Larvae were placed in individual wells 
and activity was measured over 3 consecutive nights (6-9 dpf) and averaged. disc1Y472X mutants 
showed an increased activity during the night-time and a decrease in activity during the daytime 
compared with disc1+/+ controls (Fig. 4.5A,B,C). To investigate sleeping behaviour, we quantified the 
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number of sleep episodes, defined by ≥1 min of inactivity. disc1Y472X mutants slept significantly less 
during the night compared to controls (Fig. 4.5D). During the day, there were no differences in number 
of sleep episodes between disc1Y472X mutants and controls (Fig. 4.5E). disc1exon6 mutants exhibited wild 
type-like locomotor activity and number of sleep episodes during the night (Fig. 4.6A,B,D), however, 
showed a significantly increase locomotor activity during the day (Fig. 4.6C). There was no difference 









Figure 4.5. Locomotor activity and sleep episodes in disc1Y472X maternal zygotic mutants 
Activity traces over 15 hours. +/+, wild type in-cross larvae (non-sibling); -/-, homozygous mutant in-
cross larvae. Data pooled from 2 independent clutches of embryos. N=48, 3 experimental replicates. 
White and grey boxes indicate lights ON (day) and lights OFF (night), respectively. The same data 
points were used for quantification in (B) and (C).  
(A) Lines and shaded areas represent means ± SD. Night-time activity is increased in disc1Y472X 
mutants compared wild types. Daytime activity is decreased in disc1Y472X mutants compared 
wild types.  
(B) Box and violin plots of locomotor activity during the night (grey box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data distribution did not pass the 
Shapiro-Wilk normality test., Mann-Whitney test, *** = p < 0.001. 
(C) Box and violin plots of locomotor activity during the day. Dashed lines indicate median 
(middle), first (lower) and third (higher) quartile. Data distribution did not pass the Shapiro-
Wilk normality test., Mann-Whitney test, *** = p < 0.001. 
(D)  Box and violin plots of sleep episodes during the night (grey box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data distribution passed the 
Shapiro-Wilk normality test., unpaired Student's t-test, ** = p < 0.01. 
(E)  Box and violin plots of sleep episodes during the day. Dashed lines indicate median (middle), 
first (lower) and third (higher) quartile. Data distribution passed the Shapiro-Wilk normality 















For the same reasons as aforementioned in the feeding assay, we measured locomotor activity in 
progeny from disc1exon6 heterozygote incrosses and performed genotyping post hoc. There was a 
significant increase in night-time locomotor activity in both disc1exon6/+ and disc1exon6/exon6 (Fig. 4.7A,B). 
There was also a significant increase in daytime locomotor activity in disc1exon6/exon6 compared to 
disc1+/+ siblings; however, disc1exon6/+ exhibited a significantly decreased locomotor activity during the 
day compared to disc1+/+ siblings and disc1exon6/exon6 (Fig. 4.7C). There was no difference in number of 
sleep episodes during neither the day or night between all genotypes (Fig. 4.7D,E). 
 
Figure 4.6. Locomotor activity and sleep episodes in in disc1exon6 maternal zygotic mutants 
Activity traces over 12 hours. +/+, wild type incross larvae (non-sibling); -/-, homozygous mutant 
incross larvae. Data pooled from 2 independent clutches of embryos. N=48, 3 experimental replicates. 
White and grey boxes indicate lights ON (day) and lights OFF (night), respectively. The same data 
pointed were used for quantification in (B) and (C). 
(A) Lines and shaded areas represent means ± SD. Night-time activity is increased in disc1exon6 
mutants compared wild types. Daytime activity is similar between disc1exon6 mutants and wild 
types. 
(B) Box and violin plots of locomotor activity during the night (grey box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data distribution did not pass the 
Shapiro-Wilk normality test., Mann-Whitney test, n.s = p > 0.05. 
(C) Box and violin plots of locomotor activity during the day. Dashed lines indicate median 
(middle), first (lower) and third (higher) quartile. Data distribution did not pass the Shapiro-
Wilk normality test., Mann-Whitney test, *** = p < 0.001. 
(D) Box and violin plots of sleep episodes during the night (grey box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data distribution passed the 
Shapiro-Wilk normality test, unpaired Student's t-test, n.s = p > 0.05. 
(E) Box and violin plots of sleep episodes during the day (white box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data distribution passed the 










4.3 Discussion  
4.3.1 Analysis of feeding and hunting behaviour in disc1 larvae 
We report a decrease in feeding which could indicate either a deficit in metabolic needs or a decrease 
in appetite. Disc1 mouse models have a decrease in sucrose consumption which was linked to 
anhedonia; however, no differences in size or weight was ever reported. No differences in size in body 
length or head width were also reported in disc1Y472X mutant zebrafish (H. Eachus PhD thesis, 
University of Sheffield, 2015). This suggests that the decrease in hunting and food intake is due to a 
decrease in appetite or motivation rather than difference in metabolic need. The consistency of this 
phenotype between disc1Y472Xand disc1exon6 indicates that this reduction in appetite is a gene-specific 
effect. The consistency of the phenotype in homozygous mutants derived from heterozygote incrosses 
which were raised in identical conditions, rules out the contribution of environmental/ rearing 
conditions. Loss of appetite and anorexia is commonly comorbid with medication-naïve 
neuropsychiatric disorders. Of note, other zebrafish models harbouring mutations in schizophrenia-
associated genes have decreases in both hunting and feeding (Thyme et al., 2019). These results seem 
to suggest that functionally diverse genetic risk factors for psychiatric disease, including disc1, 
converge at the behavioural level.  
4.3.2 The relation between stress and food consumption 
The response to stress is mediated, in part, by the HPA axis, which causes an increase in plasma 
glucocorticoids that feed back into the brain. In rats, daily injections of the synthetic glucocorticoid 
Figure 4.7. Locomotor activity and sleep episodes in progeny from a disc1exon6 heterozygote incross  
Activity traces over 15 hours. +/+, homozygous sibling; +/-, heterozygous mutant; -/-, homozygous 
mutant. Data pooled from 2 independent clutches of embryos. N=96, 2 experimental replicates. White 
and grey boxes indicate lights ON (day) and lights OFF (night), respectively. The same data points were 
used for quantification in (B) and (C).  
(A) Lines and shaded areas represent means ± SD. Night-time and daytime activity is similar 
between disc1exon6 mutants, heterozygotes, and wild types.  
(B) Box and violin plots of locomotor activity during the night (grey box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data did not pass the Shapiro-Wilks 
test. Kruskal-Wallis test with pairwise comparison was significant, P<0.01 = **, P<0.001 = ***.  
(C) Box and violin plots of locomotor activity during the day (white box). Dashed lines indicate 
median (middle), first (lower) and third (higher) quartile. Data did not pass the Shapiro-Wilks 
test. Kruskal-Wallis test with pairwise comparison was significant, P<0.01 = **, P<0.001 = ***.  
(D) Box and violin plots of sleep episodes during the night (grey box). Dashed lines indicate median 
(middle), first (lower) and third (higher) quartile. Data distribution passed the Shapiro-Wilk 
normality test, one-way ANOVA, F (2,44) = 0.696, n.s = p > 0.05. 
(E) Box and violin plots of sleep episodes during the day (white box). Dashed lines indicate median 
(middle), first (lower) and third (higher) quartile. Data distribution passed the Shapiro-Wilk 
normality test, one-way ANOVA, F (2,44) = 1.316, n.s = p > 0.05.  
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dexamethasone can suppress food intake (Jahng et al., 2008). In zebrafish larvae, hyperosmotic 
conditions which increases cortisol secretion, will also suppress food intake. When cortisol returns to 
basal levels, normal feeding is re-established (De Marco et al., 2014). In rainbow trout, the growth 
suppressing effects of cortisol administration were linked to an increase in crf in the preoptic area 
(Madison et al., 2015). In contrast, chronic stress in goldfish and sea bass (by daily intraperitoneal 
cortisol injections), increases food intake (Bernier et al., 2004; Leal et al., 2011). These differences 
could be due to the effect of chronic vs acute stress, the dose administered or species selectivity. Our 
group previously found that, unlike wild type controls, disc1Y472X mutant larvae do not upregulate 
cortisol in response to acute stress at 5 dpf (Eachus et al., 2017). We report here, that disc1Y472X mutant 
larvae do not decrease food consumption in response to acute stress (Fig. 4.4). The lack of 
downregulation of food intake after NaCl [100 mM] treatment (mild acute stress) in disc1 mutants could 
be explained by a lack of cortisol upregulation, however, the necessary repeats and rescue 
experiments to demonstrate this have not been performed yet.  
4.3.3 Analysis of locomotion in disc1 mutant larvae  
Baseline swimming activity during the day appeared decreased in disc1Y472X mutants compared to 
disc1+/+ (Fig. 4.5A,C).  This observation is in direct contrast from the ‘normal’ baseline swimming 
activity previously reported in disc1Y472X/Y472X at 5 dpf (H. Eachus PhD thesis, University of Sheffield, 
2015). Interestingly, disc1exon6 mutants, originating from both homozygous (Fig. 4.6A,C) and 
heterozygous crosses (Fig. 4.7A,C), were hyperactive during the day. Daytime hypoactivity has not 
been reported in other Disc1 animal models. In fact, the most widely reported locomotor phenotype 
in mice is hyperactivity (Clapcote et al., 2007; Hikida et al., 2007) or no change in locomotor activity 
(Koike et al., 2006; Pletnikov et al., 2008). Hyperactivity is an endophenotypes of schizophrenia and 
linked to stereotypical behaviour of schizoaffective models (lion pacing a cage/obsessive compulsion 
behaviour, anxiety). On the other hand, hypolocomotion is an endophenotype commonly observed in 
animal models of depression (de Abreu et al., 2018). It has been linked to alterations in dopaminergic 
ascending neurons and alterations to brain areas associated with motivation and initiation of 
locomotion  
 
We found that disc1Y472X mutants have an increased locomotor activity during the night and a decrease 
in number of sleep episodes (Fig. 4.5A,B,D). disc1exon6 mutants originating from homozygous crosses, 
showed no differences in their night-time activity or sleep behaviour (Fig. 4.6B,D,E); however, 
disc1exon6 mutants originating from heterozygous crosses, also exhibited night-time hyperactivity (Fig. 
4.7A,B). The number of sleep episodes during the night also appeared decreased in disc1exon6 mutants, 
however this was not statistically significant (Fig. 4.7D).  Night-time hyperactivity has also been 
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reported in Disc1 transgenic Drosophila and mice models (see section 4.1.2). In other zebrafish 
mutants modelling neurodevelopmental disorders such as cntnap2, a risk factor for autism, night-time 
hyperactivity is also a prominent phenotype and even used as a readout for determining drug efficacy 
(Hoffman et al., 2016). This work is the first study suggesting that disc1 mutant larvae sleep less than 
wild type larvae. This finding could be related to the insomnia comorbidities often reported in 
neuropsychiatric disorders. Of note, in human carriers of the DISC1 translocation and in Disc1 mice 
models, memory and learning deficits have been reported (Cannon et al., 2005; Koike et al., 2006; 
Thomson et al., 2016). As previously discussed, sleep quality and length significantly impact on 
memory and neuroplasticity. Therefore, sleep disturbances could play a secondary role in some of 
these deficits. A more thorough analysis of sleep architecture on disc1 mutant zebrafish larvae is 
needed and could include comparing slow wave sleep (SWS) and propagating wave sleep (PWS) 
episodes to pinpoint precise differences. Such techniques were recently developed for examining 
sleep architecture in larvae and reinforces the validity of larval zebrafish for modelling human sleep 
(Leung et al., 2019).  
4.3.4 Phenotypical differences between genotypes and crosses 
While the feeding phenotype was consistent between genotypes and crosses, the sleep phenotype 
showed more disparities. With regards to daytime locomotion, disc1Y472X mutants were hypoactive 
(Fig. 4.5C), whereas disc1exon6 mutants (Fig. 4.6C, 4.7C) were hyperactive. As both mutant lines have 
premature stop codons (PTC) and a significant decrease in disc1 expression (Fig. 3.9C; Eachus et al., 
2017), it is unlikely that differences observed between disc1Y472X and disc1exon6 are due to differential 
levels of zDisc1 protein. Phenotypical differences could arise due to differences in allele functionality 
between in disc1Y472X and disc1exon6 (see section 8.6.1, for detailed discussion).  
 
Differences were also observed in locomotor activity between mutants from disc1exon6 heterozygote 
incrosses versus disc1exon6 homozygote incrosses. While disc1exon6 maternal zygotic mutants were 
found to show no differences in night-time activity (Fig. 4.6B), disc1exon6/exon6 and disc1exon6/+ mutants 
from heterozygotes incrosses had an increase in night-time activity compared to disc1+/+ siblings (Fig. 
4.7B). Differences in these results could be explained by the large variability of the locomotor activity 
data in the disc1exon6 homozygous incrosses (Fig. 4.6B). To conclude, loss of disc1 causes a decrease in 
food consumption and hunting behaviour and in some cases, may affect sleep regulation. Given that 
disc1 mutant lines show opposite daytime locomotor phenotypes yet still have a decrease in 
Paramecia consumption, we concluded this phenotype is not secondary effect of hypolocomotion. 
Considering the role of disc1 in the development of the hypothalamus, these new results could 
implicate hypothalamic-driven alterations in motivation and arousal.  
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Chapter 5: Stimulus-evoked behaviours in disc1 mutants 
5.1 Introduction 
5.1.1 Stimulus-evoked behaviours and arousal 
In contrast to homeostatic behaviours, stimulus-evoked behaviours are initiated in response to 
external cues. The correct responsiveness to the external environment is key to an animal’s survival 
and heavily involved in predator evasion. Even the most primitive invertebrates possess the ability to 
respond to their external environment. In a pioneering piece of work, Eric Kandel and colleagues 
demonstrated that a tactile stimulus elicited a withdrawal response in the sea snail, Aplysia californica 
(Kandel et al., 1967). Measuring arousal is a way of quantifying responses to external stimuli. These 
stimuli are diverse (auditory, visual, chemical, mechanical), unexpected and most often aversive. 
Whereas sleep and wake are relatively simple behaviours to characterise, an animal’s arousal state is 
more ambiguous but is well defined. Arousal is characterised by an increase in motor activation, 
sensory responsiveness and emotional reactivity (Pfaff, 2006). Therefore, an animal in an elevated 
state of arousal exhibits both increased spontaneous activity (endogenous arousal) and increased 
responsiveness to sensory stimuli (exogenous arousal) (Pfaff et al., 2008). At least five major 
neurotransmitter systems (dopamine, noradrenaline, serotonin, acetylcholine, and histamine) work 
collectively to increase arousal. In more complex animals, such responses modulated by external cues 
are termed startle responses and appear relatively early in development. The relationship between 
stress and arousal is uneven; there is clear possibility to have arousal without stress but the inverse, 
stress without arousal, is not true (Pfaff et al., 2007). Functionally, arousal is crucial for motivating 
behaviours such as locomotion, escape, reward- seeking (e.g. pursuit of prey) and courtship activity.  
5.1.2 Modelling stimulus-evoked behaviours in zebrafish  
Zebrafish express a rich repertoire of stimulus-evoked behaviours with striking similarities to 
mammals. Larval zebrafish are useful vertebrate models for defensive behaviours because of their 
relatively simple nervous system. Escape reflexes to a variety of threats (visual, tactile or vibrational-
acoustic) elicit a fast, robust, high angle and stereotypical behaviour (the C bend) (O'Malley et al., 
1996). Vibrational-acoustic startle are detected through sensory hair cells of the lateral line and otic 
vesicle which project to large escape-promoting Mauthner neurons in the hindbrain (reticulospinal 
circuit) (Eaton et al., 1977; Liu and Fetcho, 1999).  
 
Other visually evoked behaviours include the visual startle response, elicited by a looming stimulus 
and which is also Mauthner-medicated (Dunn et al., 2016). These protective startle responses are 
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characterised by upregulation of activity and a change in direction to escape potential predators. 
Changes in illumination cause different light-induced locomotor responses (LLR) such as an acute 
response termed visual motor responses (VMR) which appears seconds after the change (Burgess and 
Granato, 2007). More long-term LLRs occur minutes after the change of light (Gao et al., 2014). LLRs 
can temporarily override endogenous activity levels set by the circadian clock, a phenomenon 
homologous to masking in mammals (Mrosovsky et al., 2005). Negative masking is an acute effect of 
light exposure which causes a downregulation of locomotion in nocturnal species (Aschoff, 1999). 
Arousal behaviours are modality specific. This signifies that the responsiveness to different sensory 
modalities (light, sound, pain) are dissociable. For example, transient overexpression of hcrt at 5 dpf 
selectively increases the larvae’s response to a dark flash but not to acoustic stimuli (Woods et al., 
2014). This highlights the importance of measuring responses to multiple modalities when 
investigating behavioural phenotypes.  
 
Escapes are energetically costly movements and additional modulation is provided from the 
dopaminergic (DA) and serotoninergic (5-HT) systems (Yao et al., 2016). Evidence for the involvement 
of dopaminergic neurons in exogenous arousal has primarily come from Drosophila studies (Lebestky 
et al., 2009; Van Swinderen and Andretic, 2011). Genetic variation in startle-induced locomotion is 
thought to be associated with differences in DA levels (Carbone et al., 2006; Kume et al., 2005). In 
zebrafish, changes to LLRs are often reported in models of Parkinson’s disease where the loss of DA 
neurons in ventral diencephalon causes abnormal responses to light (da Fonseca et al., 2013; Stednitz 
et al., 2015; Xi et al., 2010). 
 
The behavioural repertoire in adult zebrafish is far richer than at larval stages, even though social 
behaviours emerge as early as 3 weeks post-fertilisation (wpf). Response to a novel environment is 
widely used to examine risk-taking behaviour and anxiety in adult fish (Gerlai et al., 2000; Maximino 
et al., 2010). When placed in a novel environment or when exposed to a stressor (NaCl or alarm 
substance), adult zebrafish spend more time at the bottom of the tank termed bottom dwelling 
behaviour (Mathuru et al., 2012; Speedie and Gerlai, 2008; Waldman, 1982). Freezing and erratic 
swimming episodes increase, disrupting the baseline continuous swimming pattern (Blechinger et al., 
2007). Importantly, alterations can be reversed by acute treatment of anxiolytics (Egan et al., 2009). 
Another anxiety paradigm is the open-field test. Similarly to rodents, response to stress, zebrafish 
display avoidance of the centre of the tank (Champagne et al., 2010; Hall and Ballachey, 1932). This 
behaviour termed thigmotaxis, is abnormal in DN-Disc1, Disc1L100P and  Disc1Q31L missense mutant mice 
following immunological challenge (Abazyan et al., 2010; Lipina et al., 2013). In addition, drug 
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screening assays in adult zebrafish have shown anxiogenic drugs generally increase startle responses; 
while anxiolytic drugs generally decrease startle responses (Hale, 2000; Pittman and Lott, 2014). These 
findings suggest that stimulus-induced behaviours can become abnormal after genetic and 
environmental insult and are sensitive to relevant compounds.  
5.1.3 Neuronal gating dysfunctions in neuropsychiatric disorders 
Startle assays are commonly used in psychopharmacology studies. Arousal states and sensorimotor 
information processing are dysregulated across a subset of neuropsychiatric disorders. An imbalance 
between excitatory and inhibitory circuits could affect the dynamic of arousal circuits causing 
alterations in cognitive function. In schizophrenia, post-traumatic stress disorder (PTSD) and anxiety, 
hyperarousal is often reported whereas hypoarousal is often associated with attention deficit 
hyperactivity disorder (ADHD) and depression (Carlsson et al., 1999; de Lecea et al., 2012; Haller et al., 
2005; Miano et al., 2006). Recently, startle-evoked responses were able to reliably predict the severity 
and breadth of psychopathology in human patients (Lang et al., 2018).   
 
Sensorimotor gating (SMG) is the selective transmission of indispensable sensory signals to the motor 
system as dispensable signals are ignored. Sensorimotor gating defects are a fundamental feature in 
schizophrenia and ASD, leading to heightened perception of sensory information (McGhie and 
Chapman, 1961). A measure of SMG is prepulse inhibition (PPI) of the startle response. PPI is a form 
of SMG where the startle response is markedly attenuated when a weaker stimulus is presented 
immediately before the startling stimulus (Braff et al., 1995). PPI is diminished in individuals with a 
range of neuropsychiatric disorders including schizophrenia and bipolar disorder (Geyer, 2006; Perry 
et al., 2001). Neural circuits governing PPI are incompletely understood although dopamine agonists 
(e.g. apomorphine), NMDA antagonists (e.g. ketamine) and some antipsychotic compounds can rescue 
PPI defects in both schizophrenic patients and animal models (Schwabe and Krauss, 2018; Swerdlow 
et al., 2001).  Many Disc1 mutant mouse models have deficits in PPI (Clapcote et al., 2007; Kakuda et 
al., 2019; Shen et al., 2008); however, other groups using transgenic Disc1 mice with ectopic 
promoters or missense mutations find wild type PPI responses (Dachtler et al., 2016; Hikida et al., 
2007; Pletnikov et al., 2008). The presence of startle modulation and its similar pharmacological 
sensitivity to antipsychotics, make larval zebrafish a pertinent tool for studying neuropsychiatric 
disorders, however we decided not to assay PPI in zebrafish disc1 mutants as results previous results 
indicated a lack of PPI phenotype (personal communication with Dr Summer Thyme, Harvard 
University). The experiments described in the following Chapter utilised two mutant strains (disc1Y472X 
and disc1exon6) at different developmental stages 11 dpf (auditory), 6 dpf (visual) and 2 mpf (novel 




5.2.1 Startle responses to auditory stimuli in disc1 mutant larvae 
We first investigated responses of zebrafish disc1 mutants to auditory stimuli administered during the 
night. We decided to assay the acoustic startle during the night from 1 AM to 6:20 AM (see section 
2.22.4) in order to perform the analysis at the lowest state of arousal (during sleep). We optimised 
the testing age of larvae to reduce inter-individual variability of behaviour and selected at 11-13 dpf. 
Larvae were placed in individual wells of a 48-well plate and exposed to 8 varying intensities of 
auditory stimuli. We measured the percentage of fish that were responsive at each stimulus. Larvae 
were considered responsive if a displacement of >10 pixels in the 5 s following the auditory stimulus 
was detected. Of note, we decided to test progeny from heterozygote crosses first to avoid 
environmental contributions towards observed phenotypes. All larvae were raised together until the 
day of assay and larvae were genotyped post hoc. There were no differences in percentages of fish 
responding to auditory stimuli between disc1Y472X/Y472X homozygous mutants, disc1Y472X/+ heterozygotes 




Figure 5.1. Responses of disc1Y472X 
larvae during the night-time arousal 
test  
Percentage of larvae responding to 
varying intensity of auditory stimuli. 
+/+, disc1+/+ homozygous siblings; +/-, 
disc1Y472X/+ heterozygotes; -/-, 
disc1Y472X/Y472X homozygous mutants. 
N=48 per clutch. Responses averaged 
over 6 hours and then over 2 nights, 
data pooled from 2 independent 
experiments. Bars indicate mean ± 
SEM. Data distribution passed the 
Shapiro-Wilk normality test. See Table 





We performed the NTA test in the other disc1 line (Fig. 5.2). Overlapping error bars at low sound 
intensities (8 dB, 17 dB, 26 dB) and high sound intensities (52 dB, 60 dB, 72 dB) suggested there were 
no differences in auditory startle response between disc1exon6/exon6 homozygous mutants, disc1exon6/+ 
heterozygotes and disc1+/+ homozygous wild type siblings. Non-overlapping error bars at medium 
intensities (35 dB, 43 dB) suggested there were differences in auditory startle between disc1exon6/exon6 
mutants and disc1+/+ with a gene dosage effect for disc1exon6/+. We performed a one-way ANOVA for 
each stimulus intensity and results showed a significant difference at intensity 35 dB (F (3, 68) = 3.171, 
p = 0.030) and 43 dB (F (2, 69) = 2.703, p = 0.046). This upwards shift of the -/- and +/- lines indicates 
an increased responsiveness of disc1exon6/exon6 homozygous mutants and disc1exon6/+ heterozygotes 
respectively. As expected, the results from a factorial ANOVA with repeated measures revealed there 
was a strong effect of stimulus and weak effect of genotype (Table 5.2). We hypothesise that there is 
the interaction between genotype and stimulus is not statistically significant because, at most stimuli 
(6 out of the 8), error bars overlap and there are no significant differences between disc1exon6/exon6, 
disc1exon6/+ and disc1+/+. 
 
Table 5.1. Statistical analysis of night-time arousal test in disc1Y472X line 
The results of a factorial ANOVA with repeated measures for time and genotype are shown. There is no 
significant effect of genotype on the percentage of larvae responding. There is a significant effect of 
stimulus on response. There is no significant interaction between genotype and stimulus. P > 0.05 = n.s, 






After observing a weak effect of genotype in the disc1exon6 line and statistically significant differences 
at some stimulus intensities, we decided to perform the NTA test on disc1exon6/exon6 MZ mutants. The 
possible gene dosage effect led us to hypothesise that disc1exon6/exon6 MZ mutants, which lack maternal 
contribution of disc1, would have a more severe auditory startle phenotype. We performed the NTA 
test on disc1exon6 MZ mutants and compared them to disc1+/+ controls (Fig. 5.3). There was a significant 
difference in percentages of larvae responding to auditory stimuli between disc1exon6 MZ (red line) and 
disc1+/+ (black line) (Table 5.3). The upwards shift of the red line (disc1exon6 MZ) compared to the black 
line (disc1+/+) indicates that disc1exon6 MZ mutants are hyper-responsive to auditory stimuli during the 
Figure 5.2. Responses of disc1exon6 
larvae during the night-time arousal 
test 
Percentage of larvae responding to 
varying intensity of auditory stimuli. 
+/+, disc1+/+ homozygous siblings; +/-, 
disc1exon6/+ heterozygotes; -/-, 
disc1exon6/exon6 homozygous mutants. 
N=48. Responses averaged over 6 
hours and then over 2 nights, data 
pooled from 2 independent 
experiments. Bars indicate mean ± 
SEM. Data distribution passed the 
Shapiro-Wilk normality test. One-way 
ANOVA was performed at individual 
intensities. P < 0.05 = *. See Table 5.2 
for statistics. 
Table 5.2. Statistical analysis of night-time arousal test in disc1exon6 line 
The results of a factorial ANOVA with repeated measures for time and genotype are shown. There is a 
nominally significant effect of genotype on the percentage of larvae responding. There is a significant 
effect of stimulus on response. There is no significant interaction between genotype and stimulus. P > 
0.05 = n.s, P < 0.05 = *, P < 0.0001 = ****. See Figure 5.2 for plot.  
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night. We were unable to examine the disc1Y472X/Y472X maternal zygotes (disc1Y472X MZ) due to time and 






5.2.2 Startle responses to visual stimuli in disc1 mutant larvae 
To investigate another modality of arousal, we turned to the visual system. We used highly 
reproducible patterns of activity induced by changes in illumination as a measure for LLR. These 
responses have been extensively studied in larval zebrafish. After a transition from light to dark, 
swimming activity spikes to a maximum, 15 min after the dark onset and then decreases to reach a 
Figure 5.3. Responses of disc1exon6 
maternal zygotes during the night-
time arousal test 
Percentage of larvae responding to 
varying intensity of auditory 
stimulus+/+, disc1+/+ wild type in-cross 
larvae (non-sibling); -/-, disc1exon6/exon6 
homozygous mutant in-cross larvae. 
N=24. Responses averaged over 6 
hours and then over 2 nights, data 
pooled from 2 independent 
experiments. Bars indicate mean ± 
SEM. Non-overlapping error bars at all 
intensities suggested there are 
differences in auditory startle between 
disc1exon6 maternal zygotic mutants and 
controls. Data distribution passed the 
Shapiro-Wilk normality test, unpaired 
Student t-test was performed at 
individual intensities. P < 0.001 = ***, P 
< 0.0001 = ****. See Table 5.3 for 
statistics. 
Table 5.3. Statistical analysis of night-time arousal test in disc1exon6 maternal zygotes 
The results of a factorial ANOVA with repeated measures for time and genotype are shown. There is a 
significant effect of genotype and stimulus on the percentage of larvae responding. There is a significant 
interaction between genotype and stimulus. P < 0.0001 = ****. See Figure 5.3 for plot. 
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stable low level, 10 min after the peak. After a transition from dark to light, activity initially decreases 
(for the first 5 min), preceding a gradual increase to a stable high level, approximately 20 min after 
light onset (Burgess and Granato, 2007; MacPhail et al., 2009; Prober et al., 2006). Therefore, we used 
6 alternating cycles of dark (40 min) and light (20 min).  
 
We observed no differences in the decrease in activity during the transitions from dark to light 
between disc1Y472X MZ mutants and disc1+/+ sibling controls (Fig. 5.4B, point a.). The increase in activity 
during extended exposure to light appeared slower was delayed in disc1Y472X MZ compared with 
disc1+/+ (Fig. 5.4B, point b.). Locomotion during this period was lower in disc1Y472X MZ compared to 
controls and this difference persisted after the dark flash (Fig. 5.4B, point c.). There was no difference 
between disc1Y472X MZ and controls in the onset time (15 min after dark-flash) of the dark-induced 
increase in activity, however disc1Y472X MZ exhibited consistently lower peaks in activity (Fig. 5.4B, 
point d.). There was no difference in the latency of the decline of activity during the extended period 
of darkness between the 2 groups (Fig. 5.4B, point e.). Interestingly, when activity returned to baseline 
in the dark (Fig. 5.4B, point f.), disc1Y472X MZ mutants were more active as previously reported (Fig. 
4.5A). The results of a factorial ANOVA show there is no significant effect of genotype and no 
significant interaction between genotype and either time or light on locomotor activity (Table 5.4). 
We averaged locomotor activity during the dark phases and light phases and compared disc1Y472X MZ 
mutants and disc1+/+. Over both dark and light phases, disc1Y472X MZ mutants had a significantly lower 
swimming activity compared to disc1+/+ (Fig. 5.4C, D), indicating disc1Y472X MZ mutants are 






































Similar to disc1Y472X MZ, we observed no differences in the decrease in activity during transitions from 
dark to light between disc1exon6 MZ and controls (Fig. 5.5B, point a.). The increase in activity to 
extended exposure to light was heightened in disc1exon6 MZ compared with controls (Fig. 5.5B, point 
b.). This upregulation persisted during the rapid increase in activity after the transition from light to 
dark (Fig. 5.5B, point c.). There was no difference in onset time or peak of activity between disc1exon6 
MZ and controls (Fig. 5.5B, point d.). We observed a rightwards shift in the response of disc1exon6 MZ 
(red line) over the decline of activity during the extended period of darkness (Fig. 5.5B, point e.). 
Baseline activity in the dark was similar between disc1exon6 MZ and controls (Fig. 5.5B, point f.) as 
previously reported (Fig. 4.6A). The results of a factorial ANOVA show there is a significant effect of 
Figure 5.4. Visual motor response of disc1Y472X mutants in response to dark/ light flashes 
(A) Activity traces over 6 hours. +/+, homozygous wild type control; -/-, disc1Y472X maternal zygotic 
mutant. N=24, data pooled from 2 independent experiments. Lines and shaded areas represent 
means ± SD White and grey boxes indicate lights ON and lights OFF, respectively.  
(B) Activity traces over 1 hour, representative of mean activity. Zoom in from 220 to 280 min of 
recording with a., b., c., d., e., f. corresponding to defined changes in locomotor activity 
(C) Box and violin plots of locomotor activity during light transitions day (white box). Dashed lines 
indicate median (middle), first (lower) and third (higher) quartile. Data did not pass the Shapiro-
Wilks test. Mann-Whitney test was significant, P<0.001 = ***. Box and violin plots of locomotor 
activity during dark transitions day (grey box). Dashed lines indicate median (middle), first 
(lower) and third (higher) quartile. Data did not pass the Shapiro-Wilks test. Mann-Whitney 
test was significant, P<0.001 = ***.  
(D) Box and violin plots of locomotor activity during dark transitions day (grey box). Dashed lines 
indicate median (middle), first (lower) and third (higher) quartile. Data did not pass the Shapiro-
Wilks test. Mann-Whitney test was significant, P<0.001 = ***.  
Table 5.4. Statistical analysis of dark/ light flash test in disc1Y472X line 
The results of a three-way factorial ANOVA with repeated measures for time, genotype and light are 
shown. There is a significant effect of time and light on locomotion in larvae. There are no significant 
interactions between genotype and time or genotype and light. P > 0.05 = n.s, P < 0.0001 = ****. See 
Figure 5.4 for plot of data. 
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genotype and a significant interaction between genotype and time (Table 5.5). We averaged 
locomotor activity during the dark phases and light phases and compared disc1exon6 MZ mutants and 
disc1+/+. Over both dark and light phases, disc1exon6 MZ mutants had a significantly increased swimming 
activity compared to disc1+/+ (Fig. 5.5C, D), indicating that, as opposed to disc1Y472X, disc1exon6 MZ 






















5.2.3 Novel tank diving in disc1 adult zebrafish 
Following, characterisation of stimulus-evoked behaviours in larval zebrafish, we moved onto 
investigate behavioural parameters in the adults. We performed the novel tank diving (NTD) test, an 
extensively used assay to measure novelty stress/innate fear in adult zebrafish (Bencan et al., 2009; 
Grossman et al., 2010; Mathuru et al., 2012). When placed in a novel environment, adult zebrafish 
show a place preference for the bottom third of the tank, particularly in the first 2 min of the assay. 
After the first 2 min, zebrafish enter the top two thirds of the tank and gradually display more 
exploratory swimming behaviour. After 8 to 10 min adult zebrafish become fully acclimated to their 
environment. NTD was previously performed on the disc1Y472X/Y472X mutants on a small scale (N= 10 
Figure 5.5. Visual motor response of disc1exon6 mutants in response to dark/ light flashes 
 
(A) Activity traces over 6 hours. +/+, homozygous wild type control; -/-, disc1exon6 maternal 
zygotic mutant. N=24, data pooled from 2 independent experiments. Lines and shaded 
areas represent means ± SD. White and grey boxes indicate lights ON and lights OFF, 
respectively. 
(B) Activity traces over 1 hour, representative of mean activity. Zoom in from 220 to 280 min 
of recording with a., b., c., d., e., f. corresponding to defined changes in locomotor 
activity. 
(C) Box and violin plots of locomotor activity during light transitions day (white box). Dashed 
lines indicate median (middle), first (lower) and third (higher) quartile. Data did not pass 
the Shapiro-Wilks test. Mann-Whitney test was significant, P<0.001 = ***. 
(D) Box and violin plots of locomotor activity during dark transitions day (grey box). Dashed 
lines indicate median (middle), first (lower) and third (higher) quartile. Data did not pass 
the Shapiro-Wilks test. Mann-Whitney test was significant, P<0.001 = ***. 
Table 5.5. Statistical analysis of dark/ light flash test in disc1exon6 line 
The results of a three-way factorial ANOVA with repeated measures for time, genotype and light are 
shown. There is a significant effect of genotype, time and light on locomotion in larvae. There is a 
significant interaction between genotype and time but not between genotype and light. P < 0.05 = *, 
P < 0.01 = **, P < 0.0001 = ****. See Figure 5.5 for plot of data. 
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per group) (H. Eachus PhD thesis, University of Sheffield, 2015); however, the results obtained with 
controls did not show the characteristic decline in percentage of time spent in the bottom third over 
time (acclimation) and it was concluded that no significant differences emerged between 
disc1Y472X/Y472X homozygous mutants, disc1Y472X/+ heterozygotes and disc1+/+ siblings. 
 
We decided to repeat the NTD assay using the behavioural rig at IMCB, Singapore (custom-made by 
Dr R. Cheng and Dr A. Mathuru), with larger sample sizes (N ≥ 24 per group) on both disc1Y472X and 
disc1exon6 lines. We observed acclimation after 6 min, as previously reported in wild type adults (Egan 
et al., 2009; Levin, 2011). In the disc1Y472X line, there was a significant effect of time on the percentage 
of time spent in the bottom third (Fig. 5.6, Table 5.6) due to the shift in place preference. There was 
no significant effect of genotype and lines mapping place preference of disc1Y472X/Y472X (red), disc1Y472X/+ 
(blue) and disc1+/+ (black) overlapped. Of note, there was a small yet significant interaction between 
time and genotype and we hypothesise that this is due to downwards shift of disc1Y472X/+ group in the 











We repeated the same assay in the disc1exon6 line and observed a significant effect of time and 
genotype on the percentage of time spent in the bottom third (Fig. 5.7, Table 5.7). Interestingly, 
disc1exon6/exon6 mutants (red line) spent significantly less time in the bottom third, throughout the 10 
min of recording, particularly in the first 4 min of the assay compared to disc1exon6/+ heterozygotes and 
disc1+/+ controls (Fig. 5.7) suggesting more “explorative” swimming behaviour and an impaired 
response to a novel environment.  
 
Figure 5.6. Bottom Dwell behaviour in response to NTD test in disc1Y472X line 
Percentage of time spent in the bottom third of the tank over time. +/+, disc1+/+ homozygous siblings; 
+/-, disc1Y472X/+ heterozygotes; -/-, disc1Y472X/Y472X homozygous mutants. . N+/+= 26, N+/-= 24 and N-/-= 25. 
Bars indicate mean ± SEM. Black arrows indicate data from the first 2 min of recording and white arrows 
indicate data from the last 2 min of recording. Overlapping error bars suggest there are no differences 
in NTD test between +/+, +/- and -/-. Data distribution passed the Shapiro-Wilk normality test. See Table 
5.6 for statistical analysis. 
Table 5.6. Statistical analysis of NTD in disc1Y472X line 
The results of a factorial ANOVA with repeated measures for time and genotype are shown. There is no 
significant effect of genotype and a significant effect of time spent in bottom third. There is a significant 
interaction between genotype and time. P > 0.05 = n.s, P < 0.05 = *, P < 0.0001 = ****. See Figure 5.6 










Figure 5.7. Bottom Dwell behaviour in response to NTD test in disc1exon6 line 
Percentage of time spent in the bottom third of the tank over time. +/+, disc1+/+ homozygous siblings; 
+/-, disc1exon6/+ heterozygotes; -/-, disc1exon6/exon6 homozygous mutants. Bottom dwell behaviour over a 
10 min recording. N+/+= 26, N+/-= 30 and N-/-= 29. Bars indicate mean ± SEM. Black arrows indicate data 
from the first 2 min of recording and white arrows indicate data from the last 2 min of recording. Non-
overlapping error bars suggests there are differences in NTD test between +/+, +/- and -/-. Data 
distribution passed the Shapiro-Wilk normality test. One-way ANOVA was used to compare individual 
means are each timepoint. P < 0.05 = *, P < 0.01 = **, P < 0.001 = ***. See Table 5.7 for statistical 
analysis. 
Table 5.7. Statistical analysis of NTD in disc1exon6 line 
The results of a factorial ANOVA with repeated measures for time and genotype are shown. There is a 
significant effect of genotype and a significant effect on time spent in the bottom third. There is a 




To determine if the effect described above was due to differences in baseline swimming, we measured 
total distance and average velocity of swimming during 10 min of recording in both lines. There were 
no significant differences between disc1Y47X2/Y472X mutants and disc1+/+ controls in total distance (Fig. 
5.8A) or in average velocity (Fig. 5.8C). Similarly, there were no significant differences between 
disc1exon6/exon6 mutants and disc1+/+ controls in total distance (Fig. 5.8B) or in average velocity (Fig. 
5.8D). These results indicate that adult disc1 mutants have a wild type-like baseline locomotor activity 
under LED lighting. Of note, it appeared that disc1exon6 fish raised on an AB background swam longer 
distances than the disc1Y472X line raised on the TL background. We ensured measures and respective 








Figure 5.8. Swimming behaviour in adult disc1 zebrafish 
Baseline swimming behaviour. +/+, disc1+/+ controls; -/-, disc1-/- homozygous mutants. (A) and (C), 
disc1Y472X, N+/+= 24 and N-/-= 25. (B) and (D), disc1exon6, N+/+= 30 and N-/-= 29. Bars indicate mean ± SD. 
(A) and (B) indicate total distance covered during 10 min of recording. (C) and (D) indicate average 
velocity during 10 min of recording. Data points followed a normal distribution. Individual groups 
were compared with unpaired t-test, p value > 0.05 (n.s). 
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We next sought to investigate place preference in response to NTD in the first 2 min (stressed) and 
last 2 min (acclimated) of recording. Following exposure to a novel environment, adult zebrafish show 
a clear preference for the bottom third of the tank (bottom dwelling) and periphery/ walls of the tank 
(thigmotaxis) (see section 5.1.2). There was no significant difference in bottom dwell behaviour 
between disc1Y472X/Y472X mutants compared to disc1+/+ controls in the first 2 min (black arrow) and last 
2 min (white arrow) of recording (Fig. 5.9A, Table 9.1, Appendix). disc1exon6/exon6 mutants spent 
significantly less time in the bottom third in the first 2 and in the last 2 min of recording compared to 
disc1+/+ controls (Fig. 5.9B, Table 9.2, Appendix). Both disc1Y472X and disc1exon6 lines spent significantly 
less time in the bottom third in the last 2 min compared to the first 2 min of recording, as expected 
after a period of acclimation. Thigmotaxis was measured by defining adult zebrafish swimming in the 
periphery as “wall-hugging” (see section 2.25; Fig. 2.3). There was no significant difference in 
thigmotaxis between disc1Y472X/Y472X mutants and disc1+/+ controls in either the first 2 or the last 2 min 
of recording (Fig. 5.9C, Table 9.3, Appendix). In the other line, during the first 2 min, disc1exon6/exon6 
mutants spent significantly less time near the wall compared to disc1+/+ controls. There was no 
significant difference between disc1exon6/exon6 mutants and disc1+/+ controls during the last 2 min of 
recording (Fig. 5.9D, Table 9.4, Appendix). There were significant differences between the first 2 min 
and the last 2 min of recording in the disc1+/+ controls but not disc1exon6/exon6 mutants. These results 
suggest that adult disc1exon6/exon6 mutants do not display a thigmotaxic response or bottom dwell 




Figure 5.9. Place preference in response to NTD in adult disc1 zebrafish 
+/+, disc1+/+ controls; -/-, disc1-/- homozygous mutants. (A) and (C), disc1Y472X, N+/+= 24 and N-/-= 25. (B) 
and (D), disc1exon6, N+/+= 30 and N-/-= 29. Bars indicate mean ± SD. Black arrows indicate data from the 
first 2 min of recording and white arrows indicate data from the last 2 min of recording. (A) and (B) 
indicate percentage of time spent in the bottom third of the tank (bottom dwell). (C) and (D) indicate 
percentage of time spent near the walls (thigmotaxis). Data points do not follow a normal distribution, 
two-way ANOVA with pairwise comparisons was performed. P value > 0.05 (n.s), p value < 0.01 (**), p 
value < 0.001 (***), p value < 0.0001 (****). See table 9.1 & 9.2 (Appendix) for statistical analysis. 
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Other behavioural indications of anxiety in zebrafish include erratic swimming episodes (darting) 
alternating with periods of inactivity (freezing). There was no significant difference in number of 
darting episodes between disc1Y7472X/Y472X mutants and disc1+/+ controls in either the first 2 min or last 
2 min of recording (Fig. 5.10A). There is a significant difference between the first 2 min and last 2 min 
in both disc1Y7472X/Y472X mutants and disc1+/+ controls, showing time but not genotype has an effect on 
darting (Table 9.5, Appendix). Similarly, there was no significant difference between disc1exon6/exon6 
mutants and disc1+/+ controls in either the first 2 min or last 2 min of recording (Fig. 5.10B). There was 
a significant difference between the first 2 min and last 2 min in both disc1exon6/exon6 mutants and 
disc1+/+ controls, again, showing time but not genotype has a significant effect on darting (Table 9.6, 
Appendix).  
 
Next, we quantified freezing episodes in adult zebrafish. There was no significant difference between 
disc1Y7472X/Y472X mutants and disc1+/+ controls in either the first 2 min or last 2 min of recording (Fig. 
5.10C, Table 9.7, Appendix). Similar to darting, we observed a decrease in freezing, as zebrafish 
became acclimated, even though this was not statistically significant in disc1+/+ controls. Importantly, 
disc1exon6/exon6 mutants froze significantly less during the first 2 min of recording compared to disc1+/+ 
controls (Fig. 5.10D, Table 9.8, Appendix). There was no difference in number of freezing episodes 
during the last 2 min of recording between disc1exon6/exon6 mutants and disc1+/+ controls. These results 
suggest that freezing episodes but not darting episodes are decreased in disc1exon6/exon6 mutants upon 











5.3.1 Analysis of auditory startle response  
We used a quantitative behavioural assay for salient acoustic stimuli to induce startle responses in 
zebrafish larvae (designed by Dr R. Cheng). Because we previously observed changes in homeostatic 
locomotor activity during the night in disc1 mutants (Fig. 4. 5A, Fig 4.6A), we corrected acoustic 
responsiveness for background differences in locomotor activity (see section 2.22.4). In the night-time 
arousal (NTA) test, we observed no differences in the percentage of larvae responding between 
disc1Y472X/Y472X mutants, disc1Y472X/+ heterozygotes and disc1+/+ siblings (Fig. 5.1). In disc1exon6/exon6 
mutants, we observed a subtle difference in the auditory startle responses, particularly prominent at 
medium intensities when compared to disc1exon6/+ heterozygotes and disc1+/+ siblings (Fig. 5.2). This 
auditory hypersensitivity becomes more evident when comparing disc1exon6/exon6 maternal zygotic 
mutants to disc1+/+ controls (Fig. 5.3). The upwards shift in response shows disc1exon6/exon6 mutants have 
a decreased auditory arousal threshold (Fig. 5.3). Of note, it is of high importance to replicate this 
assay at least one more time to confirm the strength of this observation.  
 
Importantly, because disc1Y472X/Y472X mutants were hyperactive at night (Fig. 4.5) but had wild type-like 
acoustic startle responses (Fig. 5.1), we can deduce that changes leading to this hypersensitisation are 
independent from changes in spontaneous arousal. Conversely, disc1exon6/exon6 mutants which showed 
a no night-time hyperactivity (Fig. 4.6), are hyper-responsive to acoustic stimuli during the NTA test 
(Fig. 5.3). Moreover, the optimal (disc1Y472X) and larger than optimal (disc1exon6) responses to acoustic 
stimuli in the NTA test demonstrate that disc1 mutants do have defects in their peripheral auditory 
system and that development of the mechanosensory hair cells is not disrupted. This is important 
because disc1 is expressed in the developing ear (otic vesicle) at 24 hpf (Drerup et al., 2009).  
 
Figure 5.10. Darting and freezing episodes in adult disc1 zebrafish 
+/+, disc1+/+ controls; -/-, disc1-/- homozygous mutants. (A) and (C), disc1Y472X, N+/+= 24 and N-/-= 25. (B) 
and (D), disc1exon6, N+/= 30 and N-/-= 29. Bars indicate mean ± SD. Black arrows indicate data from the 
first 2 min of recording and white arrows indicate data from the last 2 min of recording. (A) and (B) 
indicate the number of erratic swim episodes (darting). (C) and (D) indicate the number of inactivity 
episodes (freezing). Data points do not follow a normal distribution, a two-way ANOVA with pairwise 
comparisons was performed. P value > 0.05 (n.s), p value < 0.01 (**), p value < 0.001 (***), p value < 
0.0001 (****). See Table 9.5-9.8 (Appendix) for statistics. 
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 In contrast to disc1 zebrafish larvae, Disc1 locus impairment (LI) adult mice, in which the majority 
of Disc1 isoforms are supressed, exhibit a blunted startle reflex to high intensity sounds (Jaaro-Peled 
et al., PREPRINT). Neuronal firing in the dorsomedial striatum (DMS) was significantly decreased in 
response to acoustic stimuli in the Disc1 LI mutants compared to wild type littermates. This 
discrepancy between the disc1 zebrafish and the Disc1 mouse phenotype could arise due to inherent 
divergences between zebrafish and mammalian brain architecture. Although many brain regions 
involved in the control of affective behaviours in zebrafish larvae show structural and functional 
homology to mammals (Kalueff et al., 2014), the teleost’s CNS is more primitive (Cheng et al., 2014). 
For example, the true homologue of the mammalian amygdala has been mapped to the dorsomedial 
portion of the pallium (Maximino et al., 2013). The subpallium is homologous to the basal ganglia 
(Mueller et al., 2008), which includes the striatum. An area that is lacking in the teleost brain is the 
neocortex and therefore the corticostriatal circuits remain somewhat elusive in zebrafish. Despite the 
lack of this structure, lower vertebrates retain the ability of higher order processing with 
neuropeptidergic signalling playing a major role in these pathway (Jarvis et al., 2005).  
 
In humans, hyperacusis, a form of auditory hypersensitivity, is highly prevalent in patients with 
anxiety, schizophrenia, autism spectrum disorders and other neurodevelopmental disorders (Cutting 
and Dunne, 1986; Dubal and Viaud-Delmon, 2008). This pronounced intolerance to ordinary 
environmental sound can lead to social withdrawal and isolation. It has been attributed to neural 
hyper excitability of central auditory processing. fMRI studies reveal that limbic structures (particularly 
the amygdala) show an over-activation in response to sound (Viaud-Delmon et al., 2011). Moreover, 
a prominent positive symptom often described in schizophrenic disorders is auditory hallucinations. 
Spontaneous activation of the auditory cortex and areas related to the acoustic processing of external 
cues underlies such phenomena (Hunter et al., 2006). It is challenging to assess such affective traits in 
lower vertebrates, although alterations in auditory perception and gating could offer clues of 
analogous dysfunction. Transgenic overexpression of the conserved neuropeptides adcyap1 and cgrp 
causes an upwards shift in auditory responsiveness in zebrafish larvae (Woods et al., 2014) similar to 
results observed in disc1exon6 mutants (Fig. 5.3). In rodents too, infusion of Adcyap1 or Cgrp into the 
brain enhances acoustic startle responses and increases anxiety-like phenotypes (Hammack et al., 
2009; Hashimoto et al., 2001; Kovacs et al., 1999; Sink et al., 2011), suggesting neural circuits are 
conserved throughout vertebrates and intimately linked to affective disorders.  
5.3.2 Analysis of swimming modulation in response to changes in illumination  
We used a well-established larval behavioural assay to investigate LLRs in disc1 mutant larvae. When 
disc1Y472X MZ and disc1exon6 MZ mutants were exposed to light, larvae downregulated their locomotion 
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accordingly, in a similar manner to respective controls (Fig. 5.4B, 5.5B, point a.). We observed 
differences between disc1Y472X MZ and controls and between disc1exon6 MZ and controls in the 
visuomotor response to dark onset, however we can attribute these differences to locomotor 
differences preceding the onset of darkness (Fig. 5.4B, 5.5B, point b.). As previously reported in wild 
type larvae (Prober et al., 2006), our results suggest that if locomotion is lower immediately before 
dark onset, as in disc1Y472X MZ  (red line, Fig. 5.4B, point b.) or disc1exon6 MZ (black line, Fig. 5.5B, point 
b.), the arousal threshold to dark onset becomes increased (red line and black line, Fig. 5.4B, 5.5B, 
point c.). Ultimately, both disc1Y472X MZ and disc1exon6 MZ mutants were able to up-regulate their 
locomotor activity in response to dark onset (Fig. 5.4B, 5.5B, point c.) indicating that there were no 
defects in the VMR of disc1 mutant zebrafish. These results suggest that disc1 mutants have functional 
retinal photoreceptors and can detect light (Liu et al., 2015). Our findings replicate previous 
behavioural light/dark assays performed on disc1Y472X and disc1L115X mutant lines (H. Eachus PhD thesis, 
University of Sheffield, 2015). 
 
We extended our experimental design to measure the LLR to sustained light or dark. Previous tests 
aforementioned were performed with short periods of alternating light: dark (1: 4 min). Our tests used 
longer intervals (20: 40 min) on (see section 2.22.3) to measure the biphasic LLR in response to light 
(apparent after 5 min) and the biphasic LLR in response to dark (apparent after 15 min) (Gao et al., 
2014; Prober et al., 2006). This assay revealed opposite effects of the different disc1 alleles on 
swimming adaptation to sustained periods of light/dark. Consistent with auditory arousal results, 
disc1exon6 larvae were hyperresponsive to both light and dark changes (Fig. 5.5C, D). Interestingly, 
disc1Y472X mutants were hyporesponsive to both light and dark changes (Fig. 5.4C, D).  In disc1Y472X MZ 
mutants, there was a delay and a milder upregulation of activity in response to sustained light (Fig. 
5.4B, point b.). In contrast, disc1exon6 MZ mutants had the opposite phenotype, displaying hyperactive 
swimming in response to extended periods of light (Fig. 5.5B, point b.). This disc1exon6 MZ hyperarousal 
are consistent with findings from the NTA test (Fig. 5.3). In response to extended periods of darkness, 
disc1Y472X MZ mutants exhibited a wild type-like downregulation of locomotion (Fig. 5.4B, point e.). In 
contrast, disc1exon6 MZ mutants showed a delay in response to extended periods of dark (Fig. 5.5B, 
point e.). These differences in swimming modulation, albeit in opposite directions highlight that 
arousal and long-term LLR are altered by loss of disc1.  
 
These responses are mediated by both retinal and non-retinal photoreceptors. Long-term LLRs do not 
require the visual system and act via deep brain melanopsin-expressing photoreceptors. Despite their 
lack of eyes and VMR, chokh mutants retain long-term LLR in responses to dark onset. Non-retinal 
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opn4a+ photoreceptors located in the preoptic area (PO) of the hypothalamus, a structure 
homologous to the mammalian PVN, are instrumental in this “slow light-OFF” response (Fernandes et 
al., 2012). Furthermore, exposure to light after a period of dark acclimation, elevates whole body 
cortisol in larval zebrafish (De Marco et al., 2013). Interestingly, cortisol levels return to baseline after 
20 min, which coincides, with the return to baseline of swimming activity in both light and dark 
paradigms. In addition, changes in illumination evoke bursting activity in the dopaminergic neurons of 
the caudal hypothalamus (cH) in larval zebrafish (Mu et al., 2012). By blocking the glucocorticoid 
system using genetic and pharmacologic interventions, Lee et al. (2019) showed that the function of 
HPI is required for LLRs in larval zebrafish. Yet, our group previously showed that HPI function in 
disc1Y472X mutant zebrafish larvae is affected (Eachus et al., 2017). Therefore, we hypothesise that 
these differences in disc1 LLRs could arise due to hypothalamic defects.   
 
When comparing LLRs from the disc1Y472X line (Fig. 5.4A) and from the disc1exon6 line (Fig. 5.5A), we 
identified striking differences in locomotor activity of disc1+/+ control. Locomotion of disc1Y472X controls 
in response to light increased much more rapidly (reaching 25 secs of activity/ min at 240 min) (Fig. 
5.4B, point b.) than that of disc1exon6 controls (17 secs of activity/ min at 240 min) (Fig. 5.5B, point b.). 
Furthermore, locomotion of disc1exon6 controls, in the first 10 min after dark onset, remained constant 
(Fig. 5.5B, point c.), whereas locomotion of disc1Y472X controls steadily increases (Fig. 5.4, point c. on 
inset panel). At first, results between disc1Y472X and the disc1exon6 lines were so inverse, we considered 
we had mixed up genotyping results. However, after experimental repeats, this emerged as the true 
phenotype. Different wild type strains differ in their genetics and behaviours (Coe et al., 2009). Our 
results agree with previously identified interstrain differences in LLRs between ABs and TLs (Liu et al., 
2015; van den Bos et al., 2017). ABs (which disc1exon6 were raised on) exhibit a lower activity in both 
light and dark as larvae compared to TLs (de Esch et al., 2012) (which disc1Y472X were raised on).  This 
difference could indirectly reflect differences in the baseline activity of the HPI. Recently, a study 
determined that TL larvae have a lower HPI axis activity and are more sensitive to anxiogenic stimuli 
compared to AB larvae (van den Bos et al., 2019). This could explain why we observed a steady 
increase in locomotion after dark onset in the disc1Y472X line (TLs) (Fig. 5.4B, point c.) whereas the 
locomotion of disc1exon6 (AB) initially remains constant (Fig. 5.5B, point c. ).  
 
Overall, we see a gradual dissipation of the response over the repetitive cycles of dark: light in both 
lines of disc1 mutants and controls (Fig. 5.4A, Fig. 5.5A). This represents habituation, an ancestral form 
of non-associative learning which reflects cognitive function and can easily be assessed in larval 
zebrafish (Best et al., 2008). Both disc1Y472X MZ and disc1exon6 MZ mutants downregulate their innate 
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response to changes in illumination over time. Interestingly, we also observe habituation of the 
rightwards shift in the disc1exon6 MZ mutants’ (red line) and mutants were able to downregulate their 
swimming activity at a comparable rate to disc1exon6 controls after 5 cycles (Fig. 5.5). This highlights 
that the loss of disc1 does not affect the ability of zebrafish to habituate their response to change in 
illumination at larval stages.  
5.3.3 Analysis of adult behavioural swimming  
Distance travelled and average velocity was measured repeatedly between 1PM and 4PM in the day, 
to account for fluctuations in cortisol levels which can affect swimming behaviours (Schreck, 2010). 
Adults were assayed in isolation, to avoid any contribution from potential differences in social 
interaction associated with a loss of disc1 (Tang et al., 2020). We observed no differences in baseline 
locomotion between disc1 mutants and controls (Fig. 5.8), suggesting that differences in baseline 
locomotion identified in disc1Y472X/Y472X (Fig. 4.5A), become less pronounced as larvae mature into 
adults.  
 
We decided to repeat the NTD assay in adult zebrafish even though this had previously been 
performed in Sheffield with the disc1Y472X line. First, we wanted to recapitulate findings from 
disc1Y472X/Y472X (H. Eachus PhD thesis, University of Sheffield, 2015) on the behavioural apparatus in 
Singapore. Secondly, we wanted to characterise NTD behaviour in the disc1exon6 line. The validity of 
our NTD assay is demonstrated by the expected decrease of bottom dwell behaviour over time in the 
disc1+/+ control line (Fig. 5.6). There were no differences in the response to NTD between disc1Y472X/Y472X 
mutants, disc1Y472X/+ heterozygotes and disc1+/+ controls (Fig. 5.6, 5.8A, 5.8C), as previously reported 
(H. Eachus PhD thesis, University of Sheffield, 2015). We did, however, observe differences when NTD 
was performed on the disc1exon6 line. There was a significant decrease in bottom dwell in disc1exon6/exon6 
mutants compared to disc1exon6/+ heterozygotes and disc1+/+ siblings (Fig. 5.7, 5.8B). There was also a 
loss of thigmotaxis in disc1exon6/exon6 mutants upon exposure to a novel environment (Fig. 5.8D). 
 
Freezing and darting were also assayed as measures of anxiety. Again, we observed no differences 
between disc1Y472X/Y472X mutants and disc1+/+ controls (Fig. 5.9A, Fig. 5.9C). Although disc1exon6/exon6 
mutants froze significantly less than disc1+/+ controls (Fig, 5.9D), they performed the same number of 
darting episodes (Fig. 5.9B). This adult behavioural study reinforces the notion that disc1exon6/exon6 
mutants have loss of innate fear in the NTD test. In the initial 2 min after exposure to a novel 
environment, they spent less time in the bottom third, more time in the centre of the tank and froze 
less. We did not detect any abnormal responses to stress in the disc1Y7472X/Y472X mutants, perhaps 
because the stimulus (novel environment) was too mild. In our previous experimental design, the 
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alarm substance was used to elicit a stress response and disc1Y7472X/Y472X mutants were hyporesponsive 
(Eachus et al., 2017). Therefore, the direction of change is consistent between the two disc1 lines even 
though the emergence of a quantifiable phenotype in the disc1Y472X mutants may require a stronger 
stressful stimulus. Many groups have investigated various anxiety-related behaviours in Disc1 mouse 
models. Female Disc1D453G mice show elevated novelty-induced exploration (Dachtler et al., 2016). A 
Disc1 BAC transgenic mouse model, expressing 2 copies of truncated Disc1, also showed a blunted 
response to stress freeze less than wild type littermates when presented with a tone or shock, and 
emit less vocal communication (squeaks) under stressful conditions (Shen et al., 2008).  
 
Practical limitations of the zebrafish thigmotaxis assay were highlighted here and contention about 
whether this is an anxiety-related measure has emerged (Blaser et al., 2010; Grossman et al., 2010; 
Ziv et al., 2013). Interestingly, in the first 2 min of recording, the disc1Y7472X line performs more darting 
episodes (x ̅disc1Y472X =5) compared to the disc1exon6 line (x ̅disc1exon6 =2.8). Adult zebrafish measure around 
3 cm in body length. This increased darting (requiring more space) could explain the reason why we 
report less “wall-hugging” behaviour in the disc1Y7472X line (Fig. 5.8C) compared to disc1exon6 line (Fig. 
5.8D) in the first 2 min of recording. To conclude, disc1Y472X/Y472X mutants have very subtle stimulus-
evoked phenotypes at both larval and adult stages. On the other hand, disc1exon6/exon6 mutants have 
much stronger stimulus-evoked phenotypes such as hypersensitivity to sound and long-term 
modulation to light flashes at larval stages. Adult disc1exon6/exon6 mutants are also hyporesponsive to 

















Chapter 6: Neuronal basis of disc1 mutant phenotypes 
6.1 Introduction 
Neuropsychiatric disorders are diagnosed based on behavioural criteria scores and, as is the case in 
many neurological or neurodegenerative diseases, biomarkers remain elusive. Thanks to the 
advancement of non-invasive techniques, functional brain imaging provides a window into the brain 
activity of diagnosed patients. fMRI in both resting and task-related studies has uncovered widespread 
brain pathology in schizophrenia, bipolar disorder, and depression. Abnormal fMRI signals in the 
dorsolateral prefrontal cortex (DLPFC), anterior cingulate, basal ganglia, hippocampus, 
parahippocampal gyrus and amygdala are widely reported in schizophrenia and depression. The 
aberrant activity in these regions is observed in task-related experiments and has been correlated to 
sensory processing, motor regulation, working memory performance and fear processing (Fletcher et 
al., 2010; Hirjak et al., 2015; Schlosser, 2010). In the absence of task-oriented behaviour, the resting 
brain still exhibits spontaneous slow neuronal firing. Task-independent regions (more active at rest 
than during cognitive tasks) are referred to as the "default network" (DN) and include the medial 
prefrontal cortex, the precuneus, the lateral parietal cortex, and the anterior and posterior cingulate 
cortex (Raichle et al., 2001). The DN plays a role in self-referential thought and higher cognition 
(Buckner et al., 2008). In patients with schizophrenia and depression,  a hyperactivation of the 
hippocampus at rest and an inability to suppress DN activity upon task-initiation has been reported 
(Guo et al., 2014; Schneider et al., 2017; Whitfield-Gabrieli et al., 2008) and could contribute to the 
core cognitive symptoms of such neuropsychiatric disorders (Hill et al., 2004; Liu et al., 2006a).  
In zebrafish, live brain imaging capitalises on their transparency and genetic manipulability. As 
aforementioned (see section 1.1.4), neuroanatomical regions are highly conserved. Genetically 
encoded calcium indicators (GECIs) such as GCaMP, enable the visualisation of calcium influx into cells 
upon neuronal depolarisation (Muto et al., 2011). A drawback of calcium imaging in zebrafish, is that 
the head must be immobilised to restrict its movement and therefore larvae cannot behave 
freely.  Another method uses the endogenous expression IEGs to detect neuronal activity in fixed 
samples. The expression of Fos and Arc increases in active neurons and is widely used in mammals to 
identify key nuclei involved in certain behaviours. However, such markers exhibit slow transcriptional 
time courses (Okuyama et al., 2011) and c-fos and arc are expressed with a low baseline in the teleost 
brain (Baraban et al., 2005), making them inadequate for zebrafish research. Recently, extracellular 
signal-regulated kinase (ERK) and more particularly its phosphorylation upon calcium influx into cells, 
has been successfully used to localise active neurons in zebrafish larvae (Hussain et al., 2013; Randlett 
et al., 2015; Thyme et al., 2019; Wee et al., 2019b). This procedure uses whole brain imaging and 
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mapping to specific nuclei is made possible by the creation and annotation of larval brain atlases 
(Randlett et al., 2015).  
 
In neuropsychiatric disease modelling, whole brain imaging provides a non-bias approach, eliminating 
the possibility of a priori assumptions about known dysfunctional circuitry. A study investigating the 
effect of schizophrenia-associated genes on whole brain activity was published during the course of 
my project. One hundred and thirty-two CRISPR-generated mutants harbouring mutations in GWAS-
identified genetic risk factors were characterised (Thyme et al., 2019). Over half of the mutants had 
substantial brain activity differences at baseline. As previously discussed, DISC1 was not identified in 
the most recent schizophrenia GWAS cohort (Ripke et al., 2014), despite its clear link to the disease, 
and therefore disc1 was not part of the mutated genes. Both increased and decreased activity 
differences emerged in common regions across different mutants. Overlapping signals were mostly 
reported in the tectum, pallium, hypothalamus, and olfactory bulb. Mutants for tcf4-/-, a transcription 
factor involved in neurodevelopment and associated with neuropsychiatric disorders had 
simultaneous decreases in activity in hypothalamic neurons and the retinal arborisation field 7 (AF7), 
both regions known to specifically activate upon prey hunting (Muto et al., 2017; Semmelhack et al., 
2014). Based on the role of disc1 in neurodevelopment, differences observed in hypothalamic cell 
markers at 5 dpf and decreases in food intake and hunting behaviour in disc1 mutant larvae, we 
hypothesised to also observe activity differences in hypothalamic regions and AF7, among other 
regions. 
6.2 Results  
6.2.1 Brain activity mapping  
To investigate brain activity in zebrafish larvae, we performed immunofluorescence at 7 dpf using 
antibodies against total Erk1/2 (tERK) (background staining) and phosphorylated Erk1/2 (pERK) to label 
active neurons. Western blot analysis show pERK1/2 antibodies detect only a single protein of 44 kDa in 
zebrafish larvae (Ng et al., 2012). To determine staining validity, we first imaged wild type larvae (Fig. 
6.1). We imaged Z=137 stacks (dorsal to ventral) and performed stitching to capture whole brain views 
(Fig. 6.1A). tERK expression was homogenous, labelling all anatomical regions of the larval brain. In 
contrast, pERK expression was not pan-neuronal and mostly found in the telencephalon (Fig. 6.1, white 
box) as well as in periventricular cells (Fig. 6.1, white asterisk). Spontaneous activity of these neurons 
has previously been reported and our staining reproduced published results (Randlett et al., 2015). A 
higher magnification of a single slice (Z=1) of the telencephalon (Fig. 6.1, white box) shows that tERK is 
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concentrated around the cell membrane whilst pERK is expressed in the cytosol (Fig. 6.1B). These 
differences in subcellular localisation of active vs. inactive Erk1/2 are consistent with previous findings 
(Harding et al., 2005). Initial results, therefore, indicate epitope specificity of Erk1/2 and pErk1/2 





Figure 6.1. Immunofluorescence in wild type 7 dpf zebrafish larvae using pERK and tERK 
(A) Wholemount dorsal view of Z-projection (Z=137). tERK staining (in blue) is pan-neuronal and 
pERK staining (in red) localises mainly to the telencephalon (white box) and periventricular 
mesencephalic cells (white asterisk).  Scale bar indicates 200 µm 
(B) Higher magnification of the telencephalon (Z=1). tERK staining (in blue) localises close to the 
cell-membrane, pERK staining (in red) is cytosolic. Scale bar indicates 50 µm 
(C) Schematic adapted from Thyme et al. (2019). Neuroanatomical landmarks of the larval 
zebrafish brain, dorsal view (left), transverse view (right) and legend below. A: anterior, L: 
lateral, V: ventral. 
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After establishing the specificity of staining and optimising imaging to ensure the best compromise 
between high resolution and whole brain view, we scaled up the experiment. We investigated 
differences in brain activity between disc1 mutants and controls. Larvae were raised until 7 dpf and fixed 
rapidly to ensure brain activity remained intact (see section 2.5). Immunofluorescence was performed, 
stained larvae were imbedded in agarose and whole brain images were acquired. Imaging data was 
aligned using morphing algorithms from the Computational Morphometry Toolkit for registration and 
to correct for rotation (see section 2.13). Significant changes of activity were measured between 
mutants and wild types. Anatomical areas were then localised by overlapping our brain-activity maps 
with the annotated Z-brain atlas, containing 29 labels of 294 segmented regions 
(http://stackjoint.com/zbrain/). Data are presented visually using Z-projections (Z=137) of significant 
differences in activity (Fig.6.2, 6.3), where purple indicates a relative significant decrease in activity, 
green indicates a relative significant increase in activity and black indicates similar activities between 
disc1 mutants and controls. Maps were overlaid with Z-projections from the pan-neuronal Vmat2::GFP 
maker (grey) to specify neuroanatomical landmarks (Fig. 6.2, 6.3, left panels). Dorsal and lateral views 
of Z-projections were then displayed over a black background for contrast enhancement (Fig. 6.2, 6.3, 
right panels).  
 
In disc1Y472X mutants, differences in brain activity emerged in broad patterns across the brain (Fig. 6.2). 
We observed decreased activities (purple) in hypothalamus, thalamus, and the posterior tuberculum 
(Fig. 6.2). Neuronal populations exhibiting a decrease in activity in disc1Y472X mutants included 
Orthopedia b (Otpb) and Oxytocin (Oxt) clusters in the diencephalon, DA clusters in posterior 
tuberculum and hypothalamus (Table 6.1). We observed increased activities (green) in the olfactory 




Figure 6.2. Brain activity maps from disc1Y472X mutants 
Wholemount dorsal view of Z-projection (Z=137). N+/+= 76, N-/-= 88, image representative of 2 
experimental repeats. Activity increases are indicated in green and localise to the olfactory epithelium 
(OE), pallium (P), subpallium (sP), cerebellum (Ce) and hindbrain (Hb). Activity decreases are indicated 
in purple and localise to posterior tuberculum (PT) and hypothalamus (Hyp). Orientation shown by 




Next, we performed the same analysis on the immunofluorescence data from the disc1exon6 line. As 
opposed to disc1Y472X mutants, disc1exon6 brain activity maps revealed differences in a more restricted 
pattern across the brain (Fig. 6. 3). Furthermore, increases and decreases were less pronounced in 
disc1exon6 brain activity maps (Fig. 6.3) compared to in disc1Y472X brain activity maps (Fig. 6.2) suggesting 
that disc1exon6 mutants have a less severe brain activity phenotype. Similar hits identified between 
disc1exon6 mutants and disc1Y472X mutants were underlined (Table 6.2). Common neuronal populations 
exhibiting a decrease in activity included subpallial Otpb strip, Otpb cluster 4 in the diencephalon, Oxt 
cluster 1 in the PO, DA cluster 2 in the PT, and Hcrt clusters 1 and 2 in the hypothalamus. Common 
neuronal populations exhibiting an increase in activity include the olfactory epithelium, the 
subpallium, pallium, neuromast OC1 cells of the lateral line (Table 6.3). These brain activity maps 
reveal the diversity of phenotypes caused by mutations in disc1 but also uncover common populations 
with altered neuronal activity. 
Table 6.1. Identified ROIs with differences in brain activity in disc1Y472X line 
Neuronal populations were identified using ZBrainAnalysisOfMAPMaps.m (MATLAB) which generates 
output as an excel table. The ROIs displayed above satisfy the criteria of i. signal in ROI ≥ 100 and ii. 
validated in ≥ 2 experimental repeats. Organised by anatomical location from anterior most (top) to 




Figure 6.3. Brain activity maps from disc1exon6 mutants 
Wholemount dorsal view of Z-projection (Z=137). N+/+= 40, N-/-= 35, image representative of 2 
experimental repeats. Activity increases are indicated in green and localise to the olfactory epithelium 
(OE), pallium (P), subpallium (sP) and hindbrain (Hb). Activity decreases are indicated in purple and 
localise to the preoptic area (PO), posterior tuberculum (PT) and hypothalamus (Hyp), cerebellum (Ce). 




6.2.2 Developmental expression of identified neuronal populations 
After establishing common and reproducible ROIs with differences in neuronal activity, we decided to 
investigate the developmental expression of the neuronal populations identified with differences 
common to both disc1 mutant lines. RNA in situ hybridisation is a common technique used in zebrafish 
research and circumvents the immediate need for zebrafish-specific antibodies. We designed and 
synthesised probes against orthopedia B (otpb) and oxcytocin (oxt). We synthesised a previously 
designed probe (template kind gift from Dr L. Trollope) against tyrosine hydroxylase (th) and 
performed wholemount in situ hybridisation (WISH). Tyrosine hydroxylase (TH) is the rate-limiting 
enzyme in the dopamine synthesis pathway and is often used as a marker for DA neurons (Molinoff 
and Axelrod, 1971).  
 
disc1 is highly expressed at 2-3 dpf  (De Rienzo et al., 2011; Wood et al., 2009) and differences in 
hypothalamic cell markers were previously identified in disc1Y472X mutants at 3 dpf (Eachus et al., 
2017). In addition, WISH and the visualisation of ventral neuronal populations are problematic after 5 
dpf due to limited cell permeability and formation of the jaw cartilage. Therefore, we assessed the 
expression of oxt, otpb and th at 3 dpf. Bilateral nuclei of oxt-expressing neurons appear as early as 
36 hpf in the developing zebrafish embryo and by 3 dpf are localised to the PO (Unger and Glasgow, 
2003). There was a significant increase in oxt+ neurons in both disc1Y472X mutants and disc1exon6 mutants 
at 3 dpf (Fig. 6.4).  
Table 6.2. Identified ROIs with differences in brain activity in disc1exon6 line 
Neuronal populations were identified using ZBrainAnalysisOfMAPMaps.m (MATLAB) which generates 
output as an excel table. The ROIs displayed above satisfy the criteria of i. signal in ROI ≥ 100 and ii. 
validated in ≥ 2 experimental repeats. Organised by anatomical location from anterior most (top) to 





Figure 6.4 Wholemount in situ hybridisation (WISH) and cell counts of oxytocin-expressing neurons 
in disc1 mutants at 3 dpf  
Wholemount ventral view (A, B, E, and F) and preoptic area (dashed box, C, D, G, and H). Purple signal 
indicates spatial expression of oxytocin (oxt). Large scale bar (left) indicates 100 µm and smaller scale 
bar (right) indicates 25 µm. Quantification of oxt+ cells in disc1Y472X (I) and disc1exon6 (J). PO: preoptic 
area. Box and violin plots represent sample distribution, full lines indicate median, and dotted lines 
indicate first quartile (below) and third quartile (top). N = 6 per group, 3 experimental replicates. Data 





Next, we performed WISH using a probe against optb.  At 3 dpf, optb is expressed in the preoptic area 
(PO), posterior tuberculum (PT), caudal hypothalamus (cH) and hindbrain (Hb) (Fernandes et al., 
2013). We observed an apparent overall increase in the intensity of optb expression in disc1Y472X and 
disc1exon6 mutants compared to controls (Fig. 6.5). We quantified otpb+ cells in the cH of the disc1Y472X 
line only, as cellular resolution of otpb+ cells in the PO, PT and Hb as well as in the cH of disc1exon6 line 
was limited (Fig. 6.5). While there was an increase in the number of otpb+ cells counted in the cH of 





 Finally, we performed WISH using a th1 probe, to identify DA cell populations at 3 dpf (Fig. 6.6). 
Zebrafish express two homologues of the tyrosine hydroxylase (th) gene: th1 and th2 (Candy and 
Collet, 2005; Rink and Wullimann, 2002). th1 is expressed in the telencephalon and diencephalon 
whereas th2 is preferentially expressed in the latter and also labels cH populations. th1+ clusters (2-6) 
located in the PT and hypothalamus were unaffected in disc1exon6 mutants compared to controls (Fig. 
6.6B, 6.6D, 6.6E). Similar th1+ cluster analysis was also performed in the disc1Y472X line (A. Malkowska 
BSc thesis, University of Sheffield, 2018), and no differences were detected in disc1Y472X mutants.  
Figure 6.5 Wholemount in situ hybridisation (WISH) and cell counts of orthopedia b-expressing 
neurons in disc1 mutants at 3 dpf  
Wholemount ventral view (A, B, E, and F) and caudal hypothalamus (dashed box, C, D, G, and H). Purple 
signal indicates spatial expression of orthopedia b (otpb). Large Scale bar (left) indicates 100 µm and 
small scale bar (right) indicates 25 µm. PT: posterior tuberculum, cH: caudal hypothalamus. 
Quantification of otpb+ cells in disc1Y472X (I). Box and violin plots represent sample distribution, full lines 
indicate median, and dotted lines indicate first quartile (below) and third quartile (top). N = 6 per group, 
3 experimental replicates. Data distribution passed the Shapiro-Wilk normality test, unpaired Student's 






Finally, we investigated the expression of pomc in both disc1 mutant lines. We observed no differences 
in pomc+ cell number at 52 hpf  in either disc1Y472X mutants or in disc1exon6 mutants, compared to their 
respective controls (Fig. 6.8), as previously reported by our group (Eachus et al., 2017). 
Figure 6.7 Wholemount in situ hybridisation (WISH) of retinal homeobox 3 and steroidogenic factor 
1 in disc1 mutants at 52 hpf  
Wholemount ventral view (A, B, E, F, I, J, M, N) and ventral diencephalon (dashed box, C, D, G, H, K, L, 
O, P). Purple signal indicates spatial expression of rx3 and ff1b. Small scale bar (left) indicates 100 µm 







Figure 6.8 Wholemount in situ hybridisation (WISH) and cell counts of proopiomelanocortin-
expressing neurons in disc1 mutants at 52 hpf  
Wholemount ventral view (A, B, E, and F) and ventral diencephalon (dashed box, C, D, G, and H). Purple 
signal indicates spatial expression of pomc. Small scale bar (left) indicates 100 µm and large scale bar 
(right) indicates 25 µm. N = 6 per group, 3 experimental replicates. Data distribution passed the Shapiro-
Wilk normality test, unpaired Student's t-test, n.s = p > 0.05. 
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6.3 Discussion  
Using a non-biased approach, we identified altered neuronal activity in the larval hypothalamus of 
disc1 mutants supporting the role of disc1 in hypothalamic development and function. Importantly, 
there was a strong decrease in activity from oxytocinergic, dopaminergic, Orthopedia b+ and 
Hypocretin+ neuronal populations in the ventral diencephalon (Fig. 6.2, Table 6.1, Fig. 6.3, Table 6.2). 
6.3.1 Interpretation of oxytocinergic deficits in disc1 mutants 
We investigated oxytocin (oxt) expression at 3 dpf in disc1 mutants and observed a significant increase 
in the number of oxt+ cells (Fig. 6.4). At first, this result appeared counterintuitive, as neuronal activity 
in the preoptic Otx cluster 1 (part of the same lineage) is decreased in mutants (Table 6.1, 6.2). 
Neuronal circuits are complex and upstream neurotransmitter systems (which govern neuronal 
activity) are multiplex. It is also important to note that relationships between cell number and activity 
are not linear. Furthermore, interpretation becomes more ambiguous because of the differences in 
developmental stages analysed in the different experiments (3 vs. 7 dpf). For example in humans, the 
expression of OXT and its receptor (OXTR1) changes dynamically with age (Gimpl and Fahrenholz, 
2001). Nevertheless, a loss of disc1 causes a significant difference in preoptic oxt cell number and 
activity (Fig. 6.2, Table 6.1, Fig. 6.3, Table 6.2, Fig. 6.4). In Disc1L100P male adult mice, hypothalamic Oxt 
expression was also significantly affected (O’Tuathaigh et al., 2017). In accordance with these results, 
the oxytocinergic system has been linked to the pathophysiology of neurodevelopmental disorders. 
Specific genetic polymorphisms in OXTR are associated with schizophrenia and autism (Jacob et al., 
2007; Wu et al., 2005). In individuals with major depression, the number of OXT-producing neurons is 
increased in the PVN (Meynen et al., 2007). Interestingly, oxytocinergic abnormalities extend beyond 
the hypothalamus, evidenced by an increased expression of OXTR in the dorsolateral prefrontal cortex 
(DLPFC) of depressive and bipolar disorder patients (Lee et al., 2018). In addition, peripheral OXT and 
OXTR expression was increased and OXT neuropeptide levels in the CSF and blood were reduced in 
individuals with schizophrenia (Yang et al., 2017). Additional links of OXT to mental illness are provided 
by studies investigating the therapeutic use OXT. Both intravenous injections (Bakharev et al., 1986) 
and more recently, intranasal administration of oxytocin (Lee et al., 2013) led to an improvement of 
negative symptoms in schizophrenia and depression. Thus, our observations in disc1 mutant larvae 
are consistent with the wealth of literature implicating OXT in mental illness.  
6.3.2 Interpretation of dopaminergic deficit in disc1 mutants 
After observing a decrease in activity in dopaminergic neurons of the PT in disc1 mutants (Table 6.1, 
6.2), we wanted to investigate the expression of tyrosine hydroxylase (th) expression at 3 dpf in disc1 
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mutants. Expression of th1 was investigated in the disc1Y472X line in Sheffield. There was no significant 
difference in the number of th1+ cells in disc1Y472X mutants compared to controls at 3 dpf (A. 
Malkowska BSc thesis, University of Sheffield, 2018). We performed the same experiment on the 
disc1exon6 line in Singapore and also observed no significant differences in th1+ cells between disc1exon6 
mutants and controls (Fig. 6.6). These results suggest that the altered activity in dopaminergic 
populations is not because of an early developmental mispatterning of th1+ clusters.     
 
A large body of results indicate a link between Disc1 and the dopaminergic system in the mature brain. 
The expression of TH in the frontal cortex is significantly decreased in a transient Disc1 knockdown 
mouse model (Niwa et al., 2010). In another mouse model, overexpressing DISC1, a decrease in 
dopaminergic neurons in the striatum has been reported (Hamburg et al., 2016). Moreover, Disc1 
directly interacts with the dopamine receptor D2 (D2R) (Lipina et al., 2010). The same group 
investigated levels of this receptor in the striatum and found a significant increase in Disc1L100P mice 
(Lipina et al., 2012). Furthermore, uncoupling of this Disc1-D2R interaction in mutant mice 
ameliorated behavioural phenotypes (Su et al., 2014) and administration of intranasal dopamine in a 
transgenic DISC1 rat model, can reverse memory and attention deficits (Wang et al., 2017). The 
dopamine hypothesis posits that excessive dopamine at rest and release in the ventral striatal 
projections from the midbrain play a central role in the symptoms of schizophrenia (Kegeles et al., 
2010) and compounds that raise dopamine levels at the synapse cause psychosis (Davis et al., 1991). 
The periventricular dopaminergic neurons identified in our studies with cell bodies in the posterior 
tuberculum have projections to the subpallium in the teleost brain, the mammalian equivalent of the 
mesostriatal pathway (Rink and Wullimann, 2001; Tay et al., 2011). Therefore, the increase in activity 
in the subpallium in disc1 mutant activity maps could mirror the hyperactive striatal connections 
reported in mammals.  
 
A limitation of the use of zebrafish larvae in modelling dopaminergic abnormalities in the CNS is the 
lack of a midbrain dopaminergic population in zebrafish analogous to ventral tegmental area (VTA) 
(Rink and Wullimann, 2002), which play an important role in the mammalian mesolimbic reward 
pathway. However, projectome and developmental analysis suggests that the aforementioned ventral 
diencephalic-subpallial dopamine system, forms part of reward network in zebrafish and therefore 
comparative analysis can still be made (Lohr et al., 2009). Another pitfall in the experimental design 
could be the use of th1 as a marker for specific dopaminergic neuronal populations. Tyrosine 
hydroxylase is expressed in both dopaminergic and noradrenergic neurons. Therefore, the lack of 
difference in th1+ cell numbers in disc1exon6 mutants could arise due to masking by a concurrent 
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decrease in noradrenergic populations. An alternative and more specific marker for dopaminergic 
populations that could be used in future experiments is dopamine transporter (dat) (Meng et al., 
2008).  
6.3.3 Interpretation of orthopedia b deficits in disc1 mutants 
The activity of subpallial neurons and cluster 4 Otpb neurons was significantly decreased in disc1 
mutants at 7 dpf (Table 6.1, 6.2). Expression of otpb appeared increased in disc1 mutants at 3 dpf (Fig. 
6.5). Due to poor cellular resolution of otpb WISH staining, quantification was only performed on otpb+ 
cells of the cauddal hypothalamus and no significant difference was noted. It is however important to 
note that otpb expression in the PO, PT and lateral hindbrain strips appeared increased, particularly 
in disc1exon6 mutants compared to controls (Fig. 6.5E-H). Two otp paralogs exist in the zebrafish 
genome (otpa and otpb), display some functional redundancy. The function of OTP is highly conserved 
throughout vertebrates, acting as a transcription factor involved in the differentiation of a subset of 
dopaminergic and oxytocinergic neurons cell types involved in hypothalamic neuroendocrine function 
(Blechman et al., 2007). This is the first report of altered activity in Otpb populations in disc1 or any 
animal model recapitulating features of schizophrenia or depression. Considering the role of otp in 
neuroendocrine cell lineages and the fact that otpb colocalises with rx3+ cells (Muthu et al., 2016) and 
with DA clusters 3 and 4 in zebrafish at 3 dpf  (S. Brown PhD thesis, University of Sheffield, 2016), its 
dysregulation is not unexpected.  Further investigation into this cell type could provide important 
insights. The next steps could include quantification of otpb mRNA levels using qPCR or using a 
previously synthesised zebrafish-specific OTP (by Prof. G. Levkowitz). In addition, we could perform 
WISH against neurod4, a  marker for newly determined neuronal cells (Mueller and Wullimann, 2002) 
and  often used in combination with otpb to investigate dopaminergic neuronal differentiation 
(Thompson et al., 2017).  
6.3.4 Other identified populations in disc1 mutants 
Other cell populations with altered neuronal activity in the hypothalamus are Hcrt clusters 1 and 2. 
Hypocretin (aka. Orexin) is a critical sleep neuromodulator and loss of these neurons in mammals leads 
to narcolepsy (excessive sleeping during the day and disturbed sleep at night) (Lin et al., 1999). The 
function of HCRT in sleep regulation and arousal is conserved in zebrafish larvae and neuronal activity 
of these neurons drives wakefulness (Adamantidis et al., 2007; Prober et al., 2006; Yokogawa et al., 
2007). Although sleep disturbances have been reported in DISC1 animal models, no group has 
investigated the expression or activity of HCRT+ neurons. Moreover, multiple lines of evidence link this 
system to neuropsychiatric disorders. The orexin 1 receptor (HCRTR1) was identified as a susceptibility 
factor for schizophrenia and major depression (Cengiz et al., 2019; Fukunaka et al., 2007). Another 
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study found that plasma orexin-A levels were significantly reduced in patients with bipolar disorder 
(Tsuchimine et al., 2019). Thus, our observations in disc1 mutant larvae are in line with clinical 
observations of HCRT defects in neuropsychiatric disorders. Hyperactivity in the pallium was observed 
in both disc1 mutant brain activity maps. The teleost pallium functions in spatial and emotional 
learning and memory and contains the functional homolog of the mammalian amygdala and 
hippocampus (Portavella et al., 2002; Riedel, 1997). The identification of altered activity in this region 
of disc1 mutants is consistent with previous results reporting hyperactivation of the hippocampus, 
parahippocampal gyrus and amygdala in schizophrenia patients discussed above (see section 6.1).  
 
Odour-evoked activity in the olfactory bulb (OB) can be seen as early as 3 dpf in zebrafish (Hussain et 
al., 2013). An interesting result from the brain maps is the increased neuronal activity in the olfactory 
bulb of disc1 mutants compared to controls (Fig. 6.2, Table 6.1, Fig. 6.3, Table 6.2). This result was 
unexpected due to the previous observation of a decrease in food intake, which one could hypothesise 
would be due to a decrease in nutrient detection. MRI scans from patients with schizophrenia revealed 
structural deficits in the olfactory bulbs (Turetsky et al., 2000). A subset of individuals with major 
depression also have decreased olfactory bulb volume and olfactory sensitivity (Negoias et al., 2010). 
OB abnormalities are commonly reported in such disorders and this feature is used in the olfactory 
bulbectomy model of depression in rats (Kelly et al., 1997). Importantly, depressive-like phenotypes 
following the removal of OBs are reversible following chronic administration of antidepressants. 
Another observation we made, was the widespread increase in activity in more caudal areas of the 
larval brain. Notably, the activity of the cerebellum and hindbrain was affected by a loss of disc1. The 
cerebellum is an area of the brain involved in motor function and coordination. Disc1 is strongly 
expressed in the cerebellum, in all cell types (Goudarzi et al., 2013). The role of DISC1 in cerebellar 
physiology, has been investigated using a mouse model of inducible expression of human mutant 
DISC1 in the cerebellum. The frequency and amplitude of Purkinje cell firing was significantly increased 
in mutant Disc1 samples (Ayhan et al., 2011). To our surprise, there was no difference in activity in 
AF7, despite the strength of the feeding phenotype (Fig. 4.1, 4.2, 4.3) in disc1 mutants. AF7 neuronal 
activity is directly correlated with hunting and was dysregulated in other larval zebrafish mutants 
modelling schizophrenia and autism (Thyme et al., 2019). These results point to a convergence of 
behavioural phenotypes despite the diversity of risk gene function and brain activity phenotypes.  
6.3.5 The expression of previously characterised neuroendocrine hypothalamic 
cell fates 
After creating the disc1exon6 line, we decided to characterise previously investigated cell types, 
identified as being altered in the disc1Y472X line (Eachus et al., 2017). At 52 hpf, both disc1 and rx3 are 
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coexpressed in the lateral recesses and cells lining the 3rd ventricle of the zebrafish hypothalamus (H. 
Eachus PhD thesis, University of Sheffield, 2015). Disc1 expression is also detected in hypothalamic 
cells in embryonic and adult mice (Austin et al., 2003; James et al., 2004). In mice, Rax+ cells label 
hypothalamic progenitor cells and are required for the development of Sf-1+ and Pomc+ cells (Lu et al., 
2013). The expression of rx3 and ff1b in disc1exon6 mutants was also altered, albeit in different 
directions to the disc1Y472X mutants (Fig. 6.7), indicating that the hypothalamic progenitor pool and 
neuronal differentiation is altered in disc1 mutants. pomc which is expressed in the arcuate nucleus 
and in the pituitary gland at 3 dpf was also investigated (Fig. 6.8). No differences in expression or cell 
number were observed in disc1exon6 mutants and disc1Y472X mutants compared to respective controls 
as previously found (H. Eachus PhD thesis, University of Sheffield, 2015). Our analysis of rx3, ff1b and 
pomc expression in the disc1exon6 line offers less depth of analysis compared to the previous 
characterisation in disc1Y472X  as we did not perform a longitudinal expression analysis (from 24 hpf to 
5 dpf), and only focussed on 52 hpf (H. Eachus PhD thesis, University of Sheffield, 2015). Furthermore, 
we did not perform any sectioning to compare differences along the rostro-caudal axis, due to time 
constraints. At 5 dpf, there were significantly fewer pomc+ cells in the hypothalamus and pituitary in 
disc1Y472X mutants compared to controls (H. Eachus PhD thesis, University of Sheffield, 2015). We 
hypothesise that performing pomc WISH at a later developmental stage in disc1exon6 larvae, may also 
reveal significant differences between mutants and controls. Our findings suggest an imbalance in 
hypothalamic cell fates caused by disc1-driven proliferative and/ or cell migration defects. This early 
cellular mispatterning could lead to a broad dysregulation of behaviour, consistent with the role of 
















Chapter 7: Early inhibition of GSK-3β as a therapy for disc1-related 
phenotypes 
7.1 Introduction  
 
Glycogen synthase kinase 3 (GSK-3) is a serine/ threonine protein kinase expressed as two isoenzymes 
(GSK-3α and GSK-3β) which are encoded by distinct genes. Expression is ubiquitous and these kinases 
are active under basal conditions (Woodgett, 1994). The canonical Wnt signalling pathway involves 
Wnt proteins, which are involved in morphogenesis and neural progenitor proliferation. In the 
absence of extracellular Wnt ligand, the transmembrane Frizzled (Fz) receptor is inactive. GSK-3β is a 
member of the destruction complex and phosphorylates β-catenin, causing its degradation. When 
Wnt ligands bind Fz receptors, GSK-3β is phosphorylated and becomes inactive. Stable β-catenin can 
then translocate into the nucleus and form a complex with T cell factor/ lymphoid enhancer factor 
(TCF/ LEF). This allows for transcription of Wnt target genes (Moon et al., 1997). 
 
Alterations in Wnt signalling have been shown to cause shifts in neuronal fates and could contribute 
to psychiatric disease aetiology. Elevated WNT1 expression and low β-catenin levels were reported in 
post-mortem tissue from the hippocampus of schizophrenia patients (Cotter et al., 1998; Miyaoka et 
al., 1999). GSK-3β protein levels were 41% lower in prefrontal cortex (PFC) samples of schizophrenia 
patients compared with normal controls (Kozlovsky et al., 2000). Moreover, levels of phosphorylated 
(at Ser9) GSK-3β (pGSK-3β) were also significantly decreased in the PFC tissue and lymphocytes of 
individuals with schizophrenia (Emamian et al., 2004; Nadri et al., 2002). In a rat model of 
schizophrenia, generated through prenatal exposure to methylazoxymethanol acetate (MAM), a 
significant difference in the pGSK-3β/ GSK-3β ratio in juveniles was reported (Xing et al., 2016). 
 
Modulation of GSK-3β may also play a pivotal role in alleviating symptoms in neuropsychiatric 
disorders. Lithium, one of the most effective mood stabilisers functions through multiple mechanisms 
of action. Most relevant to this study, is its ability to selectively inhibit GSK-3β activity at a far higher 
potency compared to other protein kinases (Bain et al., 2007). Indeed, mice lacking one GSK-3β allele, 
phenocopied behaviours of mice treated with lithium (O'Brien et al., 2004). Other antipsychotics such 
as clozapine and haloperidol have also been found to stimulate GSK-3β phosphorylation, reducing its 
activity (Emamian et al., 2004; Kang et al., 2004). In addition, a newly synthesised, more potent GSK-
3β inhibitors conferred antidepressant and antimanic properties in rodent studies (Khan et al., 2016; 




DISC1 is a critical regulator of canonical Wnt signalling. Human lymphoblast cell lines (LCLs) from 
bipolar disorder patients, homozygous for DISC1RR264/RR264 and healthy controls were infected with a 
TCF/LEF luciferase reporter gene to determine the level of Wnt activity. DISC1R264Q/R264Q LCLs had 
significantly lower TCF/LEF reporter activity compared with controls (Singh et al., 2011). Disruption of 
exon 2 and/or exon 8 of DISC1 in human neural cells leads to an increase in canonical Wnt signalling 
and causes changes in cell fate. Strikingly, the Wnt antagonist XAV939 rescued expression of 
downstream factors FoxG1 and Tbr2, normalising cell fates (Srikanth et al., 2015). Critically, DISC1 was 
found to interact directly with and inhibits GSK-3β, thus stabilising β-catenin (Newburn et al., 2011). 
Two different binding domains were mapped, spanning amino acids (aa) 1–220 and 356–595 in DISC1. 
Relatively conserved domains are found in mice and zebrafish, and also demonstrate similar binding 
dynamics. The N-terminally located fragment (aa 1-220) possess a stronger inhibitory activity on GSK-
3β (Mao et al., 2009). In the absence of GSK-3β-DISC1 interactions, GSK-3β activity increases, leading 
to an increase in β-catenin degradation and a decrease in Wnt target gene transcription. This in turn 
affects neural progenitors, reducing their proliferation and causing premature cell cycle exit (Freyberg 
et al., 2010; Mao et al., 2009). In mice, missense Disc1Q31L and Disc1L100P both reduce the GSK-3β-Disc1 
interaction. Moreover, acute administration of the GSK-3β inhibitor TDZD-8 (TDZD-8) was effective in 
reversing behavioural deficits in both Disc1Q31L and Disc1L100P mice models (Lipina et al., 2012; Lipina et 
al., 2011). Another missense mutation Disc1D453G, occurring within the second interacting fragment (aa 
356–595), also led to a decrease in GSK-3β-Disc1 interaction and reduced β-catenin abundance. 
Disc1D453G mutant mice showed sex-dependant anxiety-related and social behavioural deficits 
(Dachtler et al., 2016). 
 
 In zebrafish, expression of DN-GSK-3β was able to rescue abnormal brain morphology and axonal tract 
defects in disc1 MO embryos (De Rienzo et al., 2011). In cell culture, treatment with CHIR99021 (a 
GSK-3β antagonist), pushed NPCs to spontaneously differentiate. We hypothesised that treating disc1 
mutants with the same compound during hypothalamic development would rescue cell fate 
determination and have durable effects on behaviours. We assayed its effect by investigating the 
strongest and most consistent phenotypes observed in disc1Y472X mutants: ff1b expression, food intake 
and brain activity. We decided to perform the following experiments on the disc1Y472X line only for two 
reasons: i. reproducibility of the map-identified ROIs was weak in the disc1exon6 line and ii. RNA in situ 




7.2 Results  
An initial toxicity assay of CHIR99021 treatment in zebrafish embryos was performed by C. Donaldson 
(MSc thesis, University of Sheffield, 2017). Previous studies used doses varying from 600 nM to 25 µM 
(Chen et al., 2014; Veldman et al., 2013). Wild type embryos were treated with 2 µM, 10 µM and 50 
µM CHIR99021. Drug treatment did not cause any teratogenic effects (morphological abnormalities) 
and therefore 50 µM was selected as the most suitable dose to achieve the largest pharmacological 
effect. Drug treatment was applied between 24-52 hpf of embryonic development to inhibit GSK-3β 
during hypothalamic patterning. We hypothesised this would normalise the hypothalamus-associated 
deficits in disc1-/- mutants. Following fixation at 52 hpf, in situ hybridisation was performed to examine 
hypothalamic cell phenotypes. Expression of ff1b was chosen because of how strong and reproducible 
this phenotype was in disc1Y472X mutants (Fig. 6.7; Eachus et al., 2017). In DMSO-treated embryos, we 
observed the characteristic increase in ff1b staining in disc1Y472X mutants compared to controls (Fig. 
7.1A, B). Following GSK-3β inhibition, we observed a strong reduction in ff1b expression in disc1Y472X 
mutants compared to DMSO-treated disc1Y472X mutants (Fig. 7.1B, D). This suggests that GSK-3β 
inhibition during a specific developmental time window (28 hours of treatment), can normalise ff1b 
expression to wild type levels. Interestingly, GSK-3β inhibition also affected disc1+/+ controls, in which 
we observed an increase in ff1b expression compared to DMSO-treated controls (Fig. 7.1A, C). 
 
 
After establishing that GSK-3β inhibition could normalise ff1b expression in disc1Y472X mutants at 52 
hpf, we wanted to determine the effect of drug treatment on behaviour. Again, we selected a highly 
reproducible behavioural phenotype in disc1Y472X mutants: feeding. Drug treatment was applied during 
a specific embryonic developmental time window as previously described, washed off and embryos 
were left to develop until 7 dpf. Similar to observations in embryos, larvae did not develop any 
Figure 7.1. Early GSK-3β inhibition can 
normalise ff1b expression in disc1Y472X 
mutants  
Experiment performed and imaged by C. 
Donaldson (MSc thesis, University of 
Sheffield, 2017). Ventral view of the 
ventral diencephalon of CHRI99021-
treated (C, D) and controls (DMSO) (A, 
B) disc1Y472X controls (A, C) and disc1Y472X 
mutants (B, D). Purple signal indicates 
spatial expression of ff1b. Scale bar. 
Images representative of N = 5 per 






downstream teratogenicity from the drug treatment. Subsequently, we performed the feeding assay 
on DMSO and CHIR99021-treated disc1Y472X mutants and disc1+/+ controls. As previously reported (Fig. 
4.1), there was a significant decrease in gut fluorescence in disc1Y472X mutants compared to disc1+/+ 
controls (Fig. 7.2). Remarkably, early GSK-3β inhibition, significantly increased food intake in disc1Y472X 
mutants to levels comparable with untreated disc1+/+ controls (Fig. 7.2). Notably, the effect of 
CHIR99021 treatment was again, not exclusive to the mutants; there was significant decrease in gut 
fluorescence in disc1+/+ controls following drug treatment. These observations are consistent with the 
changes in direction of ff1b expression observed in drug-treated disc1+/+ controls (Fig. 7.1C).  
 
 
Figure 7.2. Early inhibition of GSK-
3β can normalise feeding in 
disc1Y472X mutants  
Points represent individual larvae, 
bars indicate mean ± SD. Wild type 
(disc1+/+), wild type in-cross larvae 
(non-sibling); mutant 
(disc1Y472X/Y472X), homozygous 
mutant in-cross larvae. N= 114. 2 
experimental repeats. Early 
CHIR99021 treatment rescues the 
feeding phenotype observed in 
disc1Y472X mutant larvae at 7 dpf. See 





Table 7.1. Tukey’s post hoc multiple comparison for gut fluorescence in disc1Y472X after 
exposure to CHIR99021 
 
 
To ensure that larval feeding behaviour at 7 dpf was not affected by residual compound still present 
in the E3 medium (after washes at 52 hpf), we investigated acute effects of GSK-3β inhibition on 
feeding behaviour. Wild type larvae were treated 30 min prior to the feeding assay (See Methods, 
section 2.23.2). We observed no significant effect of acute DMSO or CHIR99021-treatment on gut 




Next, we sought to investigate if the rescue of ff1b expression (Fig. 7.1) and feeding phenotype (Fig. 
7.2) was underlying a rescue in brain activity. CHIR99021 and DMSO-treated disc1Y472X mutants and 
disc1+/+ were fixed at 7 dpf and immunofluorescence against pERK/ tERK was performed. Firstly, brain 
activity maps were created to compare CHIR99021-treated disc1Y472X mutants and untreated disc1Y472X 
mutants (Fig. 7.4). This was to determine if drug treatment could reverse the brain activity in 
previously identified regions of interest in disc1Y472X mutants (Fig. 6.2, Table 6.1). Early GSK-3β 
inhibition reversed activity (i.e. increase instead of decrease in activity or decrease instead of increase 
in activity) in three previously identified ROIs (olfactory epithelium, preoptic Otx cluster 1 and Otpb 
cluster 2 in the diencephalon) (labelled in bold, Table 7.2). Early GSK-3β inhibition also caused changes 
Figure 7.3. Acute inhibition of GSK-
3β has no effect on feeding in wild 
type larvae  
Points represent individual larvae, 
bars indicate mean ± SD. N= 160. 2 
experimental repeats. Data 
distribution passed the Shapiro-Wilk 
normality test, one-way ANOVA, F (2, 
157) = 1.402, n.s = p > 0.05. 
Treatment had no effect on food 






in the same direction in some neuronal populations (underlined in Table 7.2) previously identified in 
disc1Y472X mutants (Table 6.1). This suggests that drug treatment exacerbated the increases in activity 
in the pallium, subpallium and rhombomere 7 of larvae (Fig. 7.4).  
 
 
Figure 7.4. Brain activity maps from CHIR99021-treated disc1Y472X mutants vs. DMSO-treated 
disc1Y472X mutants  
Wholemount dorsal view of Z-projection (Z=137). N-/-DMSO= 36, N-/-DRUG= 37. Activity increases are 
indicated in green and localise to the pallium (P) and subpallium (sP), preoptic area (PO) and hindbrain 
(Hb). Activity decreases are indicated in purple and localise to the olfactory epithelium (OE), 
hypothalamus (Hyp) and spinal cord (SC). Orientation shown by arrows at the bottom right. A: anterior, 




Secondly, brain activity differences were compared between CHIR99021-treated disc1Y472X mutants 
and untreated disc1+/+ controls and brain activity maps were created (Fig. 7.5). This was to assess if 
the drug treatment could normalise brain activity to a similar level as controls. We reasoned that if 
this were the case, brain maps would appear black (i.e. no significant differences). Brain activity maps 
revealed that activity was significantly increased in a widespread pattern throughout CHIR99021-
treated disc1Y472X mutant brains compared to untreated disc1+/+ controls, particularly in the tectum 
and hypothalamus. We also observed a slight decrease in activity in the olfactory epithelium (Fig. 7.5). 
The combination of both these activity maps (Fig. 7.4 and Fig. 7.5) suggests that, unlike ff1b expression 
(Fig. 7.1) and the feeding phenotype (Fig. 7.2), early CHIR99021 treatment did not normalise specific 
brain activity patterns.  
Table 7.2. Identified ROIs with differences in brain activity in CHIR99021-treated disc1Y472X mutants 
vs. DMSO-treated disc1Y472X mutants  
Neuronal populations were identified using ZBrainAnalysisOfMAPMaps.m (MATLAB) which generates 
output as an excel table. The ROIs displayed above satisfy the criteria of i. signal in ROI ≥ 100 and ii. 
validated in ≥ 2 experimental repeats. Organised by anatomical location from anterior most (top) to 
posterior (bottom). Populations underlined highlight common ROIs with disc1Y472X mutants. Population 





Transient inhibition of GSK-3β during embryonic development led to altered expression of 
hypothalamic ff1b in zebrafish at 52 hpf (Fig. 7.1). In disc1Y472X mutants, cell fate perturbation leads to 
an excessive production of ff1b+ cells (Eachus et al., 2017; Fig. 6.5, Fig.7.1E-F). The dramatic rescue of 
ff1b expression in disc1Y472X mutants suggests that alterations in cell fate have been rectified. This 
experiment was performed before the identification of oxt and otpb phenotypes in disc1Y472X mutants 
(Fig. 6.4, 6.5) and therefore future experiments analysing the expression of these markers would 
Figure 7.5. Brain activity maps from CHIR99021-treated disc1Y472X mutants vs. DMSO-treated disc1+/+ 
controls  
Wholemount dorsal view of Z-projection (Z=137). N+/+DMSO= 40, N-/-DRUG= 37. Activity increases are 
indicated in green and widespread, particularly prominent in the tectum (Tec). Activity decreases are 
indicated in purple and localise to the olfactory epithelium (OE) only. Orientation shown by arrows at 
the bottom right. A: anterior, L: lateral, V: ventral. 
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provide additional insight. Our results also reflect the effect of Wnt modulation on hypothalamic ff1b+ 
cell development. Canonical Wnt signalling is a major signalling pathway required for the patterning 
and function of the zebrafish hypothalamus (Kapsimali et al., 2004; Lee et al., 2006). Wnt ligands are 
highly expressed in the developing hypothalamus from 2-3 dpf in zebrafish embryos (Duncan et al., 
2016). Future work could also include quantification of CHIR99021-mediated Wnt modulation using a 
tcf/ lef reporter line as a readout.  
 
Given the role of the hypothalamus in regulating appetite and feeding, we set out to investigate if 
GSK-3β inhibition could normalise food intake in disc1Y472X mutants. Extraordinarily, a brief exposure 
to CHIR99021 in early development, seems to have a lasting effect on behaviour, as disc1Y472X mutants 
increased their food intake to similar levels as controls (Fig. 7.2) more than 4 days after treatment. 
Xing et al. (2016) also inhibited GSK-3β during pre-symptomatic stages in a rat model of schizophrenia 
and found long-term effects on spiny neuron deficits and amelioration of cognitive symptoms. 
Importantly, we found that acute drug treatment had no effect on gut fluorescence (Fig. 7.3). This 
illustrates that behavioural changes induced by early drug treatment derive from developmental 
origin and are not a secondary acute effect of residual drug in the E3 medium.  
 
Of relevance to these findings, Sf-1/ff1b-expressing neurons are nutrient and hormone-responsive 
and play a role in food intake (Bingham et al., 2008; Dhillon et al., 2006; Tong et al., 2007). Sf-1 
knockout (KO) mice are non-viable due to adrenal agenesis. Nonetheless, Sf-1 KO mice supplemented 
with adrenal transplants and glucocorticoid injections were viable and developed obesity (Majdic et 
al., 2002). Potential secondary metabolic effects from the transplantations and injections could, 
however, contribute to this weight gain. In a CNS-specific knockout of Sf-1 using the Nestin-Cre system, 
Sf-1Nestin-Cre mice showed gross abnormalities in the patterning of the ventromedial hypothalamic 
nucleus (VMH) (Kim et al., 2011). Behaviourally, Sf-1Nestin-Cre mice exhibited hyperphagia and a 
reduction in locomotion, ultimately leading to obesity (Kinyua et al., 2016). Optogenetic stimulation 
of Sf-1 neurons in the VMH suppressed feeding and chemogenic ablation of these neurons increased 
food intake (Viskaitis et al., 2017). Therefore, Sf-1/ff1b expression is critical for VMH development and 
function in satiety. The decrease in ff1b expression in response to CHIR99021 (Fig. 7.1) could underlie 
the changes in feeding behaviour in disc1Y472X mutants (Fig. 7.2). Many groups have postulated that 
activity from SF-1+ neurons in the VMH increases excitatory input to POMC neurons in the arcuate 
nucleus, which in turn activates the anorexigenic circuits (Cowley et al., 2001; Sternson et al., 2005). 
Unexpectedly however, when blocking all Sf-1 mediated excitatory output from the VMH, Vglut2Sf-1-
Cre mice did not develop obesity (Cheung et al., 2015). Rather, prenatal ablation of vGlut2-expressing 
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neurons from the Sf-1 lineage led to a sex-dependant reduction in body mass in female mice. 
Furthermore, CRISPR-generated ff1b maternal zygotic knockout zebrafish are viable yet display 
phenotypes and are smaller at 6 dpf (Wu et al., 2017a). Even though these studies highlight that the 
circuitry is not as simple as previously believed, there is an indisputable link between Sf-1/ff1b neurons 
in the VMH and food intake. To contribute to this knowledge and reinforce our hypothesis, we could 
perform further experiments to silence ff1b neurons using nitroreductase (NTR) and then assess 
hunting/ feeding behaviour. Food intake could also be assessed in larvae overexpressing ff1b using 
heat-shock methods. In order to understand the underlying changes in circuity governing alterations 
in larval behaviour, we measured brain activity at 7 dpf. Interestingly, exposure to CHIR99021 in early 
development seemed to also have a lasting effect on brain activity as well (Fig. 7.4, 7.5). We compared 
ROIs from disc1Y472X brain activity maps (Table 6.1) and ROIs from drug-treated disc1Y472X brain activity 
maps (Table 7.2). The extent to which the drug treatment reversed activity patterns was limited and 
localised to only 3 neuronal populations: olfactory epithelium, Oxt cluster 1 in the PO and Otpb cluster 
2 in the diencephalon. Activity in these populations has been linked to nutrient sensing and appetite 
modulation (Hussain et al., 2013; Muto et al., 2017; Wee et al., 2019b). In addition, Oxt and Otp cell 
lineages derive from Sf-1 expressing cells in the hypothalamus (Kurrasch et al., 2007).  
 
Using brain activity changes to measure drug effectiveness is at the basis of the rapidly expanding area 
of pharmacological MRI (phMRI). Studies have revealed in vivo drug action in the brains of 
neuropsychiatric disease patients. For example, the antidepressant venlafaxine, a serotonin and 
noradrenaline reuptake inhibitor, increased brain activity in the left insula and left anterior cingulate 
after 2 and 8 weeks of treatment, respectively (Davidson et al., 2003). The antipsychotic olanzapine, 
normalised functional connections between the cerebellum and PFC in treated patients (Stephan et 
al., 2001). Oxytocin treatment attenuated amygdala hyperactivity in patients with social anxiety 
disorder (Labuschagne et al., 2010). In a rodent model of schizophrenia, pretreatment with both 
lamotrigine and risperidone caused attenuation of ketamine-induced MRI changes (Doyle et al., 2013).  
The widespread increase in brain activity from maps comparing CHIR99021-treated disc1Y472X mutants 
to DMSO-treated disc1+/+ (Fig. 7.5) showed that baseline brain activity differed significantly between 
the 2 groups, despite similarities in feeding behaviour (Fig. 7.2). This begs the question of how 
important it is to restore the function/activity of all neuronal populations affected in the disc1 
mutants. In other words, if the drug treatment can normalise behavioural phenotypes, then it does 
not necessarily have to normalise the activity of all ROIs. To answer this, we would need to perform a 
more comprehensive behavioural profiling of treated disc1Y472X mutants, which could include sleep 
and stimulus-evoked phenotypes that we identified (Chapter 3, Chapter 4, Chapter 5). Relevant to 
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this, is the role GSK-3β plays in sleep regulation: overexpression of shaggy (the GSK-3β ortholog in 
Drosophila), has been shown to affect circadian clock-regulated locomotion (Martinek et al., 2001). In 
addition, transgenic mice overexpressing GSK-3β exhibited fragmentated sleep-wake cycles during 
both the light and dark periods (Ahnaou and Drinkenburg, 2011). 
 
Throughout this chapter, in every parameter assayed, we observed an effect of the drug treatment on 
disc1+/+ control zebrafish. Hypothalamic expression of ff1b was visibly increased in CHIR99021-treated 
(Fig. 7.1F) compared to DMSO-treated disc1+/+ embryos (Fig. 7.1E). In addition, CHIR99021-treated 
disc1+/+ larvae had significantly reduced gut fluorescence compared to DMSO-treated disc1+/+ larvae, 
indicating drug treatment negatively affected food intake in disc1+/+ larvae (Fig. 7.2). Finally, brain 
activity maps comparing CHIR99021-treated disc1+/+ against DMSO-treated disc1+/+ larvae showed low 
widespread increases in brain activity (data not shown). The adverse effects of GSK-3β inhibition is 
predictable, as canonical Wnt signalling is a key regulator of hypothalamic patterning and function 
(Lee et al., 2006) and therefore its modulation could affect normal developmental processes. Similar 
results were reported in rodents exposed to SB216763, another GSK-3β inhibitor. In a rat model of 
schizophrenia treatment rescued phenotypes; however, treatment also led to deficits in spine 
morphology and working memory in wild type littermates (Xing et al., 2016). Therefore, inhibiting GSK-
3β in animals without abnormal GSK-3β activity has detrimental effects and should be considered 
when designing clinical trials. It was recently proposed that combined therapies (e.g. CHIR99021 and 
lithium) could be administered at lower doses than their respective effective doses to produce 
synergistic effects, thus avoiding detrimental side effects (Haggarty et al., 2016). 
 
CHIR99021 is a highly selective GSK-3 inhibitor. Despite its selectivity for GSK-3, it potentiates the 
activity of both GSK-3α and GSK-3β activity, with a slightly higher potency for GSK-3β (Ring et al., 
2003).  It is not implausible that crosstalk occurs and that the effect of embryonic drug treatment in 
disc1+/+ and disc1Y472X mutant zebrafish is mediated through Wnt-independent GSK-3α inhibition. 
Interestingly, Disc1 also interacts with GSK-3α and genetic inhibition of GSK-3α in Disc1L100P mice 
reversed behavioural phenotypes to a similar extent as the GSK-3 inhibitor TDZD-8 (Lipina et al., 2011).   
To conclude, these results suggest that GSK-3 inhibition during a critical time window of 
neurodevelopment can alter cell fate, brain activity and behavioural phenotypes in the disc1Y472X 
mutant zebrafish. These results also support the hypothesis that GSK-3 plays an important role in the 





Chapter 8: General discussion 
8.1 Key findings  
Using two disc1 zebrafish mutants (Chapter 3), a range of behavioural and developmental phenotypes 
were characterised.  We identified that disc1 mutants show a specific decrease in hunting, feeding 
and sleeping (Chapter 4). Arousal also seems to be affected in disc1 mutants; however, results differed 
between the two disc1 lines (Chapter 5). After a comprehensive investigation of behaviours, we 
investigated brain activity signatures and found abnormal baseline neuronal activity in disc1Y472X and 
disc1exon6 mutants when compared to their respective controls (Chapter 6). Despite not phenocopying 
each other, common hits in both mutants manifested as an increase in activity in the pallium and 
subpallium and decreased activity was reported in hypothalamic nuclei at 7 dpf larval zebrafish. 
Abnormal expression of the hypothalamic markers rx3 and ff1b in disc1 mutant embryos was also 
reported at 2 dpf. Mutations in disc1 also caused abnormal expression of the hypothalamic markers 
otpb and oxt in embryos at 3 dpf (Chapter 6). Most interesting, is the finding that transient inhibition 
of GSK-3β, rescues the decreased expression of the hypothalamic marker: ff1b in embryos and in 
larvae, normalises feeding behaviour and affects brain activity (Chapter 7).  
 
8.2 disc1 mutants have subtle neurodevelopmental defects 
Loss of function of disc1 in our study, is not as severe as first observed in zebrafish. Originally, 
characterisation of disc1 morphants revealed gross developmental abnormalities between 24 hpf and 
5 dpf (Drerup et al., 2009; Wood et al., 2009). disc1fh291/ fh291 mutants demonstrated both brain, muscle 
segments and convergence/ extension phenotypes as early as 24 hpf. At 5 dpf, disc1fh291/ fh291 mutants 
had bent tails, abnormal pigmentation and uninflated swim bladders (De Rienzo et al., 2011). In our 
hands, we did not observe such severe phenotypes and defects appear more subtle (Eachus et al., 
2017). It is possible that these originally observed phenotypes were caused by off-target mutations. 
Consistent with previous findings from our group, we observed altered expression of the hypothalamic 
markers rx3 and ff1b, with additional characterisation of otpb and oxt expression and dopaminergic 
clusters. Interestingly both disc1Y472X and disc1exon6 mutants have altered rx3 expression, albeit in 
different directions. While disc1Y472X mutants have a decrease, disc1exon6 have an increase in rx3 
expression in the hypothalamus at 52 hpf (Fig. 6.7). rx3 is expressed in proliferating progenitors of the 
hypothalamus and upon differentiation, a fraction of these become ff1b+. Therefore, abnormal 
numbers of rx3+ progenitor cells in the hypothalamus could affect differentiating cells. Indeed, ff1b 
expression is also altered in disc1Y472X and disc1exon6 mutants compared to their respective controls (Fig. 
6.7). In essence, disc1Y472X mutants have a decrease in rx3 expression and therefore an increase in ff1b 
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expression compared to controls whereas disc1exon6 mutants have an increase in rx3 expression and 
decreased ff1b expression compared to controls. A limitation is that WISH was performed at 52 hpf 
only, and direction of change in rx3 and ff1b expression is likely to change over time. For example, it 
was observed that rx3 expression is reduced in disc1Y472X mutants at 52 hpf however is increased 
relative to controls at 5 dpf (H. Eachus PhD thesis, University of Sheffield, 2015). These results highlight 
an imbalance in early hypothalamic cells’ fate determination. Importantly, we also report a 
widespread increase in otpb expression (Fig. 6.5) and an increase in oxt expression in the PO at 3 dpf 
in both disc1 mutant lines (Fig. 6.4). Orthopedia b is a key transcription factor found to regulate the 
specification of various hypothalamic cell types including DA, oxt, crf and pomc. Accordingly, the 
increase in oxt+ cells may be a direct consequence of the increase in otpb expression.   
Subtle alterations in cytoarchitecture in disc1 mutants could arise from abnormal proliferation during 
neurogenesis. Indeed, the role of DISC1 in NPC proliferation is well established. DISC1 is highly 
expressed in NPCs and both Disc1 transgenic and shRNA DISC1 new-born mouse pups, have a 
significant reduction in BrdU labelling in the cortex (Mao et al., 2009; Shen et al., 2008). This reduction 
in NPC proliferation leads to premature cell cycle exit and differentiation. At 24 hpf, disc1Y472X zebrafish 
mutants show brain-specific widespread increase in phosphorylated histone H3 (phosH3), an M-phase 
marker, compared to controls. This is followed by a decrease in phosH3 in disc1Y472X mutants at 3 dpf 
compared to controls, suggesting that disc1 is also required to maintain NPCs in zebrafish embryos 
(Eachus et al., 2017). We therefore hypothesise that the increase oxt and optb expression at 3 dpf is 
caused by altered cell fate determination, perhaps owning to a decrease in NPC proliferation and 
premature cell cycle exit. In future experiments, BrdU/EdU pulse chase labelling or 
immunofluorescence against phosH3 could be performed on both disc1Y472X and disc1exon6 mutants to 
confirm this.  
DISC1 has been shown to act in cell proliferation via the Wnt signalling pathway and more specifically 
through GSK-3β. Some DISC1 variants which are unable to bind and inhibit GSK-3β (DISC1A83V, 
DISC1R264Q and DISC1L607F), lose their ability to activate Wnt signalling, causing a decrease in NPC 
proliferation compared to wild type DISC1 (Singh et al., 2011). Recapitulating the balanced DISC1 
translocation in iPSCs using TALENs, led to altered Wnt activity and a reduced NPC proliferation, 
changing neuronal cell fates (Srikanth et al., 2015). To increase Wnt signalling and rescue NPC 
proliferation at 24 hpf, disc1Y472X mutants and control embryos were treated with the GSK-3β inhibitor 
CHIR99021. This reduced the abnormally elevated expression of ff1b in the hypothalamus of disc1Y472X 
at 52 hpf and increased the expression of ff1b in the hypothalamus of control embryos (C. Donaldson 
MSc thesis, University of Sheffield, 2017). These findings suggest that altering Wnt signalling in early 
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development can normalise differentiation of ff1b cells in disc1Y472X mutants; however, this also 
affected normal development in control embryos (Fig. 7.1). 
 
Despite the 0.7-fold decrease of disc1 mRNA in disc1exon6 mutants compared to controls (Fig. 3.9) and 
the 0.6-fold decrease of disc1 mRNA in disc1Y472X, we speculated that due to the slightly longer and 
more stable exon 6 transcripts (containing coiled-coil domains), disc1exon6 could express more, albeit 
truncated zDisc1 proteins compared to disc1Y472X. As the GSK-3β binding site in zDisc1 is located at the 
N-terminus, disc1exon6 zDisc1 transcripts could still retain the ability to bind and inhibit GSK-3β. This 
could explain why rx3 and ff1b expression is not altered as severely and in the same direction as in 
disc1Y472X mutants. To investigate this further, a zDisc1 zebrafish antibody is necessary to first examine 
whether disc1 mutants are nulls or express low levels of truncated zDisc1. Secondly, an antibody 
would also be useful to perform pull-down experiments and investigate interactions between mutant 
variants and GSK-3β. Unfortunately, efforts to synthesise a high affinity antibody with in vivo zDisc1-
specificity proved unsuccessful (Fig. 3.5, 3.6, 3.10). We hypothesise that phosH3 may also be 
dysregulated in disc1exon6, but possibly to a lesser extent than in disc1Y472X and perhaps again, not in 
the same direction. Interestingly, a parallel can be drawn from a humanised mouse model study 
showing that the DISC1S704C variant (C-terminus) does not bind and inhibit GSK-3β and therefore has 
no effect on Wnt signalling and NPC proliferation. Rather, the DISC1S704C variant negatively affects 
neuronal migration, due to a reduced interaction with Dix domain containing 1 (Dixdc1) (Singh et al., 
2011). This study and our results together suggest that due to the multifunctionality of DISC1, different 
DISC1 variants cause convergent deleterious effects on brain development, not necessarily arising 
through the same molecular and cellular mechanisms.   
 
8.3 Behavioural interplay of map-identified neuronal populations 
The rx3 and ff1b alterations first identified in disc1Y472X mutants, were functionally associated to the 
hypothalamic neuroendocrine system, and naturally, endocrine function and behavioural responses 
to stress were investigated. disc1Y472X mutants failed to increase cortisol in response to osmotic (NaCl) 
and organic (alarm substance) stress (Eachus et al., 2017). Baseline cortisol levels and expression of 
ff1b in the interrenal gland of disc1Y472X mutants was unaffected (H. Eachus PhD thesis, University of 
Sheffield, 2015). Moreover, calcium imaging in zebrafish larvae, revealed that crf+ neurons are highly 
responsive to osmotic stress (vom Berg-Maurer et al., 2016). We decided to assay whole brain activity 
using pERK brain-mapping at 7 dpf in zebrafish larvae (Randlett et al., 2015). Brain activity was 
significantly different between disc1 mutants and their respective wild type controls (Fig. 6.2, 6.3). 
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Despite the inter-line variations of brain activity maps, some convergent neuronal populations were 
characterised and are summarised in Table 8.1. It is crucial to elucidate common phenotypes to inform 
us about the general disease aetiology and to identify populations to focus therapeutic efforts on. Of 
note, the decrease in DA neuronal activity in the PT of disc1 mutant larvae was an unexpected finding 
given that hyperdopaminergic activity is an established feature of schizophrenia (Seeman et al., 1976). 
However, results from these brain maps align with the current view of excitatory and inhibitory 
imbalance underlying these disorders (Lisman, 2012). 
 
Many different processes could be responsible for the observed alterations in brain activity in these 
neural circuits. For example, intrinsic changes in excitability of different neuronal populations have 
been reported in the hippocampus (Duan et al., 2007; Kvajo et al., 2011), in the forebrain (Holley et 
al., 2013; Juan et al., 2014) and in the cerebellum (Shevelkin et al., 2017) of different Disc1 mouse 
models. The interaction between DISC1 and different receptors present at the synapse is another 
possibility for alteration in brain activity. In rat striatal neurons, DISC1 was found to interact with D2R 
and inhibit its agonist-induced internalisation. This interaction was found to be increased in post-
mortem tissue from patients with schizophrenia (Su et al., 2014). Furthermore,  DISC1 reduces NRG1-
induced ERRB4 activation and thus excitability of cortical interneurons by competing with ERRB4 for 
the same binding site on PSD95, a major postsynaptic density protein of the glutamatergic synapse 
(Hayashi-Takagi et al., 2010; Seshadri et al., 2015). However, all these studies relate to the function of 
DISC1 in the mature brain. Therefore, we do not rule out that brain activity differences in disc1 larvae 
could arise from a non-developmental origin. However, our observations, showing that zebrafish 
embryos have an altered expression of oxt and otpb at 3 dpf, led us to hypothesise that the decreased 
activity of the subpallial Optb neurons, Otpb cluster 4 in the diencephalon and Oxt cluster 1 in the PO 
could be due to developmental abnormalities.  
Table 8.1. Common neuronal populations with differences in brain activity in disc1 mutants  
Common neuronal populations identified as having altered brain activity in the same direction in 
disc1Y472X (Table 6.2) and disc1exon6 (Table 6.3) mutants were combined. Organised by anatomical 
location from anterior most (top) to posterior (bottom). PT = Posterior tuberculum. 
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A limitation from the brain maps is that the method can only identify changes in distinct neuronal 
populations. However, in recent years there has been a hypothesis-shift towards the perspective that 
impaired connectivity underlies schizoaffective and depressive disorders (Pezawas et al., 2005; 
Schmitt et al., 2011). Methods have recently been developed in wild type zebrafish larvae to study 
functional connectivity (Betzel, PREPRINT), but have yet to be used in disease models.  We hypothesise 
that connectivity would be significantly affected in both disc1 mutant lines. Extending beyond the 
function of the HPI axis, we decided to assay a more comprehensive repertoire of zebrafish larval 
behaviours, still tightly linked to the homeostatic and neuromodulatory function of the hypothalamus. 
Based on the cell populations identified from the brain activity maps (Fig. 6.2, 6.3), one can draw 
correlations between cell types and the multiple behavioural phenotypes that emerged in disc1 
mutants.  
Both disc1 mutants appeared to have increased otpb expression at 3 dpf (Fig. 6.5) and decreased 
activity of Otpb populations in the subpallium and cluster 4 in the diencephalon (Table 8.1). We also 
observed differences in light-induced locomotor responses (LLRs) in both disc1 lines (Fig. 5.4, 5.5). Of 
note, Otp diencephalic neurons play a role in LLRs. In otpa-/- mutants and/ or following chemogenic 
ablation of Otpb+ neurons, larval zebrafish lose their ability to fully upregulate swimming in response 
to darkness, (Fernandes et al., 2012). This phenotype resembles the altered LLR in disc1Y472X mutants 
(Fig. 5.4). The same group showed that deep brain photoreception is independent of dopaminergic 
clusters and rather, relies of opn4a+ neurons in PO and PT. It would therefore be interesting to 
investigate this opsin population in disc1 mutants.  
Another behavioural phenotype reported in disc1 mutants is their altered response to stress (Fig. 4.4, 
5.7, 5.8, 5.10; Eachus et al., 2017). As was observed in disc1exon6 mutants (Fig. 5.8), otpa-/- adult mutant 
zebrafish spend less time in the bottom third of the tank during the NTD assay (Amir-Zilberstein et al., 
2012). Interestingly, otpa-/- mutants do not display the characteristic increase in crf levels in response 
to osmotic stress at 6 dpf. ChIP sequencing revealed that, upon stressful stimuli, Otp is recruited to 
the crf promoter, increasing transcription of crf in fish and mammals. At baseline, hypothalamic crf 
expression is slightly decreased in disc1Y472X mutants (Eachus et al., 2017). In future experiments, crf 
expression could be measured in disc1 mutant lines before and after osmotic stress. Considering the 
loss of stress-induced cortisol increase (Eachus et al., 2017), the loss of stress-induced anorexia in 
disc1Y472X larvae (Fig. 4.4)  and the loss of innate fear in disc1exon6 adults (Fig. 5.8), we hypothesise that 
similar to otpa-/- mutants, larvae would fail to upregulate crf expression in response to stress.   
OTP, appetite, and neuropsychiatric disorders are tightly linked. In humans, rare LOF mutations in OTP 
are associated with hyperphagic obesity as well as ADHD In mice, missense OtpR108W/+ mutants display 
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increased anxiety in response to a novel environment as well as increases in food intake leading to 
weight gain (Moir et al., 2017). The most reproducible behavioural phenotype, in our study, was the 
decrease in food intake observed in both disc1Y472X and disc1exon6 mutants compared to their respective 
controls (Fig. 4.1). Again, this could relate to altered expression of otpb causing developmental 
mispatterning of key hypothalamic populations involved in appetite. Indeed, the previously 
mentioned mouse study found a striking reduction in Oxt+ neurons in the PVN, thought to be driving 
hyperphagia. The number of Avp+ neurons in the PVN was also reduced in the OtpR108W/+ mutant mice. 
Avp-expressing neurons are structurally and functionally linked to the Oxt system, under the 
transcriptional control of Otp and are involved in neuropsychiatric disorders (Bernstein et al., 2019). 
Our group also performed WISH for avp in the disc1Y472X line; however, there was no significant 
difference at 2-3 dpf (data not shown). 
The strongest cellular phenotype reported in both disc1 mutant lines is the increase of oxt+ cells in PO 
(Fig. 6.4). In addition, baseline activity of these Oxt neurons is significantly decreased in disc1 mutants 
compared to controls (Table 6.1, 6.2). In zebrafish larvae, this neuronal population plays an important 
role in driving the behavioural response to aversive stimuli (electric shock, mustard oil, heat) (Wee et 
al., 2019a). Indeed, aversive stimuli increased brain activity in Oxt clusters in the PO and optogenetic 
activation of Oxt neurons induced large-angle tail bends, similar to the escape response. In humans, 
OXT can increase defensive responses to unpredictable acoustic startle (Striepens et al., 2012). 
disc1Y472X mutants showed no differences in acoustic startle responses during the NTA (Fig. 5.1). 
Conversely, disc1exon6 mutants display significantly increased acoustic startle responses, which were 
more pronounced in maternal zygotics (Fig. 5.2, 5.3). These results can be juxtaposed with sleep 
results, whereby disc1Y472X mutants and disc1exon6 mutants slept significantly less than their respective 
controls (Fig. 4.5, 4.6). One neuropeptide associated with sleep and arousal is hypocretin (Hcrt) and 
hypothalamic Hcrt neurons showed decreased activity in disc1 mutants (Table 8.1). The role of HCRT 
plays in sleep is conserved throughout vertebrates. Overexpression via hcrt:heat-shock (hs:hcrt) 
stimulates locomotor activity during the night and decreases sleep episodes in zebrafish larvae (Prober 
et al., 2006). Tg(hs:hcrt_Dr) show a leftward shift in LLR traces suggesting hypersensitivity to dark-
induced locomotion similar to disc1exon6 mutants (Fig. 5.5). HCRT is also involved in appetite regulation. 
Indeed, a psychopharmacology study found that, of all antipsychotics tested in rats, only those with 
an ability to modulate the activity of hypothalamic hypocretinergic neurons (e.g. clozapine, 
olanzapine, risperidone and chlorpromazine) induced weight gain (Fadel et al., 2002). Therefore, the 
decreased activity of Hcrt clusters 1 and 2 in disc1 mutant larvae could not only play a role in the 
differences reported in sleep and arousal but also have an effect on appetite in disc1 mutants. 
Curiously, the direction of change in activity (i.e. decrease) is again opposite to what we would expect 
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to observe behaviourally. Our aim was to eventually investigate the developmental expression of hcrt, 
and an mRNA probe was designed and synthesised, however, time restrictions did not allow for these 
experiments to be performed. Despite the wealth of data involving DISC1 in sleep regulation (Jaaro-
Peled et al., 2016; Sawamura et al., 2008), not all DISC1 mutations affect sleep. Evidence comes from 
the observation that some inbred mouse strains have a naturally occurring deletion in Disc1 (Clapcote 
and Roder, 2006). When sleep behaviour was assessed in these mice, no sleep phenotype was 
detected (Dittrich et al., 2017).  
 
8.4 Neuronal interplay of identified behaviours  
We have addressed the fact that disruptions in single cell types can have consequences on multiple 
behavioural parameters and that sleep, appetite and stress regulation are all interlinked. If we 
consider this in the inverse direction, there is no single neuronal population that is responsive to 
precise sensory modalities (e.g. light, acoustic, pain). In reality, multiple cell types are recruited and 
fire in a concerted manner to efferent pathways. We postulate that these populations are affected by 
a loss of disc1 and that these in turn, drive alterations in zebrafish behaviours. In a recent extraordinary 
effort to study sensory perception of osmotic stress in the hypothalamus, Lovett-Barron et al. 
(PREPRINT)  reported that stress is encoded in the majority of the preoptic hypothalamic population 
and recruits multiple types of peptidergic cells (oxt, crf, npy, avp). Therefore, we suggest that any 
disruption in the expression of these markers could have downstream effects on the response to 
osmotic stress and most likely other behaviours as well. Interestingly, ablation of pomc+ pituitary cells 
had no effect on the fast response to osmotic stress, indicating that the fast motor response to salt is 
independent of the slow endocrine system. This could explain why, even though we did not find any 
differences in pomc+ at 52 hpf cell numbers (Fig. 6.8), significant differences in stimulus-evoked 
behaviours were reported in disc1exon6 mutants.   
The anatomical diversity of the various cell populations identified in the brain maps is not unexpected 
given the wealth of data supporting the role of DISC1 in various brain areas. Some of these populations 
may be affected due to their afferent connections to the preoptic and tuberal hypothalamus. For 
example, afferents projecting from the pallium, subpallium and efferents projecting to brainstem 
spinal-projecting neurons have been mapped in larval zebrafish. In mammals, the hypothalamus is 
interconnected with itself and mutual communication between PVN, VMH and arcuate nucleus has 




8.5 Early CHIR99021 treatment has later functional and behavioural effects  
In our experimental design, we decided to treat embryos with CHIR99021 between 24 and 52 hpf, 
when primary neurogenesis rates are the highest (Kinch et al., 2015). This is unusual in the field, as 
most groups investigating the use of GSK-3 inhibitors as a therapy for neuropsychiatric disorders, 
administer it acutely or chronically at adult stages. The concept of brain plasticity postulates that 
during the early stages of neurodevelopment, whilst new neurons are being born and migrating, early 
life events can affect neural circuitry formation and consequently behaviour. We found that brief 
embryonic inhibition of GSK-3, had long-term effects in zebrafish larvae, and was able to rescue 
feeding deficits in disc1 mutants and partially ameliorate brain activity (Fig. 7.2, 7.4). Developmental 
antagonism of GSK-3 during a postnatal time window (P7-P28) normalised neural synchrony and 
memory in the Df(16A)+/- mouse model of the schizophrenia-associated microdeletion in 22q11.2 
(Tamura et al., 2016). Twenty-four hpf in zebrafish and P7 in mice are analogous to the second and 
third trimester in human embryonic development, respectively (Hill, 2020; Workman et al., 2013). In 
another rodent model of schizophrenia, treatment with a GSK-3 inhibitor between P21-P28 
(corresponding to adolescence), normalised spine deficits and cognitive symptoms (Xing et al., 2016). 
These findings suggest that developmental antagonism of GSK-3 can have lasting effects on neuronal 
morphology, brain activity and behaviour. Some groups found that drug treatment has beneficial 
effects only if applied early enough. A mouse model of Tuberous Sclerosis Complex (TSC) was used to 
investigate comorbid ASD. Exposure to rapamycin (an mTOR inhibitor) at P7, prevented cerebellar 
deficits and ameliorated defects in social behaviours (Tsai et al., 2012). Remarkably, when Tsc1-/- 
mutant mice were exposed to rapamycin at 10 weeks, this had no therapeutic effect (Tsai et al., 2018). 
Acute CHIR99021 treatment at 7 dpf in zebrafish larvae, equally, had no effect on behaviour (Fig. 7.3). 
These results suggest, that in order to rescue deficits, exposure must be administered during a 
sensitive/ neuroplastic window. Rapamycin treatment also holds potential for disc1 mutant zebrafish, 
as therapeutic benefits have been demonstrated in Disc1 shRNA knockdown mice (Zhou et al., 2013) 
In zebrafish research, many groups focus on studying the detrimental effects of early exposure to 
neurotoxicants. For example, prenatal exposure to low doses of ethanol caused abnormal social 
behaviour in larval and adult zebrafish, relating to abnormal development of the dopaminergic system 
(Fernandes and Gerlai, 2009; Mahabir et al., 2014). Valproate exposure from 0-2 dpf, led to 
hypersensitivity and hyperactivity in response to dark flashes in 6 dpf larvae (Zellner et al., 2011). 
Exposure to bisphenol A (BPA), caused precocious hypothalamic neurogenesis and led to anxiety-like 
hyperactive swimming bursts in zebrafish larvae (Kinch et al., 2015). We hypothesise that CHIR99021 
also alters hypothalamic neurogenesis in disc1 mutants via an increase in Wnt signalling, and that this 
may be driving the alterations in feeding behaviour (Fig. 7.2). Indeed, ample evidence suggests 
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hypothalamic neurogenesis in both the embryonic and mature brain can affect feeding and satiety 
pathways (Baoji and Xiangyang, 2016; Pierce and Xu, 2010; Xu et al., 2005). For example, intracerebral 
infusion of ciliary neurotrophic factor (CNTF), which increases hypothalamic cell proliferation, 
suppressed food intake in adult mice (Kokoeva et al., 2005).  
These findings provide crucial evidence that cellular, functional, and behavioural phenotypes are 
pharmacologically reversible. Pursuing such early (pre/postnatal) treatments in humans poses a 
challenge, as up until now, no prodromal biomarkers can reliably provide early diagnoses of 
neuropsychiatric disorders (Debbané et al., 2015). However, this remains a critical goal in the field and 
would significantly advance the development of preventative therapies. As opposed to 
neurodevelopmental disorders such as ASD, neuropsychiatric disorders are late onset, and thus, the 
time window for potential intervention is much longer.  
 
8.6 Project limitations and future directions 
Linking behavioural changes to molecular and neural circuits alterations is challenging, even in a 
simple model system like the larval zebrafish. One difficulty with these studies is that most cellular/ 
molecular observations relating to the function of disc1 are qualitative, and therefore the exact 
mechanism by which disc1 alters proliferation and cell fate in zebrafish embryos is still unknown. Other 
potential drawbacks are described below.  
8.6.1 Phenotypic variations between disc1Y472X and disc1exon6 mutants 
While some phenotypes (e.g. feeding, optb expression, oxt expression) were consistent between the 
disc1 mutant lines and crosses, others (e.g. sleep, acoustic startle, LLR, brain activity, ff1b expression, 
rx3 expression) showed discrepancies.  As both mutant lines have PTC and significant decreases in 
disc1 expression (Fig. 3.9; Eachus et al., 2017), it is unlikely that differences observed between 
disc1Y472X and disc1exon6 mutants result from differential levels of zDisc1 protein; although, a modest 
expression of truncated zDisc1  in disc1exon6 mutants cannot be excluded. Observed differences could 
arise due to allele functionality differences as PTC in disc1Y472X occurs in exon 2 whereas the stop codon 
in disc1exon6 occurs in exon 6. Importantly, major components of the Disc1 interactome have been 
shown to bind to the C-terminus of Disc1 (Morris et al., 2003). 
A difference in background is also a possible source of discrepancy, as disc1Y472X were raised on wild 
type Tüpfel long fin (TL) and disc1exon6 were raised on wild type AB. Interstrain variability exists for 
locomotor activity, sleep and HPI in zebrafish larvae (de Esch et al., 2012; Liu et al., 2015; van den Bos 
et al., 2017); however, corrections for this should be ensured by comparing mutants to their respective 
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siblings. Another possibility is that differences are due to effects of mutagenesis techniques: ENU 
mutagenesis was used to generate disc1Y472X mutants. Chemical mutagens can induce hundreds of 
mutations in the organism and this high mutational load may affect behaviour. As multiple rounds of 
outcrossing have been performed prior to and during this study, off-target mutations generated by 
ENU mutagenesis in disc1Y472X mutants should have been eliminated. Although unlikely, it could be 
possible that mutants have retained additional closely linked, recessive mutations (near the disc1 
locus). The more precise CRISPR/ Cas9 system was used to generate disc1exon6 mutants. This genome 
editing technique has proven an effective way of eliminating specific gene function with a decreased 
incidence of off-target events, however a lack of phenotype is commonly observed and, in some cases, 
has been linked to genetic compensation (Rossi et al., 2015).  
To resolve genotypic differences, we could incross disc1Y472X/+ heterozygotes to disc1exon6/+ 
heterozygotes to obtain a disc1Y472X/exon6 trans-heterozygotes through heteroallelic combination (Yue 
et al., 1999). We could also generate a second CRISPR/ Cas9 mutant using a single gRNA targeting exon 
2, upstream of the Y472X locus. This would elucidate if differences are a consequence of allelic 
function or due to different genome editing techniques. Of note, another variation we observed in our 
larval behavioural experiments was intrinsic inter-individual variability. This has been reported in 
many larval behavioural studies and can only be overcome by increasing sample sizes and 
experimental repeat numbers to strengthen the power of significance (Hoffman et al., 2016; Thyme 
et al., 2019) 
8.6.2 Limitations of brain activity mapping  
A limitation of using pERK to measure neuronal activity in this study is the fact that the DISC1 scaffold 
protein may function in a pathway directly related to the former protein kinase. In primary neuronal 
culture, DISC1 knockdown by siRNA resulted in ERK inactivation (Hashimoto et al., 2006). In astrocytes, 
DISC1 regulates the ERK signalling pathway by associating with RASSF7 (Wang et al., 2016). In iPSCs 
derived from patients harbouring a 4 bp deletion in DISC1, kinome analysis uncovered dysregulation 
of multiple kinases, including ERK (Bentea et al., 2019). However, until now, no differences in ERK 
signalling have been investigated in disc1 mutant zebrafish. This protein kinase cascade orchestrates 
neuronal proliferation, differentiation, survival and plasticity (Cowan and Storey, 2003). An 
impairment in ERK signalling could underlie structural abnormalities in major depression. Indeed, a 
significant decrease in both tERK and pERK expression was measured in post-mortem brains from 
depressive-suicidal individuals (Dwivedi et al., 2001). To consolidate the brain activity maps, we would 
suggest crossing the disc1 mutants to a line expressing a pan-neuronal GCaMP line to investigate live 
neuronal activity independent of ERK/ pERK expression.  
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A limitation of using the Z-brain atlas for aligning the areas with significant differences in brain activity 
with pre-annotated ROIs is that, because the atlas was constructed based on available transgenic lines, 
the results do not take into account the overlap between the different molecular markers. For 
example, in Tg(otpba:Gal4) larvae, signal is present in oxt, avp, and crf-expressing PO neurons. 
Furthermore, we investigated expression of the identified cell populations at 3 dpf, whereas activity 
differences were detected at 7 dpf. It is more than likely that some neurons identified at 7 dpf do not 
correspond to those expressing the markers at 3 dpf. Therefore, the list of ROIs provides important 
information about the neuroanatomical locations of altered activity, however, it is restrictive in the 
list of markers to be studied. An alternative method could be to combine live calcium imaging with 
fluorescent in situ hybridisation (FISH) at the same stage, a method recently optimised (Lovett-Barron 
et al., 2017). FISH can increase the cellular resolution, detect much lower levels of mRNA expression 
and enable the combination of 3-4 probes in the same experiment. This, coupled with upstream task-
related behaviour, such as neuronal activity in response to prey, acoustic stimuli or osmotic stress 
could enable a more precise mapping of specific cell types (Lovett-Barron et al., PREPRINT). Engaging 
the task-related neural circuits rather than measuring the default network (see section 6.1), would 
perhaps increase homogeneity between the maps of the disc1Y472X and disc1exon6 lines, as well as 
potentially decreasing inter-individual variability.  
 
8.7 Conclusion  
In conclusion, the results in this thesis provide evidence that mutations in the genetic risk factor for 
neuropsychiatric disorders, disc1, confer subtle developmental phenotypes in zebrafish. This gene 
plays a key role in cell fate determination in both the preoptic and tuberal hypothalamus of zebrafish 
embryos and in particular, can disrupt the expression profiles of retinal homeobox 3, steroidogenic 
factor 1, orthopedia b and oxytocin at 2-3 dpf. Whether this imbalance in hypothalamic cell fates is 
driven by proliferative and/ or cell migration defects is yet to be determined. Mutations in disc1 do 
not affect baseline locomotion, however they do affect food consumption and hunting behaviour at 7 
dpf. They also affect responses to changes in illumination and in response to stressful stimuli. Imaging 
of brain activity demonstrates that neural circuits are affected at 7 dpf in disc1 mutants and 
dysregulation is not solely restricted to hypothalamic populations. Depending on the disc1 mutant line 
or even the type of cross, we found inconclusive behavioural results relating to sleep behaviours and 
acoustic startle. The genetic and environmental interplay governing the emergence of different 
human disorders (schizophrenia, bipolar disorder, major depression) in genetically similar carriers in 
the DISC1 Scottish pedigree (Millar et al., 2000) is still poorly understood, however our results suggest 
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a complex relationship between genotype and phenotypes. Finally, GSK-3 inhibition during a critical 
time window in neurodevelopment, can reverse cellular and behavioural phenotypes and significantly 
affect brain activity in the disc1Y472X mutant zebrafish. These results also support the hypothesis of 
altered GSK-3 activity in the pathophysiology of neuropsychiatric disorders. 
This thesis addresses an important research question since psychiatric illnesses are a major economic 
and societal burden. This work contributes to the field of neuropsychiatric research as results show 
that early changes in how the brain is formed and later changes in behaviour are affected by genetic 
factors and can be pharmacologically reversed. Mutations in disc1 cause specific changes in 
neurodevelopment and activity of specific brain regions which in turn, relate to maladaptive animal 
behaviour. These behavioural defects are analogous to those seen in individuals with mental illness.  
Lastly, the robustness of the hypophagic phenotype in both disc1Y472X/Y472X and disc1exon6/exon6 mutants, 
quantifiable through gut fluorescence and reversable after CHIR99021 treatment, offers a unique 
opportunity for drug screening. High throughput screens based on robust behavioural defects offer 
unbiased readouts of drug efficacy in zebrafish and are approximately two orders of magnitude faster 
than drug screens in rodents (Hoffman et al., 2016). Such techniques produce higher success rates in 

































Table 9.1. Statistical analysis of bottom dwell in disc1Y472X adults  
The results of a two-way ANOVA for time and genotype are shown. There is no significant effect of 
genotype and a significant effect of time on time spent in bottom third. There is no significant 
interaction between genotype and time. Pairwise comparison reveals no significant differences 
disc1Y472X/Y472X mutants and disc1+/+ controls in the first 2 min and last 2 min of recording (Time). There 
was also a significant difference in between the first and last 2 min in disc1+/+ controls. There is a 
significant difference in between the first and last 2 min in disc1Y472X/Y472X mutants. P > 0.05 = n.s, P < 




Table 9.2. Statistical analysis of bottom dwell in disc1exon6 adults  
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of 
genotype and time on time on time spent in bottom third. There is no significant interaction between 
genotype and time. Pairwise comparison reveals significant differences between disc1exon6/exon6 mutants 
and disc1+/+ controls in the first 2 min and last 2 min of recording (Time). There was also a significant 
difference in between the first and last 2 min in disc1exon6/exon6 mutants and disc1+/+ controls. P > 0.05 = 





 Table 9.3. Statistical analysis of thigmotaxis in disc1Y472X adults  
The results of a two-way ANOVA for time and genotype are shown. There is no significant effect of 
genotype on time on time spent in periphery of the tank. There is no significant interaction between 
genotype and time. Pairwise comparison reveals no significant differences between disc1Y472X/Y472X 
mutants and disc1+/+ controls in the first 2 min and last 2 min of recording (Time). There was also no 
significant difference in between the first and last 2 min in disc1Y472X/Y472X mutants and disc1+/+ controls. 
P > 0.05 = n.s. See Figure 5.8C for plot. 
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Table 9.4. Statistical analysis of thigmotaxis in disc1exon6 adults  
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of 
genotype on time on time spent in periphery of the tank. There is no significant effect of time on time 
spent in periphery of the tank. There is a significant interaction between genotype and time. Pairwise 
comparison reveals a significant difference between disc1exon6/exon6 mutants and disc1+/+ controls in the 
first 2 min of recording. There is no significant difference between disc1exon6/exon6 mutants and disc1+/+ 
controls in last 2 min of recording (Time). There was a significant difference in between the first and 
last 2 min in disc1+/+ controls and no significant difference between the first and last 2 min in disc1exon6 















Table 9.5. Statistical analysis of darting episodes in disc1Y472X adults  
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of time 
on darting. There is no significant effect of genotype on darting. There is no significant interaction 
between genotype and time. Pairwise comparison reveals no significant differences between 
disc1Y472X/Y472X mutants and disc1+/+ controls in the first and last 2 min of recording (Time). There is a 
significant difference in between the first and last 2 min in disc1+/+ controls and a significant difference 
in between the first and last 2 min in disc1Y472X/Y472X mutants (Genotype). P > 0.05 = n.s, P < 0.0001 = 














Table 9.6. Statistical analysis of darting episodes in disc1exon6 adults 
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of time 
on darting. There is no significant effect of genotype on darting. There is no significant interaction 
between genotype and time. Pairwise comparison reveals no significant differences between disc1+/+ 
controls and disc1exon6/exon6 mutants in the first and last 2 min of recording (Time). There is a significant 
difference in between the first and last 2 min in disc1+/+ controls and a significant difference in between 
the first and last 2 min in disc1exon6/exon6 mutants (Genotype). P > 0.05 = n.s, P < 0.0001 = ****. See Figure 














Table 9.7. Statistical analysis of freezing episodes in disc1Y472X adults 
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of time 
on freezing. There is no significant effect of genotype on freezing. There is no significant interaction 
between genotype and time. Pairwise comparison reveals no significant differences between 
disc1Y472X/Y472X mutants and disc1+/+ controls in the first and last 2 min of recording (Time). There is no 
significant difference in between the first and last 2 min in disc1+/+ controls and a significant difference 
in between the first and last 2 min in disc1Y472X/Y472X mutants (Genotype). P > 0.05 = n.s, P < 0.0001 = 






























Table 9.8. Statistical analysis of freezing episodes in disc1exon6 adults 
The results of a two-way ANOVA for time and genotype are shown. There is a significant effect of time 
and genotype on freezing. There is no significant interaction between genotype and time. Pairwise 
comparison reveals a significant difference between disc1exon6/exon6 mutants and disc1+/+ controls in the 
first 2 min of recording. There is no significant difference between disc1exon6/exon6 mutants and disc1+/+ 
controls in last 2 min of recording (Time). There is a significant difference in between the first and last 
2 min in disc1+/+ controls and no significant difference in between the first and last 2 min in 
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